CN114126665A - 眼底黄色斑点症(abca4)的基因疗法 - Google Patents

眼底黄色斑点症(abca4)的基因疗法 Download PDF

Info

Publication number
CN114126665A
CN114126665A CN202080044221.2A CN202080044221A CN114126665A CN 114126665 A CN114126665 A CN 114126665A CN 202080044221 A CN202080044221 A CN 202080044221A CN 114126665 A CN114126665 A CN 114126665A
Authority
CN
China
Prior art keywords
leu
ser
gly
ile
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080044221.2A
Other languages
English (en)
Inventor
H·康纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Massachusetts UMass
Original Assignee
University of Massachusetts UMass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Massachusetts UMass filed Critical University of Massachusetts UMass
Publication of CN114126665A publication Critical patent/CN114126665A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本公开的方面涉及可用于向受试者递送小基因的组合物和方法。因此,本公开部分地基于分离的核酸和基因治疗载体,如病毒(例如,rAAV)载体,其包含编码治疗性基因产物(如蛋白或肽(例如,小基因))的一个或多个基因片段。在一些实施方案中,本公开涉及编码ABCA4蛋白(例如,ABCA4基因的基因产物)或其部分的基因治疗载体。在一些实施方案中,本公开描述的组合物可用于治疗与ABCA4基因突变相关的疾病,例如眼底黄色斑点症。

Description

眼底黄色斑点症(ABCA4)的基因疗法
相关申请
本申请根据35 U.S.C.§119(e)要求在2019年4月19日提交的标题为“GENETHERAPIES FOR STARGARDT DISEASE(ABCA4)(眼底黄色斑点症(ABCA4)的基因疗法)”的美国临时申请序列号62/836,493的申请日的权益,该申请的全部内容通过引用并入本文。
背景技术
眼底黄色斑点症(Stargardt disease)是最常见的常染色体隐性黄斑变性类型。这种疾病是由ABCA4基因突变引起的。人ABCA4基因的长度为~7kb,超过了包装到常规腺相关病毒(AAV)载体中进行基因递送的限值。
发明概述
本公开的方面涉及用于向受试者递送小基因(minigene)的组合物和方法。因此,本公开部分地基于分离的核酸和基因治疗载体,如病毒(例如,rAAV)载体,其包含编码治疗性基因产物(例如蛋白或肽)的一个或多个基因片段(例如,小基因)。在一些实施方案中,本公开涉及编码ABCA4蛋白(例如,ABCA4的基因产物)或其部分的基因治疗载体。在一些实施方案中,本公开描述的组合物用于治疗与ABCA4基因突变相关的疾病,例如眼底黄色斑点症。
因此,在一些方面,本公开提供了一种分离的核酸,其包含编码ABCA4小基因的转基因,所述ABCA4小基因具有SEQ ID NO:3-8和15-19任一个所示的序列。
在一些方面,本公开提供了一种分离的核酸,其包含具有编码ABCA4蛋白的核酸序列的转基因,其中所述ABCA4蛋白包含SEQ ID NO:9-14和20-24任一个所示的氨基酸序列。
在一些实施方案中,转基因进一步包含与ABCA4小基因编码序列有效连接的启动子。在一些实施方案中,启动子是组成型启动子、诱导型启动子或组织特异性启动子。在一些实施方案中,启动子包括鸡β-肌动蛋白(CBA)启动子。在一些实施方案中,组织特异性启动子是光感受器特异性启动子。在一些实施方案中,光感受器特异性启动子包括视紫红质激酶启动子,如人GRK启动子。
在一些实施方案中,转基因的侧翼是腺相关病毒(AAV)反向末端重复序列(ITR)。在一些实施方案中,转基因侧翼的至少一个ITR是AAV2 ITR。在一些实施方案中,转基因侧翼的至少一个ITR缺少末端解离位点,例如ΔITR。
在一些方面,本公开提供了一种包含如本文所述的分离的核酸的载体。在一些实施方案中,载体是质粒DNA、或封闭端DNA(closed-ended DNA)、或脂质/DNA纳米颗粒、或病毒载体。在一些实施方案中,病毒载体是腺相关病毒(AAV)载体、腺病毒(Ad)载体、慢病毒载体、逆转录病毒载体或杆状病毒载体。
在一些方面,本公开提供了包含如本文所述的分离的核酸或载体的宿主细胞。在一些实施方案中,细胞是哺乳动物(人)细胞、细菌细胞、酵母细胞或昆虫细胞。
在一些方面,本公开提供了一种重组腺相关病毒(rAAV),其包含:如本文所述的分离的核酸;和AAV衣壳蛋白。
在一些实施方案中,衣壳蛋白对眼细胞具有向性。在一些实施方案中,衣壳蛋白是AAV8衣壳蛋白。
在一些实施方案中,rAAV被配制用于递送至眼睛。在一些实施方案中,rAAV被配制用于递送至感光细胞或视网膜色素上皮(RPE)。
在一些方面,本公开提供了一种组合物,其包含如本文所述的分离的核酸或rAAV和药学上可接受的赋形剂。
在一些方面,本公开提供了一种将转基因递送至细胞的方法,该方法包括将本文所述的分离的核酸或rAAV施用于细胞。
在一些实施方案中,细胞在受试者中。在一些实施方案中,受试者是哺乳动物受试者,如人类受试者。在一些实施方案中,细胞是眼细胞。在一些实施方案中,眼细胞是感光细胞或视网膜色素上皮(retinal pigmented epithelium,RPE)。
在一些方面,本公开提供了一种治疗有需要的受试者的眼底黄色斑点症的方法,该方法包括向受试者施用如本文所述的分离的核酸或rAAV。
在一些实施方案中,受试者是哺乳动物。在一些实施方案中,受试者是人。
在一些实施方案中,受试者的特征在于在ABCA4基因中具有一个或多个突变。在一些实施方案中,受试者具有一个或多个突变,其导致选自对应于野生型ABCA4蛋白(例如,SEQ ID NO:2中所示的氨基酸序列)的G1961E和D2177N的氨基酸取代。
在一些实施方案中,施用是通过注射进行的。在一些实施方案中,注射是视网膜下注射或玻璃体内注射或脉络膜上注射。
在一些实施方案中,施用是对受试者眼睛的外用给药。
附图简要说明
图1是MiniABCA4构建体的几个实施方案的示意图。显示了具有对应于SEQ ID NO:9-14的氨基酸序列的MG-1、MG-2、MG-3、MG-4、MG-5和MG-6。
图2是通过荧光显微术检查显示野生型ABCA4敲除小鼠(Abca KO)和用miniABCA4-1注射的ABCA4敲除小鼠(其对应于图1描述的MG-4构建体)。ZO-1用作细胞标志物。
图3是显示定量不同年龄的未注射和注射的ABCA4敲除小鼠的RPE自身荧光分析的图。箭头指向显著改善自身荧光的ABCA4小基因版本。在P10天或P30天进行注射。分析是在对每个小基因指示的年龄进行的。与P10注射相比,P30注射显示出高度显著的改善。在该图中,AB-1对应MG-1,AB-2对应于MG-2,AB-5对应于MG-5。
图4是MiniABCA4构建体的几个实施方案的示意图。显示了具有对应于SEQ ID NO:20-24的氨基酸序列的MG-7、MG-8、MG-9、MG-10和MG-11。
图5是显示图4所示MiniABCA4在HEK细胞中的表达的免疫印迹。箭头表示预期的波段。Lipo显示仅用媒介物转染的细胞。
发明详述
在一些方面,本公开涉及可用于治疗某些遗传疾病例如眼底黄色斑点症的组合物和方法。本公开部分地基于分离的核酸和基因治疗载体,如病毒(例如,rAAV)载体,其包含编码治疗性基因产物(如MiniABCA4蛋白(例如,ABCA4小基因的基因产物))的一个或多个基因片段。
“核酸”序列是指DNA或RNA序列。在一些实施方案中,本公开的蛋白和核酸是分离的。如本文所用,术语“分离的”是指人工生产的。如本文关于核酸所用的,术语“分离的”是指:(i)通过例如聚合酶链反应(PCR)体外扩增的;(ii)通过克隆重组生产的;(iii)如通过裂解和凝胶分离纯化的;或(iv)通过例如化学合成合成的。分离的核酸是一种易于通过本领域众所周知的重组DNA技术操作的核酸。因此,包含在载体中的核苷酸序列,其中5'和3'限制性位点是已知的,或者其聚合酶链反应(PCR)引物序列已被公开,则被认为是分离的,但以其天然状态存在于其天然宿主中的核酸序列则不是。分离的核酸可以是基本上纯化的,但不是必须的。例如,在克隆或表达载体内分离的核酸是不纯的,因为它可能仅占其所在细胞中材料的很小百分比。然而,这样的核酸是分离的,正如该术语在本文中所用的那样,因为它易于通过本领域普通技术人员已知的标准技术进行操作。如本文关于蛋白或肽所用,术语“分离的”是指已从其天然环境中分离或人工生产(例如,通过化学合成、通过重组DNA技术等)的蛋白或肽。在一些实施方案中,分离的核酸编码ABCA4蛋白,例如MiniABCA4蛋白(例如,从ABCA4基因或其部分如ABCA4小基因表达的基因产物)。
在人类中,ABCA4基因(也被称为STGD)编码ATP结合盒亚家族A(ABC1)成员4蛋白,其被定位于视杆和视锥的外节盘边缘(outer segment disk edge)并且可以作为向内定向(inward-directed)的翻转酶起作用。已经观察到ABCA4基因的突变会导致眼底黄色斑点症,其是一种黄斑变性形式。在一些实施方案中,ABCA4基因包含在NCBI参考序列登录号NM_000350.3中所示的核酸序列(SEQ ID NO:1)。在一些实施方案中,ABCA4基因编码具有在NCBI参考序列登录号NP_000341.2中所示的氨基酸序列(SEQ ID NO:2)的蛋白。
如本文所用,“小基因(minigene)”是指编码重组肽或蛋白的分离的核酸序列,其中编码天然存在的肽或蛋白的相应基因的一个或多个非必需元件已被去除并且其中由小基因编码的肽或蛋白保留相应的天然存在的肽或蛋白的功能。“治疗性小基因”是指编码可用于治疗遗传疾病的肽或蛋白的小基因,例如抗肌萎缩蛋白、dysferlin、因子VIII、淀粉样前体蛋白(APP)、酪氨酸酶(Tyr)等。小基因是本领域已知的并且例如由以下文献描述:Karpati和Acsadi(1994)Clin Invest Med 17(5):499-509;Plantier et al.(2001)Thromb Haemost.86(2):596-603;和Xiao et al.(2007)World J.Gastroenterol.13(2):244-9。在一些实施方案中,小基因不包含相应的天然存在的肽或蛋白的序列。
在一些方面,本公开涉及编码ABCA4小基因的分离的核酸。通常,编码小基因(例如,治疗性小基因,如ABCA4小基因)的分离的核酸相对于编码相应的天然存在的野生型蛋白的核酸序列(例如,SEQ ID NO:1)截短约10%至约99%(例如,约10%、约15%、约20%、约25%、约30%、约40%、约50%、约60%、约70%、约75%、约80%、约90%、约99%等)。截短可以是连续的(例如,氨基酸残基的单个、连续的截短)或不连续的(例如,氨基酸的两个或更多个截短,例如被一个或多个肽分隔的两个或更多个结构域的截短)。例如,在一些实施方案中,与野生型ABCA4基因(例如,SEQ ID NO:1)相比,编码Mini ABCA4蛋白的小基因被截短了约61%至(例如,包含约50%的所述核酸序列)。在一些实施方案中,ABCA4小基因包含SEQID NO:3-8和15-19任一个所示的核酸序列(或由其组成)。在一些实施方案中,ABCA4小基因编码包含SEQ ID NO:9-14和20-24任一个所示的氨基酸序列(或由其组成)的蛋白(称为MiniABCA4蛋白)。在一些实施方案中,编码ABCA4蛋白(例如,MiniABCA4蛋白)的核酸在编码MiniABCA4蛋白的核酸序列之前包含起始密码子(例如,核酸序列ATG)。在一些实施方案中,编码MiniABCA4蛋白的核酸序列是密码子优化的。
编码ABCA4蛋白的分离的核酸序列可以与启动子有效连接。“启动子”是指被细胞的合成机制(synthetic machinery)或引入的合成机制识别的、启动基因的特异性转录所需的DNA序列。短语“有效定位”、“控制之下”或“转录控制之下”是指启动子相对于核酸处于正确的位置和方向,以控制RNA聚合酶的起始和基因的表达。启动子可以是组成型启动子、诱导型启动子或组织特异性启动子。
组成型启动子的实例包括但不限于逆转录劳斯肉瘤病毒(RSV)LTR启动子(任选地带有RSV增强子)、巨细胞病毒(CMV)启动子(任选地带有CMV增强子)[参见例如Boshart etal.,Cell,41:521-530(1985)]、SV40启动子、二氢叶酸还原酶启动子、β-肌动蛋白启动子、磷酸甘油激酶(PGK)启动子和EF1α启动子[Invitrogen]。在一些实施方案中,启动子是鸡β-肌动蛋白(CBA)启动子。在一些实施方案中,启动子是增强的鸡β-肌动蛋白启动子。在一些实施方案中,启动子是U6启动子。在一些实施方案中,启动子是鸡β-肌动蛋白(CBA)启动子。
诱导型启动子允许调控基因表达并且可以通过外源提供的化合物、环境因素例如温度或存在特定生理状态例如,急性期、细胞的特定分化状态或仅在复制细胞中来调控。诱导型启动子和诱导型系统可从多种商业来源获得,包括但不限于Invitrogen、Clontech和Ariad。已经描述了许多其他系统并且本领域技术人员可以容易地选择这些系统。由外源提供的启动子调控的诱导型启动子的实例包括锌诱导型绵羊金属硫蛋白(metallothionine,MT)启动子、地塞米松(Dex)诱导型小鼠乳腺肿瘤病毒(MMTV)启动子、T7聚合酶启动子系统(WO 98/10088);蜕皮素昆虫启动子(No et al.,Proc.Natl.Acad.Sci.USA,93:3346-3351(1996))、四环素抑制型系统(Gossen et al.,Proc.Natl.Acad.Sci.USA,89∶5547-5551(1992))、四环素诱导型系统(Gossen et al.,Science,268∶1766-1769(1995),还参见Harvey et al.,Curr.Opin.Chem.Biol.,2∶512-518(1998))、RU486诱导型系统(Wang etal.,Nat.Biotech.,15:239-243(1997)和Wang et al.,Gene Ther.,4:432-441(1997))和雷帕霉素诱导型系统(Magari et al.,J.Clin.Invest.,100:2865-2872(1997))。在这种情况下可能有用的其他类型的诱导型启动子是那些受特定生理状态例如温度、急性期、细胞的特定分化状态,或仅在复制细胞中调控的启动子。
在一些实施方案中,调控序列赋予组织特异性基因表达能力。在一些情况下,组织特异性调控序列结合以组织特异性方式诱导转录的组织特异性转录因子。此类组织特异性调控序列(例如,启动子、增强子等)是本领域众所周知的。在一些实施方案中,组织特异性启动子是眼特异性启动子。眼特异性启动子的实例包括但不限于视网膜劈裂蛋白启动子、K12启动子、视紫红质启动子、视杆细胞特异性启动子、视锥细胞特异性启动子、视紫红质激酶启动子、GRK1启动子、光感受器间类视黄醇结合蛋白近端(IRBP)启动子和视蛋白启动子(例如,红色视蛋白启动子、蓝色视蛋白启动子等)。
在一些实施方案中,启动子是RNA聚合酶III(pol III)启动子。pol III启动子的非限制性实例包括U6和H1启动子序列。在一些实施方案中,启动子是RNA聚合酶II(pol II)启动子。pol II启动子的非限制性实例包括T7、T3、SP6、RSV和巨细胞病毒启动子序列。
本公开的多个方面涉及包含如本文所述的分离的核酸的基因治疗载体。基因治疗载体可以是病毒载体(例如,慢病毒载体、腺相关病毒载体、腺病毒(Ad)载体等)、质粒、封闭端DNA (例如,ceDNA)、脂质/DNA纳米颗粒等。在一些实施方案中,基因治疗载体是病毒载体。在一些实施方案中,编码小基因的表达盒的侧翼是一个或多个病毒复制序列,例如慢病毒长末端重复序列(LTR)或腺相关病毒(AAV)反向末端重复序列(ITR)。在一些实施方案中,病毒载体是杆状病毒载体。
本文所述的分离的核酸还可以包含期望位于启动子/增强子序列和转基因之间的内含子。在一些实施方案中,内含子是合成的或人工的(例如异源的)内含子。合成的内含子的实例包括源自SV-40的内含子序列(称为SV-40T内含子序列)和源自鸡β-肌动蛋白基因的内含子序列。在一些实施方案中,本公开描述的转基因包含一个或多个(1、2、3、4、5个或更多个)人工的内含子。在一些实施方案中,一个或多个人工内含子位于启动子和编码转基因的核酸序列之间。
在一些实施方案中,rAAV包含转录后反应元件。如本文所用,术语“转录后反应元件”是指在转录时采用增强基因表达的三级结构的核酸序列。转录后调控元件的实例包括但不限于土拨鼠肝炎病毒转录后调控元件(WPRE)、小鼠RNA转运元件(RTE)、猴1型逆转录病毒(SRV-1)的组成型转运元件(CTE)、来自摩-傅猴病毒(Mason-Pfizer monkey virus,MPMV)的CTE,以及人类热休克蛋白70的5'非翻译区(Hsp70 5′UTR)。在一些实施方案中,rAAV载体包含土拨鼠肝炎病毒转录后调控元件(WPRE)。
在一些实施方案中,载体还包含常规控制元件,其以允许转基因元件在被载体转染或被通过本发明产生的病毒感染的细胞中转录、翻译和/或表达的方式与转基因元件有效连接。如本文所用,“有效连接的”序列包括与目标基因相邻的表达控制序列和以反式或相距一定距离的方式作用以控制目标基因的表达控制序列。表达控制序列包括适当的转录起始、终止、启动子和增强子序列;有效的RNA加工信号,如剪接和聚腺苷酸化(polyA)信号;稳定细胞质mRNA的序列;提高翻译效率的序列(例如,Kozak共有序列);增强蛋白稳定性的序列;以及在需要时,增强编码产物分泌的序列。许多表达控制序列,包括天然的、组成型的、诱导型的和/或组织特异性的启动子,是本领域已知的并且可以利用。
聚腺苷酸化序列通常插入在转基因序列之后以及任选地在3'AAV ITR序列之前。可用于本公开的rAAV构建体还可以含有期望位于启动子/增强子序列和转基因之间的内含子。一种可能的内含子序列源自SV-40,称为SV-40T内含子序列。另一个可以使用的载体元件是内部核糖体进入位点(IRES)。IRES序列用于从单个基因转录物产生多于一种的多肽。IRES序列将用于产生含有多于一条多肽链的蛋白。这些和其他常见载体元件的选择是常规的,并且许多这样的序列是可用的[参见,例如,Sambrook et al.,以及其中在例如第3.183.26和16.17 16.27页中引用的参考文献,和Ausubel et al.,Current Protocols inMolecular Biology,John Wiley&Sons,New York,1989]。
本公开的分离的核酸可以是重组腺相关病毒(AAV)载体(rAAV载体)。在一些实施方案中,如本公开所述的分离的核酸包含含有第一腺相关病毒(AAV)反向末端重复序列(ITR)或其变体的区域(例如,第一区域)。分离的核酸(例如,重组AAV载体)可以包装到衣壳蛋白内并施用于受试者和/或递送至选定的靶细胞。“重组AAV(rAAV)载体”通常至少由转基因及其调控序列以及5'和3'AAV反向末端重复序列(ITR)组成。转基因可以包含编码一种或多种蛋白(例如人ABCA4或其片段)的一个或多个区域。转基因还可以包含编码例如miRNA结合位点和/或表达控制序列(例如poly-A尾)的区域。
通常,ITR序列的长度约为145bp。优选地,在分子中使用编码ITR的基本上完整的序列,尽管允许对这些序列进行一定程度的微小修饰。修饰这些ITR序列的能力在本领域技术范围内。(参见,例如,诸如Sambrook et al.,"Molecular Cloning.A LaboratoryManual",2d ed.,Cold Spring Harbor Laboratory,New York(1989);和K.Fisher etal.,J Virol.,70:520 532(1996)等教科书)。本发明中使用的这种分子的一个实例是含有转基因的“顺式作用”质粒,其中选定的转基因序列和相关调控元件的侧翼是5'和3'AAVITR序列。AAV ITR序列可以从任何已知的AAV获得,包括目前鉴定的哺乳动物AAV类型。在一些实施方案中,分离的核酸(例如,rAAV载体)包含至少一种具有选自AAV1、AAV2、AAV5、AAV6、AAV6.2、AAV7、AAV8、AAV9、AAV10、AAV11及其变体的血清型的ITR。在一些实施方案中,分离的核酸包含编码AAV2 ITR的区域(例如,第一区域)。
在一些实施方案中,分离的核酸还包含含有第二AAV ITR的区域(例如,第二区域、第三区域、第四区域等)。在一些实施方案中,第二AAV ITR具有选自AAV1、AAV2、AAV5、AAV6、AAV6.2、AAV7、AAV8、AAV9、AAV10、AAV11及其变体的血清型。在一些实施方案中,第二AAVITR是AAV2 ITR。在一些实施方案中,第二ITR是缺乏功能性末端解离位点(TRS)的突变ITR。术语“缺乏末端解离位点”可以指包含废除ITR的末端解离位点(TRS)的功能的突变(例如,有义突变,如非同义突变或错义突变)的AAV ITR,或缺乏编码功能性TRS的核酸序列的截短的AAV ITR(例如ΔTRS ITR或ΔITR)。不希望受任何特定理论的束缚,包含缺乏功能性TRS的ITR的rAAV载体产生自我互补的rAAV载体,例如如McCarthy(2008)Molecular Therapy16(10):1648-1656所述。
重组腺相关病毒(rAAV)
在一些方面,本公开提供分离的腺相关病毒(AAV)。如本文关于AAV所用,术语“分离的”是指人工生产或获得的AAV。可以使用重组方法生产分离的AAV。这样的AAV在本文中被称为“重组AAV”。重组AAV(rAAV)优选具有组织特异性靶向能力,使得rAAV的核酸酶和/或转基因将被特异性地递送至一个或多个预定组织。AAV衣壳是决定这些组织特异性靶向能力的重要因素。因此,可选择具有适合被靶向的组织的衣壳的rAAV。
获得具有所需衣壳蛋白的重组AAV的方法是本领域公知的。(参见,例如,US 2003/0138772),其内容通过引用以其整体并入本文)。通常,这些方法包括培养含有编码AAV衣壳蛋白的核酸序列;功能性rep基因;包含AAV反向末端重复序列(ITR)和转基因的重组AAV载体;和足以允许将重组AAV载体包装到AAV衣壳蛋白中的辅助功能的宿主细胞。在一些实施方案中,衣壳蛋白是由AAV的cap基因编码的结构蛋白。AAV包含三种衣壳蛋白:病毒粒子蛋白1至3(命名为VP1、VP2和VP3),所有这些蛋白都是经由选择性剪接从单个cap基因转录而来的。在一些实施方案中,VP1、VP2和VP3的分子量分别为约87kDa、约72kDa和约62kDa。在一些实施方案中,在翻译时,衣壳蛋白围绕病毒基因组形成球形的60聚体蛋白壳。在一些实施方案中,衣壳蛋白的功能是保护病毒基因组、递送基因组并与宿主相互作用。在一些方面,衣壳蛋白以组织特异性方式将病毒基因组递送至宿主。
在一些实施方案中,AAV衣壳蛋白具有选自由AAV2、AAV3、AAV4、AAV5、AAV6、AAV8、AAVrh8、AAV9和AAV10组成的组的AAV血清型。在一些实施方案中,AAV衣壳蛋白具有源自非人灵长类动物的血清型,例如AAVrh8血清型。在一些实施方案中,AAV衣壳蛋白具有对受试者眼睛具有向性的血清型,例如比其他AAV衣壳蛋白更有效地转导受试者的眼细胞的AAV(例如,AAV5、AAV6、AAV6.2、AAV7、AAV8、AAV9、AAVrh.8、AAVrh.10、AAVrh.39和AAVrh.43)。在一些实施方案中,AAV衣壳蛋白具有AAV8血清型。
在宿主细胞中培养以将rAAV载体包装在AAV衣壳中的组分可以反式提供给宿主细胞。或者,任何一种或多种所需组分(例如,重组AAV载体、rep序列、cap序列和/或辅助功能)可以由稳定的宿主细胞提供,使用本领域技术人员已知的方法已将该宿主细胞工程化为含有一种或多种所需组分。最合适地,这样的稳定的宿主细胞将含有处于诱导型启动子控制之下的所需组分。然而,所需组分可以处于组成型启动子控制之下。在讨论适合与转基因一起使用的调控元件时,本文提供了合适的诱导型和组成型启动子的实例。在另一个替代方案中,选定的稳定的宿主细胞可以含有处于组成型启动子控制之下的选定组分和处于一个或多个诱导型启动子控制之下的其他选定组分。例如,可以产生稳定的宿主细胞,其源自293细胞(其含有处于组成型启动子控制之下的E1辅助功能)但含有处于诱导型启动子控制之下的rep和/或cap蛋白。本领域技术人员可以产生其他稳定的宿主细胞。
在一些实施方案中,本公开涉及含有核酸的宿主细胞,所述核酸包含编码蛋白(例如,MiniABCA4蛋白)的编码序列。在一些实施方案中,宿主细胞是哺乳动物细胞(例如,HEK293细胞)或昆虫细胞(例如,SF9细胞)。在一些实施方案中,本公开涉及包含上述宿主细胞的组合物。在一些实施方案中,包含上述宿主细胞的组合物还包含冷冻保存剂。
可以使用任何合适的遗传元件(载体)将生产本公开的rAAV所需的重组AAV载体、rep序列、cap序列和辅助功能递送至包装宿主细胞。选定的遗传元件可以通过任何合适的方法递送,包括本文所述的那些。用于构建本公开的任何实施方案的方法是核酸操作技术人员已知的,并且包括基因工程、重组工程和合成技术。参见,例如,Sambrook et al.,Molecular Cloning:A Laboratory Manual,Cold Spring Harbor Press,Cold SpringHarbor,N.Y。类似地,产生rAAV病毒粒子的方法是众所周知的,并且合适方法的选择不是对本公开的限制。参见,例如,K.Fisher et al.,J.Virol.,70:520-532(1993)和美国专利号5,478,745。
在一些实施方案中,可以使用三重转染方法(在美国专利号6,001,650中详细描述)生产重组AAV。通常,通过用待包装到AAV颗粒中的重组AAV载体(包含转基因)、AAV辅助功能载体和附属功能载体转染宿主细胞来生产重组AAV。AAV辅助功能载体编码“AAV辅助功能”序列(即,rep和cap),其以反式起作用,用于生产性AAV复制和衣壳化。优选地,AAV辅助功能载体支持有效的AAV载体生产而不产生任何可检测的野生型AAV病毒粒子(即,含有功能性rep和cap基因的AAV病毒粒子)。适合与本公开一起使用的载体的非限制性实例包括美国专利号6,001,650中描述的pHLP19和美国专利号6,156,303中描述的pRep6cap6载体,这两个专利的全部内容通过引用整体并入本文。附属功能载体编码具有非AAV衍生的病毒和/或细胞功能的核苷酸序列,AAV依赖于这些功能进行复制(即“附属功能”)。附属功能包括AAV复制所需的那些功能,包括但不限于参与激活AAV基因转录、阶段特异性AAV mRNA剪接、AAV DNA复制、cap表达产物合成和AAV衣壳组装的那些部分。基于病毒的附属功能可以源自任何已知的辅助病毒,例如腺病毒、疱疹病毒(单纯疱疹病毒1型除外)和牛痘病毒。
在一些方面,本公开提供转染的宿主细胞。术语“转染”用于指细胞摄取外源DNA,当外源DNA被引入细胞膜内时,细胞已被“转染”。许多转染技术是本领域公知的。参见,例如,Graham et al.(1973)Virology,52:456,Sambrook et al.(1989)Molecular Cloning,a laboratory manual,Cold Spring Harbor Laboratories,New York,Davis et al.(1986)Basic Methods in Molecular Biology,Elsevier,和Chu et al.(1981)Gene 13:197。此类技术可用于将一种或多种外源核酸,例如核苷酸整合载体和其他核酸分子引入合适的宿主细胞中。
“宿主细胞”是指包含或能够包含目标物质的任何细胞。通常,宿主细胞是哺乳动物细胞。宿主细胞可以用作AAV辅助构建体、AAV小基因质粒、附属功能载体或与重组AAV生产相关的其他转移DNA的受体。该术语包括已被转染的原始细胞的后代。因此,本文所用的“宿主细胞”可以指已经用外源DNA序列转染的细胞。应当理解,由于自然、偶然或有意的突变,单个亲本细胞的后代在形态学或基因组或总DNA补体方面可能不一定与原始亲本完全相同。
如本文所用,术语“细胞系”是指能够在体外连续或延长生长和分裂的细胞群体。通常,细胞系是源自单个祖细胞的克隆群体。本领域还已知,在此类克隆群体的储存或转移期间,核型可发生自发或诱导的变化。因此,源自所提及细胞系的细胞可能与祖先细胞或培养物不完全相同,所提及细胞系包括此类变体。
如本文所用,术语“重组细胞”是指其中已引入了外源DNA片段(例如导致生物活性多肽转录或生物活性核酸(例如RNA)生产的DNA片段)的细胞。
如本文所用,术语“载体”包括任何遗传元件,例如质粒、噬菌体、转座子、粘粒、染色体、人工染色体、病毒、病毒粒子等,其在与适当的控制元件结合时能够复制并且其可以在细胞之间转移基因序列。因此,该术语包括克隆和表达载体,以及病毒载体。
方法
本文提供了将转基因递送至受试者的眼(例如,光感受器,例如视杆细胞或视锥细胞、视网膜细胞等)组织或耳朵的方法。该方法通常包括向受试者施用有效量的包含用于在受试者中表达转基因(例如,MiniABCA4蛋白)的核酸的rAAV。rAAV的“有效量”是足以感染受试者靶组织的足够数量细胞的量。在一些实施方案中,靶组织是眼(例如,光感受器、视网膜等)组织。在一些实施方案中,将转基因递送至感光细胞或视网膜色素上皮(RPE)。
rAAV的有效量可以是足以在受试者中具有治疗益处的量,例如改善受试者的疾病的一种或多种症状,例如眼底黄色斑点症(例如,与ABCA4基因的缺失或突变相关的疾病)的症状。ABCA4基因中的突变的实例包括导致ABCA4蛋白中的氨基酸取代G1961E和D2177N的突变。有效量将取决于多种因素,例如受试者的物种、年龄、体重、健康状况和要靶向的眼组织,并因此可能因受试者和组织而异。有效量还可以取决于所使用的rAAV。
在某些实施方案中,rAAV的有效量为1010、1011、1012、1013或1014个基因组拷贝/kg。在某些实施方案中,rAAV的有效量为每个受试者1010、1011、1012、1013、1014或1015个基因组拷贝。
本公开的多个方面涉及治疗有需要的受试者的眼底黄色斑点症的方法。在一些实施方案中,受试者是哺乳动物,例如人、小鼠、大鼠、狗、猫、非人灵长类动物等。在一些实施方案中,受试者是人。
如本文所用,术语“治疗”是指向表现出眼底黄色斑点症的一种或多种体征或症状(例如,视力模糊或斜视、低光下不能视物、色觉丧失、ABCA4基因中的一个或多个突变等)的受试者应用或施用组合物(例如,如本文所述的分离的核酸或rAAV),目的是治愈、愈合、减轻、缓解、改变、拯救、改善、好转或影响病症、疾病的症状或对眼底黄色斑点症的预先倾向性。
减轻眼底黄色斑点症包括延迟疾病的发展或进展,或降低疾病的严重程度。减轻疾病并不一定需要治愈性结果。如本文所用,“延迟”眼底黄色斑点症的发展是指推迟、阻碍、减缓、减慢、稳定和/或延缓疾病的进展。这种延迟可以具有不同的时间长度,取决于疾病史和/或被治疗的个体。“延迟”或减轻疾病的发展或延迟疾病的发作的方法是与不使用该方法相比时,在给定的时间范围内降低出现疾病的一种或多种症状的可能性和/或在给定的时间范围内降低症状的程度的方法。此类比较通常基于临床研究,使用的受试者数量足以得出具有统计学意义的结果。
疾病的“发展”或“进展”是指疾病的初始表现和/或随后的进展。可以使用本领域众所周知的标准临床技术检测和评估疾病的发展。然而,发展也指可能无法检测的进展。出于本公开的目的,发展或进展是指症状的生物学过程。“发展”包括发生、复发和发作。
有效量还可以取决于施用方式。例如,在某些情况下,通过基质内施用或皮下注射靶向眼(例如光感受器、视网膜等)组织可能需要与通过另一种方法(例如,全身施用、局部施用)靶向眼(例如光感受器、视网膜等)组织不同(例如,更高或更低)的剂量。在一些实施方案中,基质内注射(IS)具有某些血清型(例如,AAV5、AAV6、AAV6.2、AAV7、AAV8、AAV9、AAVrh.8、AAVrh.10、AAVrh.39和AAVrh.43)的rAAV介导眼(例如,角膜、光感受器、视网膜等)细胞的有效转导。因此,在一些实施方案中,注射是基质内注射(IS)。在一些实施方案中,施用是通过注射,任选地视网膜下注射或玻璃体内注射。在一些实施方案中,注射是局部施用(例如,局部施用于眼睛)。在一些情况下,施用多个剂量的rAAV。
可以根据本领域已知的任何适当的方法将rAAV以组合物形式递送给受试者。rAAV,优选悬浮在生理学上相容的运载体中(即,在组合物中)的,可以施用于受试者,即宿主动物,例如人、小鼠、大鼠、猫、狗、绵羊、兔、马、牛、山羊、猪、豚鼠、仓鼠、鸡、火鸡或非人灵长类动物(例如猕猴)。在一些实施方案中,宿主动物不包括人。
将rAAV递送至哺乳动物受试者可以通过例如眼内注射或局部施用(例如滴眼液)。在一些实施方案中,眼内注射包括基质内注射、结膜下注射或玻璃体内注射。在一些实施方案中,注射不是局部施用。也可使用施用方法的组合(例如,局部施用和基质内注射)。
本公开的组合物可以包含单独的rAAV,或与一种或多种其他病毒(例如,编码具有一种或多种不同转基因例如编码不同的MiniABCA4蛋白的转基因的第二rAAV)组合的rAAV。在一些实施方案中,组合物包含1、2、3、4、5、6、7、8、9、10或更多种不同的rAAV,每一种均具有一个或多个不同的转基因。
在一些实施方案中,组合物还包含药学上可接受的运载体。考虑到rAAV针对的适应症,本领域技术人员可以容易地选择合适的运载体。例如,一种合适的运载体包括盐水,其可以与多种缓冲溶液(例如磷酸盐缓冲盐水)一起配制。
其他示例性运载体包括无菌盐水、乳糖、蔗糖、磷酸钙、明胶、葡聚糖、琼脂、果胶、花生油、芝麻油和水。运载体的选择不构成对本发明的限制。
任选地,除了rAAV和(一种或多种)运载体之外,本公开的组合物还可以含有其他药物成分,例如防腐剂或化学稳定剂。合适的示例性防腐剂包括氯丁醇、山梨酸钾、山梨酸、二氧化硫、没食子酸丙酯、对羟基苯甲酸酯、乙基香草醛、甘油、苯酚和对氯苯酚。合适的化学稳定剂包括明胶和白蛋白。
rAAV以足够的量施用以转染目标组织(例如眼组织,例如光感受器、视网膜等组织)的细胞并提供足够的基因转移和表达水平,而不会产生过度的副作用。药学上可接受的施用途径的实例包括但不限于直接递送至所选器官(例如视网膜下递送至眼睛)、口服、吸入(包括鼻内和气管内递送)、眼内、静脉内、肌肉内、皮下、皮内、瘤内和其他肠胃外施用途径。如果需要,可以将施用途径组合起来。
实现特定“治疗效果”所需的rAAV病毒粒子的剂量,例如以基因组拷贝/千克体重(GC/kg)为剂量单位,将根据多种因素而变化,包括但不限于:rAAV病毒粒子的施用途径、达到治疗效果所需的基因或RNA表达水平、所治疗的特定疾病或病症,以及基因或RNA产物的稳定性。本领域技术人员可以基于上述因素以及其他因素容易地确定治疗患有特定疾病或病症的患者的rAAV病毒粒子的剂量范围。
rAAV的有效量是足以靶向感染动物、靶向模板组织的量。有效量将主要取决于诸如受试者的物种、年龄、体重、健康状况和待靶向的组织等因素,并因此可以因动物和组织而异。例如,rAAV的有效量通常在约1ml至约100ml含有约109至1016个基因组拷贝的溶液的范围内。在一些情况下,约1011至1013个rAAV基因组拷贝之间的剂量是适当的。在某些实施方案中,109个rAAV基因组拷贝有效靶向眼组织(例如,角膜组织)。
在一些实施方案中,当施用于受试者的眼睛时,比109rAAV基因组拷贝更浓的剂量是有毒的。在一些实施方案中,有效量由多个剂量的rAAV产生。在一些实施方案中,在施用rAAV之前向受试者施用一种或多种免疫抑制剂(例如,皮质类固醇类、氨甲蝶呤(methotrexate)、环孢素A(cyclosporine A)、霉酚酸酯(mycophenolate mofetil)、他克莫司(tacrolimus)、利妥昔单抗(Rituximab)、西罗莫司(sirolimus)、甲泼尼龙(methylprednisolone)、CTLA4Ig、非消耗性CD4 Ab和T细胞消耗性抗胸腺细胞γ-球蛋白(ATG)等)。
在一些实施方案中,以每个日历日(例如,24小时周期)不超过一次的频率向受试者施用一个剂量的rAAV。在一些实施方案中,以每2、3、4、5、6或7个日历日不超过一次的频率向受试者施用一个剂量的rAAV。在一些实施方案中,以每个日历周(例如,7个日历日)不超过一次的频率向受试者施用一个剂量的rAAV。在一些实施方案中,以不超过每两周一次(例如,在两个日历周期间一次)的频率向受试者施用一个剂量的rAAV。在一些实施方案中,以每个日历月不超过一次(例如,在30个日历日中一次)的频率向受试者施用一个剂量的rAAV。在一些实施方案中,以每六个日历月不超过一次的频率向受试者施用一个剂量的rAAV。在一些实施方案中,以每个日历年(例如,365天或闰年时366天)不超过一次的频率向受试者施用一个剂量的rAAV。
在一些实施方案中,rAAV组合物被配制成减少组合物中AAV颗粒的聚集,特别是在存在高rAAV浓度(例如,~1013GC/ml或更高)的情况下。可以使用用于减少聚集的合适方法,包括例如添加表面活性剂、pH调节、盐浓度调节等(参见,例如,Wright FR,et al.,Molecular Therapy(2005)12,171–178,其内容通过引用并入本文。)。
药学上可接受的赋形剂和运载体溶液的配制是本领域技术人员熟知的,并且开发用于在各种治疗方案中使用本文所述的特定组合物的合适给药和治疗方案也是本领域技术人员熟知的。通常,这些制剂可以含有至少约0.1%或更多的活性化合物,尽管(一种或多种)活性成分的百分比当然可以变化并且可以方便地在总制剂重量或体积的约1或2%至约70%或80%之间或更多。自然地,每个治疗上有用的组合物中活性化合物的量可以以这样的方式制备,即在化合物的任何给定单位剂量中将获得合适的剂量。制备此类药物制剂领域的技术人员将考虑诸如溶解度、生物利用度、生物半衰期、施用途径、产品保质期以及其他药理学考虑等因素,并且因此,各种剂量和治疗方案可能是期望的。
在一些实施方案中,将rAAV以本文公开的适当配制的药物组合物的形式直接递送至靶组织,例如直接递送至眼组织(例如,光感受器、视网膜等组织)。然而,在某些情况下,可能需要单独地或另外地经由另一途径,例如皮下、胰内、鼻内、肠胃外、静脉内、肌肉内、鞘内或经口、腹膜内或通过吸入递送基于rAAV的治疗构建体。在一些实施方案中,可以使用如美国专利号5,543,158、5,641,515和5,399,363(各自通过引用的方式明确并入本文)中所述的施用方式来递送rAAV。在一些实施方案中,优选的施用方式是通过玻璃体内注射或视网膜下注射。
适合注射使用的药物形式包括无菌水溶液或分散液以及用于临时制备无菌注射液或分散液的无菌粉剂。分散液也可以在甘油、液体聚乙二醇及其混合物中以及在油中制备。在通常的储存和使用条件下,这些制剂含有防腐剂以防止微生物生长。在许多情况下,该形式是无菌的和流动的,达到容易注射的程度。它在制造和储存条件下必须是稳定的,并且必须防止微生物(例如细菌和真菌)的污染作用。运载体可以是含有例如水、乙醇、多元醇(例如甘油、丙二醇和液体聚乙二醇等)、它们的合适混合物和/或植物油的溶剂或分散介质。例如,可以通过使用包衣剂例如卵磷脂、在分散剂的情况下通过维持所需的粒径、以及通过使用表面活性剂来保持适当的流动性。各种抗细菌剂和抗真菌剂,例如对羟基苯甲酸酯、氯丁醇、苯酚、山梨酸、硫柳汞等可以防止微生物的作用。在许多情况下,优选包括等渗剂,例如糖或氯化钠。可注射组合物的延长吸收可以通过在组合物中使用延迟吸收剂(例如单硬脂酸铝和明胶)来实现。
例如,对于可注射水性溶液的施用,如果需要,可以适当地缓冲溶液,并且首先用足够的盐水或葡萄糖使液体稀释剂等渗。这些特定的水性溶液特别适合用于静脉内、肌肉内、皮下和腹膜内施用。在这方面,可以使用合适的无菌水性介质。例如,一个剂量可以溶解在1ml等渗NaCl溶液中,并添加到1000ml皮下灌注液(hypodermoclysis fluid)中或在建议的输液部位注射,(参见例如“Remington's Pharmaceutical Sciences”,第15版,第1035-1038和1570-1580页)。根据宿主的情况,剂量必然发生一些变化。在任何情况下,负责施用的人将决定个体宿主的适当剂量。
通过将所需量的活性rAAV与本文列举的各种其他成分(需要时)一起掺入合适的溶剂中随后过滤灭菌来制备无菌可注射溶液。通常,通过将各种经过灭菌的活性成分掺入含有基础分散介质和来自上面列举的那些中的所需其他成分的无菌媒介物中来制备分散液。在用于制备无菌可注射溶液的无菌粉剂的情况下,优选的制备方法是真空干燥和冷冻干燥技术,其由先前无菌过滤的溶液得到活性成分加上任何额外的所需成分的粉末。
本文公开的rAAV组合物也可以配制成中性或盐形式。药学上可接受的盐包括酸加成盐(与蛋白的游离氨基形成的)以及与无机酸例如盐酸或磷酸或者有机酸例如乙酸、草酸、酒石酸、扁桃酸等形成的盐。与游离羧基形成的盐也可以衍生自无机碱,例如氢氧化钠、氢氧化钾、氢氧化铵、氢氧化钙或氢氧化铁,以及诸如异丙胺、三甲胺、组氨酸、普鲁卡因等有机碱。在配制时,溶液将以与剂量制剂相容的方式并且以治疗有效的量施用。该制剂易于以多种剂型施用,例如可注射溶液、药物释放胶囊等。
如本文所用,“运载体(carrier)”包括任何和所有溶剂、分散介质、媒介物(vehicle)、包衣剂、稀释剂、抗细菌剂和抗真菌剂、等渗剂和吸收延迟剂、缓冲剂、运载体溶液、悬浮液、胶体等。对药物活性物质使用此类介质和药剂是本领域公知的。补充活性成分也可以掺入到组合物中。短语“药学上可接受的”是指当施用于宿主时不产生过敏或类似的不良反应的分子实体和组合物。
可以使用诸如脂质体、纳米胶囊、微粒、微球、脂质颗粒、囊泡等的递送媒介物将本公开的组合物引入合适的宿主细胞中。特别地,rAAV载体递送的转基因可以被配制成封装在脂质颗粒、脂质体、囊泡、纳米球或纳米颗粒等中进行递送。
此类制剂可以优选用于引入本文公开的核酸或rAAV构建体的药学上可接受的制剂。脂质体的形成和使用是本领域技术人员通常已知的。最近,开发了具有改善的血清稳定性和循环半衰期的脂质体(美国专利号5,741,516)。此外,已经描述了作为潜在药物运载体的脂质体和脂质体样制剂的各种方法(美国专利号5,567,434;5,552,157;5,565,213;5,738,868和5,795,587)。
脂质体已成功用于许多通常对其他程序的转染具有抗性的细胞类型。此外,脂质体没有基于病毒的传递系统典型存在的DNA长度限制。脂质体已被有效地用于将基因、药物、放射治疗剂、病毒、转录因子和变构效应物引入多种培养的细胞系和动物中。此外,已经完成了几项考查脂质体介导的药物递送的有效性的成功临床试验。
脂质体由分散在水性介质中并自发形成多层同心双层囊泡(也称为多层囊泡(MLV))的磷脂形成。MLV通常具有25nm至4μm的直径。MLV的超声处理导致形成直径在200至
Figure BDA0003414451370000191
范围内的小单层囊泡(SUV),在核心中含有水性溶液。
或者,可以使用rAAV的纳米胶囊制剂。纳米胶囊通常可以以稳定和可重复的方式捕获物质。为避免细胞内聚合物过载引起的副作用,应使用能够在体内降解的聚合物来设计这种超细颗粒(大小约为0.1μm)。考虑使用满足这些要求的可生物降解的聚氰基丙烯酸烷基酯纳米颗粒。
实施例
实施例1:miniABC4基因构建体MG-1至MG-6
本实施例描述具有ABCA4的一个或多个结构域(例如,ABCA4小基因及其基因产物,“MiniABCA4”)的AAV载体(和rAAV)的鉴定和生产,所述结构域保留光感受器中的功能(例如,部分ABCA4功能)。通过在培养的HEK293细胞中将miniABCA4蛋白表达为MYC标记的蛋白版本来测试miniABCA4蛋白的表达和稳定性。将表现出最佳表达和稳定性的版本体内注射到Abca4-/-小鼠。病毒颗粒是假型化的(例如,AAV2/8),并且表达由主要靶向光感受器的启动子驱动。使用视网膜下注射施用MiniABCA4构建体。图1和SEQ ID NO:3-8显示了MiniABCA4构建体MG-1至MG-6的实施方案。SEQ ID NO:9-14显示了MG-1至MG-6的MiniABCA4蛋白的实施方案。
视网膜色素上皮(RPE)背景自身荧光的减少被用作替代测定以测试miniABCA4候选物的功效。Abca4-/-小鼠在出生后30天注射Abca4-1(MG-1)构建体,并通过荧光显微术测量RPE自身荧光。RPE细胞用标志物ZO-1染色。代表性数据显示在图2中。与野生型对照相比,Abca4-/-小鼠在4个月大时在488nM波长下显示出更高的RPE自身荧光。注射miniABCA4-1导致488nM波长下的自身荧光显著下降,表明miniABCA4-1具有拯救作用。
使用RPE自身荧光测定测试其他ABCA4小基因构建体,结果在图3中量化。对Abca4-/-小鼠注射miniABCA4-1(MG-1)、miniABCA4-2(MG-2)、miniABCA4-4(MG-4)或miniABCA4-5(MG-5)。注射是在出生后10天或30天(P10或P30)进行的,并在图上指定的年龄时间测量RPE自身荧光。数据表明,与未接受注射的Abca4-/-小鼠相比,几种miniABCA4构建体显著降低了RPE自身荧光,并且与P10时的注射相比,P30时的注射更好地改善了RPE自身荧光。
实施例2:miniABC4基因构建体MG-7至MG-11
本实施例描述了额外的ABCA4小基因设计,称为MG-7至MG-11,以及表达这些ABCA4小基因的AAV载体(和rAAV)的生产。通过在培养的HEK293细胞中将miniABCA4蛋白表达为该蛋白的MYC标记版本来测试miniABCA4蛋白的表达和稳定性(图5)。使用微管蛋白作为加载对照。图4和SEQ ID NO:15-19显示了MiniABCA4构建体MG-7至MG-11的实施方案。SEQ IDNO:20-24显示了MG-7至MG-11的MiniABCA4蛋白的实施方案。
序列
在一些实施方案中,本公开描述的分离的核酸或载体(例如,rAAV载体)包含SEQID NO:3-8和15-19任一个所示的序列或由其组成。在一些实施方案中,本公开描述的分离的核酸或载体(例如,rAAV载体)包含与SEQ ID NO:3-8和15-19任一个所示的序列互补(例如,是其补体)的序列或由其组成。在一些实施方案中,本公开描述的分离的核酸或载体(例如,rAAV载体)包含为SEQ ID NO:3-8和15-19任一个所示序列的反向补体的序列或由其组成。在一些实施方案中,本公开描述的分离的核酸或载体(例如,rAAV载体)包含SEQ ID NO:3-8和15-19任一个所示的序列的部分或由其组成。部分可以包含SEQ ID NO:3-8和15-19任一个所示序列的至少25%、50%、60%、70%、80%、90%、95%或99%。在一些实施方案中,本公开描述的核酸序列是核酸有义链(例如,5'至3'链),或在病毒序列的情况下是正(+)链。在一些实施方案中,本公开描述的核酸序列是核酸反义链(例如,3'至5'链),或在病毒序列的情况下是负(-)链。
等同方案
虽然本文已经描述和说明了本发明的若干实施方案,但是本领域普通技术人员将容易想到用于执行本文描述的功能和/或获得本文描述的结果和/或本文描述的一个或多个优点的各种其他装置和/或结构,并且,这些变化和/或修改中的每一个均被认为是在本发明的范围内。更一般地,本领域技术人员将容易理解,本文描述的所有参数、尺寸、材料和配置都是示例性的,并且实际参数、尺寸、材料和/或配置将取决于本发明教导使用的一个或多个特定应用。本领域技术人员将认识到或者能够使用不超过常规的实验确定本文描述的发明的具体实施方案的许多等同方案。因此,应该理解,前述实施方案仅作为示例呈现,并且在所附权利要求及其等同方案的范围内,本发明可以以不同于具体描述和要求保护的方式实施。本发明涉及本文描述的每个单独的特征、系统、物品、材料和/或方法。此外,如果这样的特征、系统、物品、材料和/或方法不相互矛盾,则两个或更多个这样的特征、系统、物品、材料和/或方法的任何组合都包括在本发明的范围内。
除非明确相反指出,否则本文在说明书和权利要求书中使用的不定冠词“一个(种)”应理解为表示“至少一个(种)”。
如本文在说明书和权利要求书中使用的短语“和/或”应理解为表示如此结合的要素中的“一个或两个”,即在一些情况下要素共同存在,以及在其他情况下分开存在。除了“和/或”从句所具体标识的要素之外,可以任选存在其他要素,而不论与具体标识的那些要素相关还是不相关,除非明确相反指出。因此,作为一个非限制性实例,当与诸如“包含”的开放式语言结合使用时,对“A和/或B”的提及在一个实施方案中可以是指A且无B(任选地包括除B之外的要素);在另一个实施方案中,是指B且无A(任选地包括除A之外的要素);在又一个实施方案中,是指A和B两者(任选地包括其他要素);等等。
如本文在说明书和权利要求书中所用,“或”应理解为具有与如上文所定义的“和/或”相同的含义。例如,当分隔列表中的项目时,“或”或“和/或”应被解释为包含性的,即包含许多要素或要素列表中的至少一个,但也包括多于一个,以及任选的其他未列出的项目。只有明确相反地指出的术语,例如“仅一个”或“唯一一个”,或“由...组成”当用于权利要求中时,将指的是包含许多要素或要素列表中的唯一一个要素。一般而言,在排他性术语之前,如“任一”、“之一”、“仅一个”或“唯一一个”,本文所用的术语“或”仅应解释为表示排他性的替代方案(即“一个或另一个,而不是两个”)。“基本上由......组成”在用于权利要求时,应具有其在专利法领域中使用的普通含义。
如本文在说明书和权利要求书中所使用的,关于一个或多个要素的列表,短语“至少一个”应理解为表示从要素列表中任何一个或多个要素中选择的至少一个要素,但不一定包括要素列表内具体列出的每一个要素中的至少一个要素,并且不排除要素列表中要素的任何组合。该定义还允许任选地存在短语“至少一个”所指要素列表内所具体标识的要素之外的要素,无论与具体标识的那些要素相关还是不相关。因此,作为一个非限制性实例,“A和B中的至少一个”(或等同地“A或B中的至少一个”;或等同地“A和/或B中的至少一个”)在一个实施方案中可以是指至少一个,任选地包括多于一个A但不存在B(并且任选地包括除B之外的要素);在另一个实施方案中,是指至少一个,任选地包括多于一个B但不存在A(并且任选地包括除A之外的要素);在又一个实施方案中,是指至少一个,任选地包括多于一个A,以及至少一个,任选地包括多于一个B(并且任选地包括其他要素);等等。
在权利要求书中以及在上述说明书中,所有过渡短语,如“包含”、“包括”、“携带”、“具有”、“含有”、“涉及”、“持有”等应理解为开放式的,即表示包括但不限于。只有过渡短语“由......组成”和“基本上由......组成”应分别是封闭或半封闭的过渡短语,如美国专利局专利审查程序手册第2111.03节中所述。
在权利要求中使用诸如“第一”、“第二”、“第三”等顺序术语来修饰权利要求要素本身并不意味着一个权利要求要素相对于另一权利要求要素的任何优先权、优先级或顺序或方法的动作执行的时间顺序,而是仅用作标签以将具有特定名称的一个权利要求要素与具有相同名称(但用于顺序术语)的另一个要素区分开来以区分权利要求要素。
数值前面的术语“约”和“基本上”代表所述数值的±10%。
序列表
<110> 马萨诸塞大学(University of Massachusetts)
<120> 眼底黄色斑点症(ABCA4)的基因疗法
<130> U0120.70122WO00
<140> 尚未指定
<141> 同上
<150> US 62/836,493
<151> 2019-04-19
<160> 24
<170> PatentIn version 3.5
<210> 1
<211> 7328
<212> DNA
<213> 智人(Homo sapiens)
<400> 1
ggacacagcg tccggagcca gaggcgctct taacggcgtt tatgtccttt gctgtctgag 60
gggcctcagc tctgaccaat ctggtcttcg tgtggtcatt agcatgggct tcgtgagaca 120
gatacagctt ttgctctgga agaactggac cctgcggaaa aggcaaaaga ttcgctttgt 180
ggtggaactc gtgtggcctt tatctttatt tctggtcttg atctggttaa ggaatgccaa 240
cccactctac agccatcatg aatgccattt ccccaacaag gcgatgccct cagcaggaat 300
gctgccgtgg ctccagggga tcttctgcaa tgtgaacaat ccctgttttc aaagccccac 360
cccaggagaa tctcctggaa ttgtgtcaaa ctataacaac tccatcttgg caagggtata 420
tcgagatttt caagaactcc tcatgaatgc accagagagc cagcaccttg gccgtatttg 480
gacagagcta cacatcttgt cccaattcat ggacaccctc cggactcacc cggagagaat 540
tgcaggaaga ggaatacgaa taagggatat cttgaaagat gaagaaacac tgacactatt 600
tctcattaaa aacatcggcc tgtctgactc agtggtctac cttctgatca actctcaagt 660
ccgtccagag cagttcgctc atggagtccc ggacctggcg ctgaaggaca tcgcctgcag 720
cgaggccctc ctggagcgct tcatcatctt cagccagaga cgcggggcaa agacggtgcg 780
ctatgccctg tgctccctct cccagggcac cctacagtgg atagaagaca ctctgtatgc 840
caacgtggac ttcttcaagc tcttccgtgt gcttcccaca ctcctagaca gccgttctca 900
aggtatcaat ctgagatctt ggggaggaat attatctgat atgtcaccaa gaattcaaga 960
gtttatccat cggccgagta tgcaggactt gctgtgggtg accaggcccc tcatgcagaa 1020
tggtggtcca gagaccttta caaagctgat gggcatcctg tctgacctcc tgtgtggcta 1080
ccccgaggga ggtggctctc gggtgctctc cttcaactgg tatgaagaca ataactataa 1140
ggcctttctg gggattgact ccacaaggaa ggatcctatc tattcttatg acagaagaac 1200
aacatccttt tgtaatgcat tgatccagag cctggagtca aatcctttaa ccaaaatcgc 1260
ttggagggcg gcaaagcctt tgctgatggg aaaaatcctg tacactcctg attcacctgc 1320
agcacgaagg atactgaaga atgccaactc aacttttgaa gaactggaac acgttaggaa 1380
gttggtcaaa gcctgggaag aagtagggcc ccagatctgg tacttctttg acaacagcac 1440
acagatgaac atgatcagag ataccctggg gaacccaaca gtaaaagact ttttgaatag 1500
gcagcttggt gaagaaggta ttactgctga agccatccta aacttcctct acaagggccc 1560
tcgggaaagc caggctgacg acatggccaa cttcgactgg agggacatat ttaacatcac 1620
tgatcgcacc ctccgcctgg tcaatcaata cctggagtgc ttggtcctgg ataagtttga 1680
aagctacaat gatgaaactc agctcaccca acgtgccctc tctctactgg aggaaaacat 1740
gttctgggcc ggagtggtat tccctgacat gtatccctgg accagctctc taccacccca 1800
cgtgaagtat aagatccgaa tggacataga cgtggtggag aaaaccaata agattaaaga 1860
caggtattgg gattctggtc ccagagctga tcccgtggaa gatttccggt acatctgggg 1920
cgggtttgcc tatctgcagg acatggttga acaggggatc acaaggagcc aggtgcaggc 1980
ggaggctcca gttggaatct acctccagca gatgccctac ccctgcttcg tggacgattc 2040
tttcatgatc atcctgaacc gctgtttccc tatcttcatg gtgctggcat ggatctactc 2100
tgtctccatg actgtgaaga gcatcgtctt ggagaaggag ttgcgactga aggagacctt 2160
gaaaaatcag ggtgtctcca atgcagtgat ttggtgtacc tggttcctgg acagcttctc 2220
catcatgtcg atgagcatct tcctcctgac gatattcatc atgcatggaa gaatcctaca 2280
ttacagcgac ccattcatcc tcttcctgtt cttgttggct ttctccactg ccaccatcat 2340
gctgtgcttt ctgctcagca ccttcttctc caaggccagt ctggcagcag cctgtagtgg 2400
tgtcatctat ttcaccctct acctgccaca catcctgtgc ttcgcctggc aggaccgcat 2460
gaccgctgag ctgaagaagg ctgtgagctt actgtctccg gtggcatttg gatttggcac 2520
tgagtacctg gttcgctttg aagagcaagg cctggggctg cagtggagca acatcgggaa 2580
cagtcccacg gaaggggacg aattcagctt cctgctgtcc atgcagatga tgctccttga 2640
tgctgctgtc tatggcttac tcgcttggta ccttgatcag gtgtttccag gagactatgg 2700
aaccccactt ccttggtact ttcttctaca agagtcgtat tggcttggcg gtgaagggtg 2760
ttcaaccaga gaagaaagag ccctggaaaa gaccgagccc ctaacagagg aaacggagga 2820
tccagagcac ccagaaggaa tacacgactc cttctttgaa cgtgagcatc cagggtgggt 2880
tcctggggta tgcgtgaaga atctggtaaa gatttttgag ccctgtggcc ggccagctgt 2940
ggaccgtctg aacatcacct tctacgagaa ccagatcacc gcattcctgg gccacaatgg 3000
agctgggaaa accaccacct tgtccatcct gacgggtctg ttgccaccaa cctctgggac 3060
tgtgctcgtt gggggaaggg acattgaaac cagcctggat gcagtccggc agagccttgg 3120
catgtgtcca cagcacaaca tcctgttcca ccacctcacg gtggctgagc acatgctgtt 3180
ctatgcccag ctgaaaggaa agtcccagga ggaggcccag ctggagatgg aagccatgtt 3240
ggaggacaca ggcctccacc acaagcggaa tgaagaggct caggacctat caggtggcat 3300
gcagagaaag ctgtcggttg ccattgcctt tgtgggagat gccaaggtgg tgattctgga 3360
cgaacccacc tctggggtgg acccttactc gagacgctca atctgggatc tgctcctgaa 3420
gtatcgctca ggcagaacca tcatcatgtc cactcaccac atggacgagg ccgacctcct 3480
tggggaccgc attgccatca ttgcccaggg aaggctctac tgctcaggca ccccactctt 3540
cctgaagaac tgctttggca caggcttgta cttaaccttg gtgcgcaaga tgaaaaacat 3600
ccagagccaa aggaaaggca gtgaggggac ctgcagctgc tcgtctaagg gtttctccac 3660
cacgtgtcca gcccacgtcg atgacctaac tccagaacaa gtcctggatg gggatgtaaa 3720
tgagctgatg gatgtagttc tccaccatgt tccagaggca aagctggtgg agtgcattgg 3780
tcaagaactt atcttccttc ttccaaataa gaacttcaag cacagagcat atgccagcct 3840
tttcagagag ctggaggaga cgctggctga ccttggtctc agcagttttg gaatttctga 3900
cactcccctg gaagagattt ttctgaaggt cacggaggat tctgattcag gacctctgtt 3960
tgcgggtggc gctcagcaga aaagagaaaa cgtcaacccc cgacacccct gcttgggtcc 4020
cagagagaag gctggacaga caccccagga ctccaatgtc tgctccccag gggcgccggc 4080
tgctcaccca gagggccagc ctcccccaga gccagagtgc ccaggcccgc agctcaacac 4140
ggggacacag ctggtcctcc agcatgtgca ggcgctgctg gtcaagagat tccaacacac 4200
catccgcagc cacaaggact tcctggcgca gatcgtgctc ccggctacct ttgtgttttt 4260
ggctctgatg ctttctattg ttatccctcc ttttggcgaa taccccgctt tgacccttca 4320
cccctggata tatgggcagc agtacacctt cttcagcatg gatgaaccag gcagtgagca 4380
gttcacggta cttgcagacg tcctcctgaa taagccaggc tttggcaacc gctgcctgaa 4440
ggaagggtgg cttccggagt acccctgtgg caactcaaca ccctggaaga ctccttctgt 4500
gtccccaaac atcacccagc tgttccagaa gcagaaatgg acacaggtca acccttcacc 4560
atcctgcagg tgcagcacca gggagaagct caccatgctg ccagagtgcc ccgagggtgc 4620
cgggggcctc ccgccccccc agagaacaca gcgcagcacg gaaattctac aagacctgac 4680
ggacaggaac atctccgact tcttggtaaa aacgtatcct gctcttataa gaagcagctt 4740
aaagagcaaa ttctgggtca atgaacagag gtatggagga atttccattg gaggaaagct 4800
cccagtcgtc cccatcacgg gggaagcact tgttgggttt ttaagcgacc ttggccggat 4860
catgaatgtg agcgggggcc ctatcactag agaggcctct aaagaaatac ctgatttcct 4920
taaacatcta gaaactgaag acaacattaa ggtgtggttt aataacaaag gctggcatgc 4980
cctggtcagc tttctcaatg tggcccacaa cgccatctta cgggccagcc tgcctaagga 5040
caggagcccc gaggagtatg gaatcaccgt cattagccaa cccctgaacc tgaccaagga 5100
gcagctctca gagattacag tgctgaccac ttcagtggat gctgtggttg ccatctgcgt 5160
gattttctcc atgtccttcg tcccagccag ctttgtcctt tatttgatcc aggagcgggt 5220
gaacaaatcc aagcacctcc agtttatcag tggagtgagc cccaccacct actgggtgac 5280
caacttcctc tgggacatca tgaattattc cgtgagtgct gggctggtgg tgggcatctt 5340
catcgggttt cagaagaaag cctacacttc tccagaaaac cttcctgccc ttgtggcact 5400
gctcctgctg tatggatggg cggtcattcc catgatgtac ccagcatcct tcctgtttga 5460
tgtccccagc acagcctatg tggctttatc ttgtgctaat ctgttcatcg gcatcaacag 5520
cagtgctatt accttcatct tggaattatt tgagaataac cggacgctgc tcaggttcaa 5580
cgccgtgctg aggaagctgc tcattgtctt cccccacttc tgcctgggcc ggggcctcat 5640
tgaccttgca ctgagccagg ctgtgacaga tgtctatgcc cggtttggtg aggagcactc 5700
tgcaaatccg ttccactggg acctgattgg gaagaacctg tttgccatgg tggtggaagg 5760
ggtggtgtac ttcctcctga ccctgctggt ccagcgccac ttcttcctct cccaatggat 5820
tgccgagccc actaaggagc ccattgttga tgaagatgat gatgtggctg aagaaagaca 5880
aagaattatt actggtggaa ataaaactga catcttaagg ctacatgaac taaccaagat 5940
ttatccaggc acctccagcc cagcagtgga caggctgtgt gtcggagttc gccctggaga 6000
gtgctttggc ctcctgggag tgaatggtgc cggcaaaaca accacattca agatgctcac 6060
tggggacacc acagtgacct caggggatgc caccgtagca ggcaagagta ttttaaccaa 6120
tatttctgaa gtccatcaaa atatgggcta ctgtcctcag tttgatgcaa ttgatgagct 6180
gctcacagga cgagaacatc tttaccttta tgcccggctt cgaggtgtac cagcagaaga 6240
aatcgaaaag gttgcaaact ggagtattaa gagcctgggc ctgactgtct acgccgactg 6300
cctggctggc acgtacagtg ggggcaacaa gcggaaactc tccacagcca tcgcactcat 6360
tggctgccca ccgctggtgc tgctggatga gcccaccaca gggatggacc cccaggcacg 6420
ccgcatgctg tggaacgtca tcgtgagcat catcagagaa gggagggctg tggtcctcac 6480
atcccacagc atggaagaat gtgaggcact gtgtacccgg ctggccatca tggtaaaggg 6540
cgcctttcga tgtatgggca ccattcagca tctcaagtcc aaatttggag atggctatat 6600
cgtcacaatg aagatcaaat ccccgaagga cgacctgctt cctgacctga accctgtgga 6660
gcagttcttc caggggaact tcccaggcag tgtgcagagg gagaggcact acaacatgct 6720
ccagttccag gtctcctcct cctccctggc gaggatcttc cagctcctcc tctcccacaa 6780
ggacagcctg ctcatcgagg agtactcagt cacacagacc acactggacc aggtgtttgt 6840
aaattttgct aaacagcaga ctgaaagtca tgacctccct ctgcaccctc gagctgctgg 6900
agccagtcga caagcccagg actgatcttt cacaccgctc gttcctgcag ccagaaagga 6960
actctgggca gctggaggcg caggagcctg tgcccatatg gtcatccaaa tggactggcc 7020
agcgtaaatg accccactgc agcagaaaac aaacacacga ggagcatgca gcgaattcag 7080
aaagaggtct ttcagaagga aaccgaaact gacttgctca cctggaacac ctgatggtga 7140
aaccaaacaa atacaaaatc cttctccaga ccccagaact agaaaccccg ggccatccca 7200
ctagcagctt tggcctccat attgctctca tttcaagcag atctgctttt ctgcatgttt 7260
gtctgtgtgt ctgcgttgtg tgtgattttc atggaaaaat aaaatgcaaa tgcactcatc 7320
acaaacta 7328
<210> 2
<211> 2273
<212> PRT
<213> 智人(Homo sapiens)
<400> 2
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Ser His His Glu Cys His Phe Pro Asn Lys Ala Met Pro Ser Ala
50 55 60
Gly Met Leu Pro Trp Leu Gln Gly Ile Phe Cys Asn Val Asn Asn Pro
65 70 75 80
Cys Phe Gln Ser Pro Thr Pro Gly Glu Ser Pro Gly Ile Val Ser Asn
85 90 95
Tyr Asn Asn Ser Ile Leu Ala Arg Val Tyr Arg Asp Phe Gln Glu Leu
100 105 110
Leu Met Asn Ala Pro Glu Ser Gln His Leu Gly Arg Ile Trp Thr Glu
115 120 125
Leu His Ile Leu Ser Gln Phe Met Asp Thr Leu Arg Thr His Pro Glu
130 135 140
Arg Ile Ala Gly Arg Gly Ile Arg Ile Arg Asp Ile Leu Lys Asp Glu
145 150 155 160
Glu Thr Leu Thr Leu Phe Leu Ile Lys Asn Ile Gly Leu Ser Asp Ser
165 170 175
Val Val Tyr Leu Leu Ile Asn Ser Gln Val Arg Pro Glu Gln Phe Ala
180 185 190
His Gly Val Pro Asp Leu Ala Leu Lys Asp Ile Ala Cys Ser Glu Ala
195 200 205
Leu Leu Glu Arg Phe Ile Ile Phe Ser Gln Arg Arg Gly Ala Lys Thr
210 215 220
Val Arg Tyr Ala Leu Cys Ser Leu Ser Gln Gly Thr Leu Gln Trp Ile
225 230 235 240
Glu Asp Thr Leu Tyr Ala Asn Val Asp Phe Phe Lys Leu Phe Arg Val
245 250 255
Leu Pro Thr Leu Leu Asp Ser Arg Ser Gln Gly Ile Asn Leu Arg Ser
260 265 270
Trp Gly Gly Ile Leu Ser Asp Met Ser Pro Arg Ile Gln Glu Phe Ile
275 280 285
His Arg Pro Ser Met Gln Asp Leu Leu Trp Val Thr Arg Pro Leu Met
290 295 300
Gln Asn Gly Gly Pro Glu Thr Phe Thr Lys Leu Met Gly Ile Leu Ser
305 310 315 320
Asp Leu Leu Cys Gly Tyr Pro Glu Gly Gly Gly Ser Arg Val Leu Ser
325 330 335
Phe Asn Trp Tyr Glu Asp Asn Asn Tyr Lys Ala Phe Leu Gly Ile Asp
340 345 350
Ser Thr Arg Lys Asp Pro Ile Tyr Ser Tyr Asp Arg Arg Thr Thr Ser
355 360 365
Phe Cys Asn Ala Leu Ile Gln Ser Leu Glu Ser Asn Pro Leu Thr Lys
370 375 380
Ile Ala Trp Arg Ala Ala Lys Pro Leu Leu Met Gly Lys Ile Leu Tyr
385 390 395 400
Thr Pro Asp Ser Pro Ala Ala Arg Arg Ile Leu Lys Asn Ala Asn Ser
405 410 415
Thr Phe Glu Glu Leu Glu His Val Arg Lys Leu Val Lys Ala Trp Glu
420 425 430
Glu Val Gly Pro Gln Ile Trp Tyr Phe Phe Asp Asn Ser Thr Gln Met
435 440 445
Asn Met Ile Arg Asp Thr Leu Gly Asn Pro Thr Val Lys Asp Phe Leu
450 455 460
Asn Arg Gln Leu Gly Glu Glu Gly Ile Thr Ala Glu Ala Ile Leu Asn
465 470 475 480
Phe Leu Tyr Lys Gly Pro Arg Glu Ser Gln Ala Asp Asp Met Ala Asn
485 490 495
Phe Asp Trp Arg Asp Ile Phe Asn Ile Thr Asp Arg Thr Leu Arg Leu
500 505 510
Val Asn Gln Tyr Leu Glu Cys Leu Val Leu Asp Lys Phe Glu Ser Tyr
515 520 525
Asn Asp Glu Thr Gln Leu Thr Gln Arg Ala Leu Ser Leu Leu Glu Glu
530 535 540
Asn Met Phe Trp Ala Gly Val Val Phe Pro Asp Met Tyr Pro Trp Thr
545 550 555 560
Ser Ser Leu Pro Pro His Val Lys Tyr Lys Ile Arg Met Asp Ile Asp
565 570 575
Val Val Glu Lys Thr Asn Lys Ile Lys Asp Arg Tyr Trp Asp Ser Gly
580 585 590
Pro Arg Ala Asp Pro Val Glu Asp Phe Arg Tyr Ile Trp Gly Gly Phe
595 600 605
Ala Tyr Leu Gln Asp Met Val Glu Gln Gly Ile Thr Arg Ser Gln Val
610 615 620
Gln Ala Glu Ala Pro Val Gly Ile Tyr Leu Gln Gln Met Pro Tyr Pro
625 630 635 640
Cys Phe Val Asp Asp Ser Phe Met Ile Ile Leu Asn Arg Cys Phe Pro
645 650 655
Ile Phe Met Val Leu Ala Trp Ile Tyr Ser Val Ser Met Thr Val Lys
660 665 670
Ser Ile Val Leu Glu Lys Glu Leu Arg Leu Lys Glu Thr Leu Lys Asn
675 680 685
Gln Gly Val Ser Asn Ala Val Ile Trp Cys Thr Trp Phe Leu Asp Ser
690 695 700
Phe Ser Ile Met Ser Met Ser Ile Phe Leu Leu Thr Ile Phe Ile Met
705 710 715 720
His Gly Arg Ile Leu His Tyr Ser Asp Pro Phe Ile Leu Phe Leu Phe
725 730 735
Leu Leu Ala Phe Ser Thr Ala Thr Ile Met Leu Cys Phe Leu Leu Ser
740 745 750
Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala Ala Cys Ser Gly Val Ile
755 760 765
Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu Cys Phe Ala Trp Gln Asp
770 775 780
Arg Met Thr Ala Glu Leu Lys Lys Ala Val Ser Leu Leu Ser Pro Val
785 790 795 800
Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val Arg Phe Glu Glu Gln Gly
805 810 815
Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn Ser Pro Thr Glu Gly Asp
820 825 830
Glu Phe Ser Phe Leu Leu Ser Met Gln Met Met Leu Leu Asp Ala Ala
835 840 845
Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp Gln Val Phe Pro Gly Asp
850 855 860
Tyr Gly Thr Pro Leu Pro Trp Tyr Phe Leu Leu Gln Glu Ser Tyr Trp
865 870 875 880
Leu Gly Gly Glu Gly Cys Ser Thr Arg Glu Glu Arg Ala Leu Glu Lys
885 890 895
Thr Glu Pro Leu Thr Glu Glu Thr Glu Asp Pro Glu His Pro Glu Gly
900 905 910
Ile His Asp Ser Phe Phe Glu Arg Glu His Pro Gly Trp Val Pro Gly
915 920 925
Val Cys Val Lys Asn Leu Val Lys Ile Phe Glu Pro Cys Gly Arg Pro
930 935 940
Ala Val Asp Arg Leu Asn Ile Thr Phe Tyr Glu Asn Gln Ile Thr Ala
945 950 955 960
Phe Leu Gly His Asn Gly Ala Gly Lys Thr Thr Thr Leu Ser Ile Leu
965 970 975
Thr Gly Leu Leu Pro Pro Thr Ser Gly Thr Val Leu Val Gly Gly Arg
980 985 990
Asp Ile Glu Thr Ser Leu Asp Ala Val Arg Gln Ser Leu Gly Met Cys
995 1000 1005
Pro Gln His Asn Ile Leu Phe His His Leu Thr Val Ala Glu His
1010 1015 1020
Met Leu Phe Tyr Ala Gln Leu Lys Gly Lys Ser Gln Glu Glu Ala
1025 1030 1035
Gln Leu Glu Met Glu Ala Met Leu Glu Asp Thr Gly Leu His His
1040 1045 1050
Lys Arg Asn Glu Glu Ala Gln Asp Leu Ser Gly Gly Met Gln Arg
1055 1060 1065
Lys Leu Ser Val Ala Ile Ala Phe Val Gly Asp Ala Lys Val Val
1070 1075 1080
Ile Leu Asp Glu Pro Thr Ser Gly Val Asp Pro Tyr Ser Arg Arg
1085 1090 1095
Ser Ile Trp Asp Leu Leu Leu Lys Tyr Arg Ser Gly Arg Thr Ile
1100 1105 1110
Ile Met Ser Thr His His Met Asp Glu Ala Asp Leu Leu Gly Asp
1115 1120 1125
Arg Ile Ala Ile Ile Ala Gln Gly Arg Leu Tyr Cys Ser Gly Thr
1130 1135 1140
Pro Leu Phe Leu Lys Asn Cys Phe Gly Thr Gly Leu Tyr Leu Thr
1145 1150 1155
Leu Val Arg Lys Met Lys Asn Ile Gln Ser Gln Arg Lys Gly Ser
1160 1165 1170
Glu Gly Thr Cys Ser Cys Ser Ser Lys Gly Phe Ser Thr Thr Cys
1175 1180 1185
Pro Ala His Val Asp Asp Leu Thr Pro Glu Gln Val Leu Asp Gly
1190 1195 1200
Asp Val Asn Glu Leu Met Asp Val Val Leu His His Val Pro Glu
1205 1210 1215
Ala Lys Leu Val Glu Cys Ile Gly Gln Glu Leu Ile Phe Leu Leu
1220 1225 1230
Pro Asn Lys Asn Phe Lys His Arg Ala Tyr Ala Ser Leu Phe Arg
1235 1240 1245
Glu Leu Glu Glu Thr Leu Ala Asp Leu Gly Leu Ser Ser Phe Gly
1250 1255 1260
Ile Ser Asp Thr Pro Leu Glu Glu Ile Phe Leu Lys Val Thr Glu
1265 1270 1275
Asp Ser Asp Ser Gly Pro Leu Phe Ala Gly Gly Ala Gln Gln Lys
1280 1285 1290
Arg Glu Asn Val Asn Pro Arg His Pro Cys Leu Gly Pro Arg Glu
1295 1300 1305
Lys Ala Gly Gln Thr Pro Gln Asp Ser Asn Val Cys Ser Pro Gly
1310 1315 1320
Ala Pro Ala Ala His Pro Glu Gly Gln Pro Pro Pro Glu Pro Glu
1325 1330 1335
Cys Pro Gly Pro Gln Leu Asn Thr Gly Thr Gln Leu Val Leu Gln
1340 1345 1350
His Val Gln Ala Leu Leu Val Lys Arg Phe Gln His Thr Ile Arg
1355 1360 1365
Ser His Lys Asp Phe Leu Ala Gln Ile Val Leu Pro Ala Thr Phe
1370 1375 1380
Val Phe Leu Ala Leu Met Leu Ser Ile Val Ile Pro Pro Phe Gly
1385 1390 1395
Glu Tyr Pro Ala Leu Thr Leu His Pro Trp Ile Tyr Gly Gln Gln
1400 1405 1410
Tyr Thr Phe Phe Ser Met Asp Glu Pro Gly Ser Glu Gln Phe Thr
1415 1420 1425
Val Leu Ala Asp Val Leu Leu Asn Lys Pro Gly Phe Gly Asn Arg
1430 1435 1440
Cys Leu Lys Glu Gly Trp Leu Pro Glu Tyr Pro Cys Gly Asn Ser
1445 1450 1455
Thr Pro Trp Lys Thr Pro Ser Val Ser Pro Asn Ile Thr Gln Leu
1460 1465 1470
Phe Gln Lys Gln Lys Trp Thr Gln Val Asn Pro Ser Pro Ser Cys
1475 1480 1485
Arg Cys Ser Thr Arg Glu Lys Leu Thr Met Leu Pro Glu Cys Pro
1490 1495 1500
Glu Gly Ala Gly Gly Leu Pro Pro Pro Gln Arg Thr Gln Arg Ser
1505 1510 1515
Thr Glu Ile Leu Gln Asp Leu Thr Asp Arg Asn Ile Ser Asp Phe
1520 1525 1530
Leu Val Lys Thr Tyr Pro Ala Leu Ile Arg Ser Ser Leu Lys Ser
1535 1540 1545
Lys Phe Trp Val Asn Glu Gln Arg Tyr Gly Gly Ile Ser Ile Gly
1550 1555 1560
Gly Lys Leu Pro Val Val Pro Ile Thr Gly Glu Ala Leu Val Gly
1565 1570 1575
Phe Leu Ser Asp Leu Gly Arg Ile Met Asn Val Ser Gly Gly Pro
1580 1585 1590
Ile Thr Arg Glu Ala Ser Lys Glu Ile Pro Asp Phe Leu Lys His
1595 1600 1605
Leu Glu Thr Glu Asp Asn Ile Lys Val Trp Phe Asn Asn Lys Gly
1610 1615 1620
Trp His Ala Leu Val Ser Phe Leu Asn Val Ala His Asn Ala Ile
1625 1630 1635
Leu Arg Ala Ser Leu Pro Lys Asp Arg Ser Pro Glu Glu Tyr Gly
1640 1645 1650
Ile Thr Val Ile Ser Gln Pro Leu Asn Leu Thr Lys Glu Gln Leu
1655 1660 1665
Ser Glu Ile Thr Val Leu Thr Thr Ser Val Asp Ala Val Val Ala
1670 1675 1680
Ile Cys Val Ile Phe Ser Met Ser Phe Val Pro Ala Ser Phe Val
1685 1690 1695
Leu Tyr Leu Ile Gln Glu Arg Val Asn Lys Ser Lys His Leu Gln
1700 1705 1710
Phe Ile Ser Gly Val Ser Pro Thr Thr Tyr Trp Val Thr Asn Phe
1715 1720 1725
Leu Trp Asp Ile Met Asn Tyr Ser Val Ser Ala Gly Leu Val Val
1730 1735 1740
Gly Ile Phe Ile Gly Phe Gln Lys Lys Ala Tyr Thr Ser Pro Glu
1745 1750 1755
Asn Leu Pro Ala Leu Val Ala Leu Leu Leu Leu Tyr Gly Trp Ala
1760 1765 1770
Val Ile Pro Met Met Tyr Pro Ala Ser Phe Leu Phe Asp Val Pro
1775 1780 1785
Ser Thr Ala Tyr Val Ala Leu Ser Cys Ala Asn Leu Phe Ile Gly
1790 1795 1800
Ile Asn Ser Ser Ala Ile Thr Phe Ile Leu Glu Leu Phe Glu Asn
1805 1810 1815
Asn Arg Thr Leu Leu Arg Phe Asn Ala Val Leu Arg Lys Leu Leu
1820 1825 1830
Ile Val Phe Pro His Phe Cys Leu Gly Arg Gly Leu Ile Asp Leu
1835 1840 1845
Ala Leu Ser Gln Ala Val Thr Asp Val Tyr Ala Arg Phe Gly Glu
1850 1855 1860
Glu His Ser Ala Asn Pro Phe His Trp Asp Leu Ile Gly Lys Asn
1865 1870 1875
Leu Phe Ala Met Val Val Glu Gly Val Val Tyr Phe Leu Leu Thr
1880 1885 1890
Leu Leu Val Gln Arg His Phe Phe Leu Ser Gln Trp Ile Ala Glu
1895 1900 1905
Pro Thr Lys Glu Pro Ile Val Asp Glu Asp Asp Asp Val Ala Glu
1910 1915 1920
Glu Arg Gln Arg Ile Ile Thr Gly Gly Asn Lys Thr Asp Ile Leu
1925 1930 1935
Arg Leu His Glu Leu Thr Lys Ile Tyr Pro Gly Thr Ser Ser Pro
1940 1945 1950
Ala Val Asp Arg Leu Cys Val Gly Val Arg Pro Gly Glu Cys Phe
1955 1960 1965
Gly Leu Leu Gly Val Asn Gly Ala Gly Lys Thr Thr Thr Phe Lys
1970 1975 1980
Met Leu Thr Gly Asp Thr Thr Val Thr Ser Gly Asp Ala Thr Val
1985 1990 1995
Ala Gly Lys Ser Ile Leu Thr Asn Ile Ser Glu Val His Gln Asn
2000 2005 2010
Met Gly Tyr Cys Pro Gln Phe Asp Ala Ile Asp Glu Leu Leu Thr
2015 2020 2025
Gly Arg Glu His Leu Tyr Leu Tyr Ala Arg Leu Arg Gly Val Pro
2030 2035 2040
Ala Glu Glu Ile Glu Lys Val Ala Asn Trp Ser Ile Lys Ser Leu
2045 2050 2055
Gly Leu Thr Val Tyr Ala Asp Cys Leu Ala Gly Thr Tyr Ser Gly
2060 2065 2070
Gly Asn Lys Arg Lys Leu Ser Thr Ala Ile Ala Leu Ile Gly Cys
2075 2080 2085
Pro Pro Leu Val Leu Leu Asp Glu Pro Thr Thr Gly Met Asp Pro
2090 2095 2100
Gln Ala Arg Arg Met Leu Trp Asn Val Ile Val Ser Ile Ile Arg
2105 2110 2115
Glu Gly Arg Ala Val Val Leu Thr Ser His Ser Met Glu Glu Cys
2120 2125 2130
Glu Ala Leu Cys Thr Arg Leu Ala Ile Met Val Lys Gly Ala Phe
2135 2140 2145
Arg Cys Met Gly Thr Ile Gln His Leu Lys Ser Lys Phe Gly Asp
2150 2155 2160
Gly Tyr Ile Val Thr Met Lys Ile Lys Ser Pro Lys Asp Asp Leu
2165 2170 2175
Leu Pro Asp Leu Asn Pro Val Glu Gln Phe Phe Gln Gly Asn Phe
2180 2185 2190
Pro Gly Ser Val Gln Arg Glu Arg His Tyr Asn Met Leu Gln Phe
2195 2200 2205
Gln Val Ser Ser Ser Ser Leu Ala Arg Ile Phe Gln Leu Leu Leu
2210 2215 2220
Ser His Lys Asp Ser Leu Leu Ile Glu Glu Tyr Ser Val Thr Gln
2225 2230 2235
Thr Thr Leu Asp Gln Val Phe Val Asn Phe Ala Lys Gln Gln Thr
2240 2245 2250
Glu Ser His Asp Leu Pro Leu His Pro Arg Ala Ala Gly Ala Ser
2255 2260 2265
Arg Gln Ala Gln Asp
2270
<210> 3
<211> 3816
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 3
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaaccc gctctacagc catcatgaat gccatttccc caacaaggcg 180
atgccctcag caggaatgct gccgtggctc caggggatct tctgcaatgt gaacaatccc 240
tgttttcaaa gccccacccc aggagaatct cctggaattg tgtcaaacta taacaactcc 300
atcttggcaa gggtatatcg agattttcaa gaactcctca tgaatgcacc agagagccag 360
caccttggcc gtatttggac agagctacac atcttgtccc aattcatgga caccctccgg 420
actcacccgg agagaattgc aggaagagga atacgaataa gggatatctt gaaagatgaa 480
gaaacactga cactatttct cattaaaaac atcggcctgt ctgactcagt ggtctacctt 540
ctgatcaact ctcaagtccg tccagagcag ttcgctcatg gagtcccgga cctggcgctg 600
aaggacatcg cctgcagcga ggccctcctg gagcgcttca tcatcttcag ccagagacgc 660
ggggcaaaga cggtgcgcta tgccctgtgc tccctctccc agggcaccct acagtggata 720
gaagacactc tgtattcttt catgatcatc ctgaaccgct gtttccctat cttcatggtg 780
ctggcatgga tctactctgt ctccatgact gtgaagagca tcgtcttgga gaaggagttg 840
cgactgaagg agaccttgaa aaatcagggt gtctccaatg cagtgatttg gtgtacctgg 900
ttcctggaca gcttctccat catgtcgatg agcatcttcc tcctgacgat attcatcatg 960
catggaagaa tcctacatta cagcgaccca ttcatcctct tcctgttctt gttggctttc 1020
tccactgcca ccatcatgct gtgctttctg ctcagcacct tcttctccaa ggccagtctg 1080
gcagcagcct gtagtggtgt catctatttc accctctacc tgccacacat cctgtgcttc 1140
gcctggcagg accgcatgac cgctgagctg aagaaggctg tgagcttact gtctccggtg 1200
gcatttggat ttggcactga gtacctggtt cgctttgaag agcaaggcct ggggctgcag 1260
tggagcaaca tcgggaacag tcccacggaa ggggacgaat tcagcttcct gctgtccatg 1320
cagatgatgc tccttgatgc tgctgtctat ggcttactcg cttggtacct tgatcaggtg 1380
gtatgcgtga agaatctggt aaagattttt gagccctgtg gccggccagc tgtggaccgt 1440
ctgaacatca ccttctacga gaaccagatc accgcattcc tgggccacaa tggagctggg 1500
aaaaccacca ccttgtccat cctgacgggt ctgttgccac caacctctgg gactgtgctc 1560
gttgggggaa gggacattga aaccagcctg gatgcagtcc ggcagagcct tggcatgtgt 1620
ccacagcaca acatcctgtt ccaccacctc acggtggctg agcacatgct gttctatgcc 1680
cagctgaaag gaaagtccca ggaggaggcc cagctggaga tggaagccat gttggaggac 1740
acaggcctcc accacaagcg gaatgaagag gctcaggacc tatcaggtgg catgcagaga 1800
aagctgtcgg ttgccattgc ctttgtggga gatgccaagg tggtgattct ggacgaaccc 1860
acctctgggg tggaccctta ctcgagacgc tcaatctggg atctgctcct gaagtatcgc 1920
tcaggcagaa ccatcatcat gtccactcac cacatggacg aggccgacct ccttggggac 1980
cgcattgcca tcattgccca gggaaggctc tactgctcag gcaccccact cttcctgaag 2040
aactgctttg gcacaggctt gtacttaacc ttggtgggcg aataccccgc tttgaccctt 2100
cacccctgga tatatgggca gcagtacacc ttcttcagca tggatgaacc aggcagtgag 2160
cagttcacgg tacttgcaga cgtcctcctg aataagccag gctttggcaa ccgctgcctg 2220
aaggaagggt ggcttccgga gtacccctgt ggcaactcaa caccctggaa gactccttct 2280
gtgtccccaa acatcaccca gctgttccag aagcagaaat ggacacaggt caacccttca 2340
ccatcctgca ggtgcagcac cagggagaag ctcaccatgc tgccagagtg ccccgagggt 2400
gccgggggcc tcccgccccc ccagagaaca cagcgcagca cggaaattct acaagacctg 2460
acggacagga acatctccga cttcttggta aaaacgtatc ctgctcttat aagaagcagc 2520
ttaaagagca aattctgggt caatgaacag aggtatggag gaatttccat tggaggaaag 2580
ctcccagtcg tccccatcac gggggaagca cttgttgggt ttttaagcga ccttggccgg 2640
atcatgaatg tgagcggggg ccctatcact agagaggcct ctaaagaaat acctgatttc 2700
cttaaacatc tagaaactga agacaacatt aaggtgtggt ttaataacaa aggctggcat 2760
gccctggtca gctttctcaa tgtggcccac aacgccatct tacggttaag gctacatgaa 2820
ctaaccaaga tttatccagg cacctccagc ccagcagtgg acaggctgtg tgtcggagtt 2880
cgccctggag agtgctttgg cctcctggga gtgaatggtg ccggcaaaac aaccacattc 2940
aagatgctca ctggggacac cacagtgacc tcaggggatg ccaccgtagc aggcaagagt 3000
attttaacca atatttctga agtccatcaa aatatgggct actgtcctca gtttgatgca 3060
attgatgagc tgctcacagg acgagaacat ctttaccttt atgcccggct tcgaggtgta 3120
ccagcagaag aaatcgaaaa ggttgcaaac tggagtatta agagcctggg cctgactgtc 3180
tacgccgact gcctggctgg cacgtacagt gggggcaaca agcggaaact ctccacagcc 3240
atcgcactca ttggctgccc accgctggtg ctgctggatg agcccaccac agggatggac 3300
ccccaggcac gccgcatgct gtggaacgtc atcgtgagca tcatcagaga agggagggct 3360
gtggtcctca catcccacag catggaagaa tgtgaggcac tgtgtacccg gctggccatc 3420
atggtaaagg gcgcctttcg atgtatgggc accattcagc atctcaagtc caaatttgga 3480
gatggctata tcgtcacaat gaagatcaaa tccccgaagg acgacctgct tcctgacctg 3540
aaccctgtgg agcagttctt ccaggggaac ttcccaggca gtgtgcagag ggagaggcac 3600
tacaacatgc tccagttcca ggtctcctcc tcctccctgg cgaggatctt ccagctcctc 3660
ctctcccaca aggacagcct gctcatcgag gagtactcag tcacacagac cacactggac 3720
caggtgtttg taaattttgc taaacagcag actgaaagtc atgacctccc tctgcaccct 3780
cgagctgctg gagccagtcg acaagcccag gactga 3816
<210> 4
<211> 3804
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 4
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaaccc gctctacagc catcatgaat gccatttccc caacaaggcg 180
atgccctcag caggaatgct gccgtggctc caggggatct tctgcaatgt gaacaatccc 240
tgttttcaaa gccccacccc aggagaatct cctggaattg tgtcaaacta taacaactcc 300
atcttggcaa gggtatatcg agattttcaa gaactcctca tgaatgcacc agagagccag 360
caccttggcc gtatttggac agagctacac atcttgtccc aattcatgga caccctccgg 420
actcacccgg agagaattgc aggaagagga atacgaataa gggatatctt gaaagatgaa 480
gaaacactga cactatttct cattaaaaac atcggcctgt ctgactcagt ggtctacctt 540
ctgatcaact ctcaagtccg tccagagcag ttcgctcatg gagtcccgga cctggcgctg 600
aaggacatcg cctgcagcga ggccctcctg gagcgcttca tcatcttcag ccagagacgc 660
ggggcaaaga cggtgcgcta tgccctgtgc tccctctccc agggcaccct acagtggata 720
gaagacactc tgtatgtatg cgtgaagaat ctggtaaaga tttttgagcc ctgtggccgg 780
ccagctgtgg accgtctgaa catcaccttc tacgagaacc agatcaccgc attcctgggc 840
cacaatggag ctgggaaaac caccaccttg tccatcctga cgggtctgtt gccaccaacc 900
tctgggactg tgctcgttgg gggaagggac attgaaacca gcctggatgc agtccggcag 960
agccttggca tgtgtccaca gcacaacatc ctgttccacc acctcacggt ggctgagcac 1020
atgctgttct atgcccagct gaaaggaaag tcccaggagg aggcccagct ggagatggaa 1080
gccatgttgg aggacacagg cctccaccac aagcggaatg aagaggctca ggacctatca 1140
ggtggcatgc agagaaagct gtcggttgcc attgcctttg tgggagatgc caaggtggtg 1200
attctggacg aacccacctc tggggtggac ccttactcga gacgctcaat ctgggatctg 1260
ctcctgaagt atcgctcagg cagaaccatc atcatgtcca ctcaccacat ggacgaggcc 1320
gacctccttg gggaccgcat tgccatcatt gcccagggaa ggctctactg ctcaggcacc 1380
ccactcttcc tgaagaactg ctttggcaca ggcttgtact taaccttggt gggcgaatac 1440
cccgctttga cccttcaccc ctggatatat gggcagcagt acaccttctt cagcatggat 1500
gaaccaggca gtgagcagtt cacggtactt gcagacgtcc tcctgaataa gccaggcttt 1560
ggcaaccgct gcctgaagga agggtggctt ccggagtacc cctgtggcaa ctcaacaccc 1620
tggaagactc cttctgtgtc cccaaacatc acccagctgt tccagaagca gaaatggaca 1680
caggtcaacc cttcaccatc ctgcaggtgc agcaccaggg agaagctcac catgctgcca 1740
gagtgccccg agggtgccgg gggcctcccg cccccccaga gaacacagcg cagcacggaa 1800
attctacaag acctgacgga caggaacatc tccgacttct tggtaaaaac gtatcctgct 1860
cttataagaa gcagcttaaa gagcaaattc tgggtcaatg aacagaggta tggaggaatt 1920
tccattggag gaaagctccc agtcgtcccc atcacggggg aagcacttgt tgggttttta 1980
agcgaccttg gccggatcat gaatgtgagc gggggcccta tcactagaga ggcctctaaa 2040
gaaatacctg atttccttaa acatctagaa actgaagaca acattaaggt gtggtttaat 2100
aacaaaggct ggcatgccct ggtcagcttt ctcaatgtgg cccacaacgc catcttacgg 2160
aacttcctct gggacatcat gaattattcc gtgagtgctg ggctggtggt gggcatcttc 2220
atcgggtttc agaagaaagc ctacacttct ccagaaaacc ttcctgccct tgtggcactg 2280
ctcctgctgt atggatgggc ggtcattccc atgatgtacc cagcatcctt cctgtttgat 2340
gtccccagca cagcctatgt ggctttatct tgtgctaatc tgttcatcgg catcaacagc 2400
agtgctatta ccttcatctt ggaattattt gagaataacc ggacgctgct caggttcaac 2460
gccgtgctga ggaagctgct cattgtcttc ccccacttct gcctgggccg gggcctcatt 2520
gaccttgcac tgagccaggc tgtgacagat gtctatgccc ggtttggtga ggagcactct 2580
gcaaatccgt tccactggga cctgattggg aagaacctgt ttgccatggt ggtggaaggg 2640
gtggtgtact tcctcctgac cctgctggtc cagcgccact tcttcctctc ccaatggatt 2700
gccgagccca ctaaggagcc cattgttgat gaagatgatg atgtggctga agaaagacaa 2760
agaattatta ctggtggaaa taaaactgac atcttaaggc tacatgaact aaccaagatt 2820
tatccaggca cctccagccc agcagtggac aggctgtgtg tcggagttcg ccctggagag 2880
tgctttggcc tcctgggagt gaatggtgcc ggcaaaacaa ccacattcaa gatgctcact 2940
ggggacacca cagtgacctc aggggatgcc accgtagcag gcaagagtat tttaaccaat 3000
atttctgaag tccatcaaaa tatgggctac tgtcctcagt ttgatgcaat tgatgagctg 3060
ctcacaggac gagaacatct ttacctttat gcccggcttc gaggtgtacc agcagaagaa 3120
atcgaaaagg ttgcaaactg gagtattaag agcctgggcc tgactgtcta cgccgactgc 3180
ctggctggca cgtacagtgg gggcaacaag cggaaactct ccacagccat cgcactcatt 3240
ggctgcccac cgctggtgct gctggatgag cccaccacag ggatggaccc ccaggcacgc 3300
cgcatgctgt ggaacgtcat cgtgagcatc atcagagaag ggagggctgt ggtcctcaca 3360
tcccacagca tggaagaatg tgaggcactg tgtacccggc tggccatcat ggtaaagggc 3420
gcctttcgat gtatgggcac cattcagcat ctcaagtcca aatttggaga tggctatatc 3480
gtcacaatga agatcaaatc cccgaaggac gacctgcttc ctgacctgaa ccctgtggag 3540
cagttcttcc aggggaactt cccaggcagt gtgcagaggg agaggcacta caacatgctc 3600
cagttccagg tctcctcctc ctccctggcg aggatcttcc agctcctcct ctcccacaag 3660
gacagcctgc tcatcgagga gtactcagtc acacagacca cactggacca ggtgtttgta 3720
aattttgcta aacagcagac tgaaagtcat gacctccctc tgcaccctcg agctgctgga 3780
gccagtcgac aagcccagga ctga 3804
<210> 5
<211> 4062
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 5
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaaccc gctctacagc catcatgaat gccatttccc caacaaggcg 180
atgccctcag caggaatgct gccgtggctc caggggatct tctgcaatgt gaacaatccc 240
tgttttcaaa gccccacccc aggagaatct cctggaattg tgtcaaacta taacaactcc 300
atcttggcaa gggtatatcg agattttcaa gaactcctca tgaatgcacc agagagccag 360
caccttggcc gtatttggac agagctacac atcttgtccc aattcatgga caccctccgg 420
actcacccgg agagaattgc aggaagagga atacgaataa gggatatctt gaaagatgaa 480
gaaacactga cactatttct cattaaaaac atcggcctgt ctgactcagt ggtctacctt 540
ctgatcaact ctcaagtccg tccagagcag ttcgctcatg gagtcccgga cctggcgctg 600
aaggacatcg cctgcagcga ggccctcctg gagcgcttca tcatcttcag ccagagacgc 660
ggggcaaaga cggtgcgcta tgccctgtgc tccctctccc agggcaccct acagtggata 720
gaagacactc tgtatgccaa cgtggacttc ttcaagctct tccgtgtgct tcccacactc 780
ctagacagcc gttctcaagg tatcaatctg agatcttggg gaggaatatt atctgatatg 840
tcaccaagaa ttcaagagtt tatccatcgg ccgagtatgc aggacttgct gtgggtgacc 900
aggcccctca tgcagaatgg tggtccagag acctttacaa agctgatggg catcctgtct 960
gacctcctgt gtggctaccc cgagggaggt ggctctcggg tgctctcctt caactggtat 1020
gaagacaata actataaggc ctttctgggg attgactcca caaggaagga tcctatctat 1080
tcttatgaca gaagaacaac atccttttgt aatgcattga tccagagcct ggagtcaaat 1140
cctttaacca aaatcgcttg gagggcggca aagcctttgc tgatgggaaa aatcctgtac 1200
actcctgatt cacctgcagc acgaaggata ctgaagaatg ccaactcaac ttttgaagaa 1260
ctggaacacg ttaggaagtt ggtcaaagcc tgggaagaag tagggcccca gatctggtac 1320
ttctttgaca acagcacaca gatgaacatg atcagagata ccctggggaa cccaacagta 1380
aaagactttt tgaataggca gcttggtgaa gaaggtatta ctgctgaagc catcctaaac 1440
ttcctctaca agggccctcg ggaaagccag gctgacgaca tggccaactt cgactggagg 1500
gacatattta acatcactga tcgcaccctc cgcctggtca atcaatacct ggagtgcttg 1560
gtcctggata agtttgaaag ctacaatgat gaaactcagc tcacccaacg tgccctctct 1620
ctactggagg aaaacatgtt ctgggccgga gtggtattcc ctgacatgta tccctggacc 1680
agctctctac caccccacgt gaagtataag atccgaatgg acatagacgt ggtggagaaa 1740
accaataaga ttaaagacag gtattgggat tctggtccca gagctgatcc cgtggaagat 1800
ttccggtaca tctggggcgg gtttgcctat ctgcaggaca tggttgaaca ggggatcaca 1860
aggagccagg tgcaggcgga ggctccagtt ggaatctacc tccagcagat gccctacccc 1920
tgcttcgtgg acgattcttt catgatcatc ctgaaccgct gtttccctat cttcatggtg 1980
ctggcatgga tctactctgt ctccatgact gtgaagagca tcgtcttgga gaaggagttg 2040
cgactgaagg agaccttgaa aaatcagggt gtctccaatg cagtgatttg gtgtacctgg 2100
ttcctggaca gcttctccat catgtcgatg agcatcttcc tcctgacgat attcatcatg 2160
catggaagaa tcctacatta cagcgaccca ttcatcctct tcctgttctt gttggctttc 2220
tccactgcca ccatcatgct gtgctttctg ctcagcacct tcttctccaa ggccagtctg 2280
gcagcagcct gtagtggtgt catctatttc accctctacc tgccacacat cctgtgcttc 2340
gcctggcagg accgcatgac cgctgagctg aagaaggctg tgagcttact gtctccggtg 2400
gcatttggat ttggcactga gtacctggtt cgctttgaag agcaaggcct ggggctgcag 2460
tggagcaaca tcgggaacag tcccacggaa ggggacgaat tcagcttcct gctgtccatg 2520
cagatgatgc tccttgatgc tgctgtctat ggcttactcg cttggtacct tgatcaggtg 2580
ctaacagagg aaacggagga tccagagcac ccagaaggaa tacacgactc cttctttgaa 2640
cgtgagcatc cagggtgggt tcctggggta tgcgtgaaga atctggtaaa gatttttgag 2700
ccctgtggcc ggccagctgt ggaccgtctg aacatcacct tctacgagaa ccagatcacc 2760
gcattcctgg gccacaatgg agctgggaaa accaccacct tgtccatcct gacgggtctg 2820
ttgccaccaa cctctgggac tgtgctcgtt gggggaaggg acattgaaac cagcctggat 2880
gcaggcgaat accccgcttt gacccttcac ccctggatat atgggcagca gtacaccttc 2940
ttcagcatgg atgaaccagg cagtgagcag ttcacggtac ttgcagacgt cctcctgaat 3000
aagccaggct ttggcaaccg ctgcctgaag gaagggtggc ttccggagta cccctgtggc 3060
aactcaacac cctggaagac tccttctgtg tccccaaaca tcacccagct gttccagaag 3120
cagaaatgga cacaggtcaa cccttcacca tcctgcaggt gcagcaccag ggagaagctc 3180
accatgctgc cattaaggct acatgaacta accaagattt atccaggcac ctccagccca 3240
gcagtggaca ggctgtgtgt cggagttcgc cctggagagt gctttggcct cctgggagtg 3300
aatggtgccg gcaaaacaac cacattcaag atgctcactg gggacaccac agtgacctca 3360
ggggatgcca ccgtagcagg caagagtatt ttaaccaata tttctgaagt ccatcaaaat 3420
atgggctact gtcctcagtt tgatgcaatt gatgagctgc tcacaggacg agaacatctt 3480
tacctttatg cccggcttcg aggtgtacca gcagaagaaa tcgaaaaggt tgcaaactgg 3540
agtattaaga gcctgggcct gactgtctac gccgactgcc tggctggcac gtacagtggg 3600
ggcaacaagc ggaaactctc cacagccatc gcactcattg gctgcccacc gctggtgctg 3660
ctggatgagc ccaccacagg gatggacccc caggcacgcc gcatgctgtg gaacgtcatc 3720
gtgagcatca tcagagaagg gagggctgtg gtcctcacat cccacagcat ggaagaatgt 3780
gaggcactgt gtacccggct ggccatcatg gtaaagggcg cctttcgatg tatgggcacc 3840
attcagcatc tcaagtccaa atttggagat ggctatatcg tcacaatgaa gatcaaatcc 3900
ccgaaggacg acctgcttcc tgacctgaac cctgtggagc agttcttcca ggggaacttc 3960
ccaggcagtg tgcagaggga gaggcactac aacatgctcc agttccaggt ctcctcctcc 4020
tccctggcga ggatcttcca ggtgtttgta aattttgctt ga 4062
<210> 6
<211> 3669
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 6
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaaccc gctctacagc catcatgaat gccatttccc caacaaggcg 180
atgccctcag caggaatgct gccgtggctc caggggatct tctgcaatgt gaacaatccc 240
tgttttcaaa gccccacccc aggagaatct cctggaattg tgtcaaacta taacaactcc 300
atcttggcaa gggtatatcg agattttcaa gaactcctca tgaatgcacc agagagccag 360
caccttggcc gtatttggac agagctacac atcttgtccc aattcatgga caccctccgg 420
actcacccgg agagaattgc aggaagagga atacgaataa gggatatctt gaaagatgaa 480
gaaacactga cactatttct cattaaaaac atcggcctgt ctgactcagt ggtctacctt 540
ctgatcaact ctcaagtccg tccagagcag ttcgctcatg gagtcccgga cctggcgctg 600
aaggacatcg cctgcagcga ggccctcctg gagcgcttca tcatcttcag ccagagacgc 660
ggggcaaaga cggtgcgcta tgccctgtgc tccctctccc agggcaccct acagtggata 720
gaagacactc tgtatgccaa cgtggacttc ttcaagctct tccgtgtgct tcccacactc 780
ctagacagcc gttctcaagg tatcaatctg agatcttggg gaggaatatt atctgatatg 840
tcaccaagaa ttcaagagtt tatccatcgg ccgagtatgc aggacttgct gtgggtgacc 900
aggcccctca tgcagaatgg tggtccagag acctttacaa agctgatggg catcctgtct 960
gacctcctgt gtggctaccc cgagggaggt ggctctcggg tgctctcctt caactggtat 1020
gaagacaata actataaggc ctttctgggg attgactcca caaggaagga tcctatctat 1080
tcttatgaca gaagaacaac atccttttgt aatgcattga tccagagcct ggagtcaaat 1140
cctttaacca aaatcgcttg gagggcggca aagcctttgc tgatgggaaa aatcctgtac 1200
actcctgatt cacctgcagc acgaaggata ctgaagaatg ccaactcaac ttttgaagaa 1260
ctggaacacg ttaggaagtt ggtcaaagcc tgggaagaag tagggcccca gatctggtac 1320
ttctttgaca acagcacaca gatgaacatg atcagagata ccctggggaa cccaacagta 1380
aaagactttt tgaataggca gcttggtgaa gaaggtatta ctgctgaagc catcctaaac 1440
ttcctctaca agggccctcg ggaaagccag gctgacgaca tggccaactt cgactggagg 1500
gacatattta acatcactga tcgcaccctc cgcctggtca atcaatacct ggagtgcttg 1560
gtcctggata agtttgaaag ctacaatgat gaaactcagc tcacccaacg tgccctctct 1620
ctactggagg aaaacatgtt ctgggccgga gtggtattcc ctgacatgta tccctggacc 1680
agctctctac caccccacgt gaagtataag atccgaatgg acatagacgt ggtggagaaa 1740
accaataaga ttaaagacag gtattgggat tctggtccca gagctgatcc cgtggaagat 1800
ttccggtaca tctggggcgg gtttgcctat ctgcaggaca tggttgaaca ggggatcaca 1860
aggagccagg tgcaggcgga ggctccagtt ggaatctacc tccagcagat gccctacccc 1920
tgcttcgtgg acgattcttt catgatcatc ctgaaccgct gtttccctat cttcatggtg 1980
ctggcatgga tctactctgt ctccatgact gtgaagagca tcgtcttgga gaaggagttg 2040
cgactgaagg agaccttgaa aaatcagggt gtctccaatg cagtgatttg gtgtacctgg 2100
ttcctggaca gcttctccat catgtcgatg agcatcttcc tcctgacgat attcatcatg 2160
catggaagaa tcctacatta cagcgaccca ttcatcctct tcctgttctt gttggctttc 2220
tccactgcca ccatcatgct gtgctttctg ctcagcacct tcttctccaa ggccagtctg 2280
gcagcagcct gtagtggtgt catctatttc accctctacc tgccacacat cctgtgcttc 2340
gcctggcagg accgcatgac cgctgagctg aagaaggctg tgagcttact gtctccggtg 2400
gcatttggat ttggcactga gtacctggtt cgctttgaag agcaaggcct ggggctgcag 2460
tggagcaaca tcgggaacag tcccacggaa ggggacgaat tcagcttcct gctgtccatg 2520
cagatgatgc tccttgatgc tgctgtctat ggcttactcg cttggtacct tgatcaggtg 2580
gtccggcaga gccttggcat gtgtccacag cacaacatcc tgttccacca cctcacggtg 2640
gctgagcaca tgctgttcta tgcccagctg aaaggaaagt cccaggagga ggcccagctg 2700
gagatggaag ccatgttgga ggacacaggc ctccaccaca agcggaatga agaggctcag 2760
gacctatcag gtggcatgca gagaaagctg tcggttgcca ttgcctttgt gggagatgcc 2820
aaggtggtga ttctggacga acccacctct ggggtggacc cttactcgag acgctcaatc 2880
tgggatctgc tcctgaagta tcgctcaggc agaaccatca tcatgtccac tcaccacatg 2940
gacgaggccg acctccttgg ggaccgcatt gccatcattg cccagggaag gctctactgc 3000
tcaggcaccc cactcttcct gaagaactgc tttggcacag gcttgtactt aaccttggtg 3060
ggcgaatacc ccgctttgac ccttcacccc tggatatatg ggcagcagta caccttcttc 3120
agcatggatg aaccaggcag tgagcagttc acggtacttg cagacgtcct cctgaataag 3180
ccaggctttg gcaaccgctg cctgaaggaa gggtggcttc cggagtaccc ctgtggcaac 3240
tcaacaccct ggaagactcc ttctgtgtcc ccaaacatca cccagctgtt ccagaagcag 3300
aaatggacac aggtcaaccc ttcaccatcc tgcaggtgca gcaccaggga gaagctcacc 3360
atgctgccat taaggctaca tgaactaacc aagatttatc caggcacctc cagcccagca 3420
gtggacaggc tgtgtgtcgg agttcgccct ggagagtgct ttggcctcct gggagtgaat 3480
ggtgccggca aaacaaccac attcaagatg ctcactgggg acaccacagt gacctcaggg 3540
gatgccaccg tagcaggcat caaatccccg aaggacgacc tgcttcctga cctgaaccct 3600
gtggagcagt tcttccaggg gaacttccca ggcagtgtgc agagggaggt gtttgtaaat 3660
tttgcttga 3669
<210> 7
<211> 3069
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 7
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaaccc gctctacagc catcatgaat gccatttccc caacaaggcg 180
atgccctcag caggaatgct gccgtggctc caggggatct tctgcaatgt gaacaatccc 240
tgttttcaaa gccccacccc aggagaatct cctggaattg tgtcaaacta taacaactcc 300
atcttggcaa gggtatatcg agattttcaa gaactcctca tgaatgcacc agagagccag 360
caccttggcc gtatttggac agagctacac atcttgtccc aattcatgga caccctccgg 420
actcacccgg agagaattgc aggaagagga atacgaataa gggatatctt gaaagatgaa 480
gaaacactga cactatttct cattaaaaac atcggcctgt ctgactcagt ggtctacctt 540
ctgatcaact ctcaagtccg tccagagcag ttcgctcatg gagtcccgga cctggcgctg 600
aaggacatcg cctgcagcga ggccctcctg gagcgcttca tcatcttcag ccagagacgc 660
ggggcaaaga cggtgcgcta tgccctgtgc tccctctccc agggcaccct acagtggata 720
gaagacactc tgtattcttt catgatcatc ctgaaccgct gtttccctat cttcatggtg 780
ctggcatgga tctactctgt ctccatgact gtgaagagca tcgtcttgga gaaggagttg 840
cgactgaagg agaccttgaa aaatcagggt gtctccaatg cagtgatttg gtgtacctgg 900
ttcctggaca gcttctccat catgtcgatg agcatcttcc tcctgacgat attcatcatg 960
catggaagaa tcctacatta cagcgaccca ttcatcctct tcctgttctt gttggctttc 1020
tccactgcca ccatcatgct gtgctttctg ctcagcacct tcttctccaa ggccagtctg 1080
gcagcagcct gtagtggtgt catctatttc accctctacc tgccacacat cctgtgcttc 1140
gcctggcagg accgcatgac cgctgagctg aagaaggctg tgagcttact gtctccggtg 1200
gcatttggat ttggcactga gtacctggtt cgctttgaag agcaaggcct ggggctgcag 1260
tggagcaaca tcgggaacag tcccacggaa ggggacgaat tcagcttcct gctgtccatg 1320
cagatgatgc tccttgatgc tgctgtctat ggcttactcg cttggtacct tgatcaggtg 1380
ctaacagagg aaacggagga tccagagcac ccagaaggaa tacacgactc cttctttgaa 1440
cgtgagcatc cagggtgggt tcctggggta tgcgtgaaga atctggtaaa gatttttgag 1500
ccctgtggcc ggccagctgt ggaccgtctg aacatcacct tctacgagaa ccagatcacc 1560
gcattcctgg gccacaatgg agctgggaaa accaccacct tgtccatcct gacgggtctg 1620
ttgccaccaa cctctgggac tgtgctcgtt gggggaaggg acattgaaac cagcctggat 1680
gcacacaagg acttcctggc gcagatcgtg ctcccggcta cctttgtgtt tttggctctg 1740
atgctttcta ttgttatccc tccttttggc gaataccccg ctttgaccct tcacccctgg 1800
atatatgggc agcagtacac cttcttcagc atggatgaac caggcagtga gcagttcacg 1860
gtacttgcag acgtcctcct gaataagcca ggctttggca accgctgcct gaaggaaggg 1920
tggcttccgg agtacccctg tggcaactca acaccctgga agactccttc tgtgtcccca 1980
aacatcaccc agctgttcca gaagcagaaa tggacacagg tcaacccttc accatcctgc 2040
aggtgcagca ccagggagaa gctcaccatg ctgccaaact tcctctggga catcatgaat 2100
tattccgtga gtgctgggct ggtggtgggc atcttcatcg ggtttcagaa gaaagcctac 2160
acttctccag aaaaccttcc tgcccttgtg gcactgctcc tgctgtatgg atgggcggtc 2220
attcccatga tgtacccagc atccttcctg tttgatgtcc ccagcacagc ctatgtggct 2280
ttatcttgtg ctaatctgtt catcggcatc aacagcagtg ctattacctt catcttggaa 2340
ttatttgaga ataaccggac gctgctcagg ttcaacgccg tgctgaggaa gctgctcatt 2400
gtcttccccc acttctgcct gggccggggc ctcattgacc ttgcactgag ccaggctgtg 2460
acagatgtct atgcccggtt tggtgaggag cactctgcaa atccgttcca ctgggacctg 2520
attgggaaga acctgtttgc catggtggtg gaaggggtgg tgtacttcct cctgaccctg 2580
ctggtccagc gccacttctt cctctcccaa tggattgccg agcccactaa ggagcccatt 2640
gttgatgaag atgatgatgt ggctgaagaa agacaaagaa ttattactgg tggaaataaa 2700
actgacatct taaggctaca tgaactaacc aagatttatc caggcacctc cagcccagca 2760
gtggacaggc tgtgtgtcgg agttcgccct ggagagtgct ttggcctcct gggagtgaat 2820
ggtgccggca aaacaaccac attcaagatg ctcactgggg acaccacagt gacctcaggg 2880
gatgccaccg tagcaggcat caaatccccg aaggacgacc tgcttcctga cctgaaccct 2940
gtggagcagt tcttccaggg gaacttccca ggcagtgtgc agagggagag gcactacaac 3000
atgctccagt tccaggtctc ctcctcctcc ctggcgagga tcttccaggt gtttgtaaat 3060
tttgcttga 3069
<210> 8
<211> 4401
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 8
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaaggg ccaacgtgga cttcttcaag ctcttccgtg tgcttcccac actcctagac 180
agccgttctc aaggtatcaa tctgagatct tggggaggaa tattatctga tatgtcacca 240
agaattcaag agtttatcca tcggccgagt atgcaggact tgctgtgggt gaccaggccc 300
ctcatgcaga atggtggtcc agagaccttt acaaagctga tgggcatcct gtctgacctc 360
ctgtgtggct accccgaggg aggtggctct cgggtgctct ccttcaactg gtatgaagac 420
aataactata aggcctttct ggggattgac tccacaagga aggatcctat ctattcttat 480
gacagaagaa caacatcctt ttgtaatgca ttgatccaga gcctggagtc aaatccttta 540
accaaaatcg cttggagggc ggcaaagcct ttgctgatgg gaaaaatcct gtacactcct 600
gattcacctg cagcacgaag gatactgaag aatgccaact caacttttga agaactggaa 660
cacgttagga agttggtcaa agcctgggaa gaagtagggc cccagatctg gtacttcttt 720
gacaacagca cacagatgaa catgatcaga gataccctgg ggaacccaac agtaaaagac 780
tttttgaata ggcagcttgg tgaagaaggt attactgctg aagccatcct aaacttcctc 840
tacaagggcc ctcgggaaag ccaggctgac gacatggcca acttcgactg gagggacata 900
tttaacatca ctgatcgcac cctccgcctg gtcaatcaat acctggagtg cttggtcctg 960
gataagtttg aaagctacaa tgatgaaact cagctcaccc aacgtgccct ctctctactg 1020
gaggaaaaca tgttctgggc cggagtggta ttccctgaca tgtatccctg gaccagctct 1080
ctaccacccc acgtgaagta taagatccga atggacatag acgtggtgga gaaaaccaat 1140
aagattaaag acaggtattg ggattctggt cccagagctg atcccgtgga agatttccgg 1200
tacatctggg gcgggtttgc ctatctgcag gacatggttg aacaggggat cacaaggagc 1260
caggtgcagg cggaggctcc agttggaatc tacctccagc agatgcccta cccctgcttc 1320
gtggacgatt ctttcatgat catcctgaac cgctgtttcc ctatcttcat ggtgctggca 1380
tggatctact ctgtctccat gactgtgaag agcatcgtct tggagaagga gttgcgactg 1440
aaggagacct tgaaaaatca gggtgtctcc aatgcagtga tttggtgtac ctggttcctg 1500
gacagcttct ccatcatgtc gatgagcatc ttcctcctga cgatattcat catgcatgga 1560
agaatcctac attacagcga cccattcatc ctcttcctgt tcttgttggc tttctccact 1620
gccaccatca tgctgtgctt tctgctcagc accttcttct ccaaggccag tctggcagca 1680
gcctgtagtg gtgtcatcta tttcaccctc tacctgccac acatcctgtg cttcgcctgg 1740
caggaccgca tgaccgctga gctgaagaag gctgtgagct tactgtctcc ggtggcattt 1800
ggatttggca ctgagtacct ggttcgcttt gaagagcaag gcctggggct gcagtggagc 1860
aacatcggga acagtcccac ggaaggggac gaattcagct tcctgctgtc catgcagatg 1920
atgctccttg atgctgctgt ctatggctta ctcgcttggt accttgatca ggtggtccgg 1980
cagagccttg gcatgtgtcc acagcacaac atcctgttcc accacctcac ggtggctgag 2040
cacatgctgt tctatgccca gctgaaagga aagtcccagg aggaggccca gctggagatg 2100
gaagccatgt tggaggacac aggcctccac cacaagcgga atgaagaggc tcaggaccta 2160
tcaggtggca tgcagagaaa gctgtcggtt gccattgcct ttgtgggaga tgccaaggtg 2220
gtgattctgg acgaacccac ctctggggtg gacccttact cgagacgctc aatctgggat 2280
ctgctcctga agtatcgctc aggcagaacc atcatcatgt ccactcacca catggacgag 2340
gccgacctcc ttggggaccg cattgccatc attgcccagg gaaggctcta ctgctcaggc 2400
accccactct tcctgaagaa ctgctttggc acaggcttgt acttaacctt ggtgcgcaag 2460
atgaaaaaca tccagagcca aaggaaaggc agtgagggga cctgcagctg ctcgtctaag 2520
ggtttctcca ccacgtgtcc agcccacgtc gatgacctaa ctccagaaca agtccacaag 2580
gacttcctgg cgcagatcgt gctcccggct acctttgtgt ttttggctct gatgctttct 2640
attgagtgcc ccgagggtgc cgggggcctc ccgccccccc agagaacaca gcgcagcacg 2700
gaaattctac aagacctgac ggacaggaac atctccgact tcttggtaaa aacgtatcct 2760
gctcttataa gaagcagctt aaagagcaaa ttctgggtca atgaacagag gtatggagga 2820
atttccattg gaggaaagct cccagtcgtc cccatcacgg gggaagcact tgttgggttt 2880
ttaagcgacc ttggccggat catgaatgtg agcgggggcc ctatcactag agaggcctct 2940
aaagaaatac ctgatttcct taaacatcta gaaactgaag acaacattaa ggtgtggttt 3000
aataacaaag gctggcatgc cctggtcagc tttctcaatg tggcccacaa cgccatctta 3060
cgggccagcc tgcctaagga caggagcccc gagaacttcc tctgggacat catgaattat 3120
tccgtgagtg ctgggctggt ggtgggcatc ttcatcgggt ttcagaagaa agcctacact 3180
tctccagaaa accttcctgc ccttgtggca ctgctcctgc tgtatggatg ggcggtcatt 3240
cccatgatgt acccagcatc cttcctgttt gatgtcccca gcacagccta tgtggcttta 3300
tcttgtgcta atctgttcat cggcatcaac agcagtgcta ttaccttcat cttggaatta 3360
tttgagaata accggacgct gctcaggttc aacgccgtgc tgaggaagct gctcattgtc 3420
ttcccccact tctgcctggg ccggggcctc attgaccttg cactgagcca ggctgtgaca 3480
gatgtctatg cccggtttgg tgaggagcac tctgcaaatc cgttccactg ggacctgatt 3540
gggaagaacc tgtttgccat ggtggtggaa ggggtggtgt acttcctcct gaccctgctg 3600
gtccagcgcc acttcttcct ctcccaatgg attgccgagc ccactaagga gcccattgtt 3660
gatgaagatg atgatgtggc tgaagaaaga caaagaatta ttactggtgg aaataaaact 3720
gacatcttaa agagtatttt aaccaatatt tctgaagtcc atcaaaatat gggctactgt 3780
cctcagtttg atgcaattga tgagctgctc acaggacgag aacatcttta cctttatgcc 3840
cggcttcgag gtgtaccagc agaagaaatc gaaaaggttg caaactggag tattaagagc 3900
ctgggcctga ctgtctacgc cgactgcctg gctggcacgt acagtggggg caacaagcgg 3960
aaactctcca cagccatcgc actcattggc tgcccaccgc tggtgctgct ggatgagccc 4020
accacaggga tggaccccca ggcacgccgc atgctgtgga acgtcatcgt gagcatcatc 4080
agagaaggga gggctgtggt cctcacatcc cacagcatgg aagaatgtga ggcactgtgt 4140
acccggctgg ccatcatggt aaagggcgcc tttcgatgta tgggcaccat tcagcatctc 4200
aagtccaaat ttggagatgg ctatatcgtc acaatgaagc tcctcctctc ccacaaggac 4260
agcctgctca tcgaggagta ctcagtcaca cagaccacac tggaccaggt gtttgtaaat 4320
tttgctaaac agcagactga aagtcatgac ctccctctgc accctcgagc tgctggagcc 4380
agtcgacaag cccaggactg a 4401
<210> 9
<211> 1271
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 9
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Ser His His Glu Cys His Phe Pro Asn Lys Ala Met Pro Ser Ala
50 55 60
Gly Met Leu Pro Trp Leu Gln Gly Ile Phe Cys Asn Val Asn Asn Pro
65 70 75 80
Cys Phe Gln Ser Pro Thr Pro Gly Glu Ser Pro Gly Ile Val Ser Asn
85 90 95
Tyr Asn Asn Ser Ile Leu Ala Arg Val Tyr Arg Asp Phe Gln Glu Leu
100 105 110
Leu Met Asn Ala Pro Glu Ser Gln His Leu Gly Arg Ile Trp Thr Glu
115 120 125
Leu His Ile Leu Ser Gln Phe Met Asp Thr Leu Arg Thr His Pro Glu
130 135 140
Arg Ile Ala Gly Arg Gly Ile Arg Ile Arg Asp Ile Leu Lys Asp Glu
145 150 155 160
Glu Thr Leu Thr Leu Phe Leu Ile Lys Asn Ile Gly Leu Ser Asp Ser
165 170 175
Val Val Tyr Leu Leu Ile Asn Ser Gln Val Arg Pro Glu Gln Phe Ala
180 185 190
His Gly Val Pro Asp Leu Ala Leu Lys Asp Ile Ala Cys Ser Glu Ala
195 200 205
Leu Leu Glu Arg Phe Ile Ile Phe Ser Gln Arg Arg Gly Ala Lys Thr
210 215 220
Val Arg Tyr Ala Leu Cys Ser Leu Ser Gln Gly Thr Leu Gln Trp Ile
225 230 235 240
Glu Asp Thr Leu Tyr Ser Phe Met Ile Ile Leu Asn Arg Cys Phe Pro
245 250 255
Ile Phe Met Val Leu Ala Trp Ile Tyr Ser Val Ser Met Thr Val Lys
260 265 270
Ser Ile Val Leu Glu Lys Glu Leu Arg Leu Lys Glu Thr Leu Lys Asn
275 280 285
Gln Gly Val Ser Asn Ala Val Ile Trp Cys Thr Trp Phe Leu Asp Ser
290 295 300
Phe Ser Ile Met Ser Met Ser Ile Phe Leu Leu Thr Ile Phe Ile Met
305 310 315 320
His Gly Arg Ile Leu His Tyr Ser Asp Pro Phe Ile Leu Phe Leu Phe
325 330 335
Leu Leu Ala Phe Ser Thr Ala Thr Ile Met Leu Cys Phe Leu Leu Ser
340 345 350
Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala Ala Cys Ser Gly Val Ile
355 360 365
Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu Cys Phe Ala Trp Gln Asp
370 375 380
Arg Met Thr Ala Glu Leu Lys Lys Ala Val Ser Leu Leu Ser Pro Val
385 390 395 400
Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val Arg Phe Glu Glu Gln Gly
405 410 415
Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn Ser Pro Thr Glu Gly Asp
420 425 430
Glu Phe Ser Phe Leu Leu Ser Met Gln Met Met Leu Leu Asp Ala Ala
435 440 445
Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp Gln Val Val Cys Val Lys
450 455 460
Asn Leu Val Lys Ile Phe Glu Pro Cys Gly Arg Pro Ala Val Asp Arg
465 470 475 480
Leu Asn Ile Thr Phe Tyr Glu Asn Gln Ile Thr Ala Phe Leu Gly His
485 490 495
Asn Gly Ala Gly Lys Thr Thr Thr Leu Ser Ile Leu Thr Gly Leu Leu
500 505 510
Pro Pro Thr Ser Gly Thr Val Leu Val Gly Gly Arg Asp Ile Glu Thr
515 520 525
Ser Leu Asp Ala Val Arg Gln Ser Leu Gly Met Cys Pro Gln His Asn
530 535 540
Ile Leu Phe His His Leu Thr Val Ala Glu His Met Leu Phe Tyr Ala
545 550 555 560
Gln Leu Lys Gly Lys Ser Gln Glu Glu Ala Gln Leu Glu Met Glu Ala
565 570 575
Met Leu Glu Asp Thr Gly Leu His His Lys Arg Asn Glu Glu Ala Gln
580 585 590
Asp Leu Ser Gly Gly Met Gln Arg Lys Leu Ser Val Ala Ile Ala Phe
595 600 605
Val Gly Asp Ala Lys Val Val Ile Leu Asp Glu Pro Thr Ser Gly Val
610 615 620
Asp Pro Tyr Ser Arg Arg Ser Ile Trp Asp Leu Leu Leu Lys Tyr Arg
625 630 635 640
Ser Gly Arg Thr Ile Ile Met Ser Thr His His Met Asp Glu Ala Asp
645 650 655
Leu Leu Gly Asp Arg Ile Ala Ile Ile Ala Gln Gly Arg Leu Tyr Cys
660 665 670
Ser Gly Thr Pro Leu Phe Leu Lys Asn Cys Phe Gly Thr Gly Leu Tyr
675 680 685
Leu Thr Leu Val Gly Glu Tyr Pro Ala Leu Thr Leu His Pro Trp Ile
690 695 700
Tyr Gly Gln Gln Tyr Thr Phe Phe Ser Met Asp Glu Pro Gly Ser Glu
705 710 715 720
Gln Phe Thr Val Leu Ala Asp Val Leu Leu Asn Lys Pro Gly Phe Gly
725 730 735
Asn Arg Cys Leu Lys Glu Gly Trp Leu Pro Glu Tyr Pro Cys Gly Asn
740 745 750
Ser Thr Pro Trp Lys Thr Pro Ser Val Ser Pro Asn Ile Thr Gln Leu
755 760 765
Phe Gln Lys Gln Lys Trp Thr Gln Val Asn Pro Ser Pro Ser Cys Arg
770 775 780
Cys Ser Thr Arg Glu Lys Leu Thr Met Leu Pro Glu Cys Pro Glu Gly
785 790 795 800
Ala Gly Gly Leu Pro Pro Pro Gln Arg Thr Gln Arg Ser Thr Glu Ile
805 810 815
Leu Gln Asp Leu Thr Asp Arg Asn Ile Ser Asp Phe Leu Val Lys Thr
820 825 830
Tyr Pro Ala Leu Ile Arg Ser Ser Leu Lys Ser Lys Phe Trp Val Asn
835 840 845
Glu Gln Arg Tyr Gly Gly Ile Ser Ile Gly Gly Lys Leu Pro Val Val
850 855 860
Pro Ile Thr Gly Glu Ala Leu Val Gly Phe Leu Ser Asp Leu Gly Arg
865 870 875 880
Ile Met Asn Val Ser Gly Gly Pro Ile Thr Arg Glu Ala Ser Lys Glu
885 890 895
Ile Pro Asp Phe Leu Lys His Leu Glu Thr Glu Asp Asn Ile Lys Val
900 905 910
Trp Phe Asn Asn Lys Gly Trp His Ala Leu Val Ser Phe Leu Asn Val
915 920 925
Ala His Asn Ala Ile Leu Arg Leu Arg Leu His Glu Leu Thr Lys Ile
930 935 940
Tyr Pro Gly Thr Ser Ser Pro Ala Val Asp Arg Leu Cys Val Gly Val
945 950 955 960
Arg Pro Gly Glu Cys Phe Gly Leu Leu Gly Val Asn Gly Ala Gly Lys
965 970 975
Thr Thr Thr Phe Lys Met Leu Thr Gly Asp Thr Thr Val Thr Ser Gly
980 985 990
Asp Ala Thr Val Ala Gly Lys Ser Ile Leu Thr Asn Ile Ser Glu Val
995 1000 1005
His Gln Asn Met Gly Tyr Cys Pro Gln Phe Asp Ala Ile Asp Glu
1010 1015 1020
Leu Leu Thr Gly Arg Glu His Leu Tyr Leu Tyr Ala Arg Leu Arg
1025 1030 1035
Gly Val Pro Ala Glu Glu Ile Glu Lys Val Ala Asn Trp Ser Ile
1040 1045 1050
Lys Ser Leu Gly Leu Thr Val Tyr Ala Asp Cys Leu Ala Gly Thr
1055 1060 1065
Tyr Ser Gly Gly Asn Lys Arg Lys Leu Ser Thr Ala Ile Ala Leu
1070 1075 1080
Ile Gly Cys Pro Pro Leu Val Leu Leu Asp Glu Pro Thr Thr Gly
1085 1090 1095
Met Asp Pro Gln Ala Arg Arg Met Leu Trp Asn Val Ile Val Ser
1100 1105 1110
Ile Ile Arg Glu Gly Arg Ala Val Val Leu Thr Ser His Ser Met
1115 1120 1125
Glu Glu Cys Glu Ala Leu Cys Thr Arg Leu Ala Ile Met Val Lys
1130 1135 1140
Gly Ala Phe Arg Cys Met Gly Thr Ile Gln His Leu Lys Ser Lys
1145 1150 1155
Phe Gly Asp Gly Tyr Ile Val Thr Met Lys Ile Lys Ser Pro Lys
1160 1165 1170
Asp Asp Leu Leu Pro Asp Leu Asn Pro Val Glu Gln Phe Phe Gln
1175 1180 1185
Gly Asn Phe Pro Gly Ser Val Gln Arg Glu Arg His Tyr Asn Met
1190 1195 1200
Leu Gln Phe Gln Val Ser Ser Ser Ser Leu Ala Arg Ile Phe Gln
1205 1210 1215
Leu Leu Leu Ser His Lys Asp Ser Leu Leu Ile Glu Glu Tyr Ser
1220 1225 1230
Val Thr Gln Thr Thr Leu Asp Gln Val Phe Val Asn Phe Ala Lys
1235 1240 1245
Gln Gln Thr Glu Ser His Asp Leu Pro Leu His Pro Arg Ala Ala
1250 1255 1260
Gly Ala Ser Arg Gln Ala Gln Asp
1265 1270
<210> 10
<211> 1267
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 10
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Ser His His Glu Cys His Phe Pro Asn Lys Ala Met Pro Ser Ala
50 55 60
Gly Met Leu Pro Trp Leu Gln Gly Ile Phe Cys Asn Val Asn Asn Pro
65 70 75 80
Cys Phe Gln Ser Pro Thr Pro Gly Glu Ser Pro Gly Ile Val Ser Asn
85 90 95
Tyr Asn Asn Ser Ile Leu Ala Arg Val Tyr Arg Asp Phe Gln Glu Leu
100 105 110
Leu Met Asn Ala Pro Glu Ser Gln His Leu Gly Arg Ile Trp Thr Glu
115 120 125
Leu His Ile Leu Ser Gln Phe Met Asp Thr Leu Arg Thr His Pro Glu
130 135 140
Arg Ile Ala Gly Arg Gly Ile Arg Ile Arg Asp Ile Leu Lys Asp Glu
145 150 155 160
Glu Thr Leu Thr Leu Phe Leu Ile Lys Asn Ile Gly Leu Ser Asp Ser
165 170 175
Val Val Tyr Leu Leu Ile Asn Ser Gln Val Arg Pro Glu Gln Phe Ala
180 185 190
His Gly Val Pro Asp Leu Ala Leu Lys Asp Ile Ala Cys Ser Glu Ala
195 200 205
Leu Leu Glu Arg Phe Ile Ile Phe Ser Gln Arg Arg Gly Ala Lys Thr
210 215 220
Val Arg Tyr Ala Leu Cys Ser Leu Ser Gln Gly Thr Leu Gln Trp Ile
225 230 235 240
Glu Asp Thr Leu Tyr Val Cys Val Lys Asn Leu Val Lys Ile Phe Glu
245 250 255
Pro Cys Gly Arg Pro Ala Val Asp Arg Leu Asn Ile Thr Phe Tyr Glu
260 265 270
Asn Gln Ile Thr Ala Phe Leu Gly His Asn Gly Ala Gly Lys Thr Thr
275 280 285
Thr Leu Ser Ile Leu Thr Gly Leu Leu Pro Pro Thr Ser Gly Thr Val
290 295 300
Leu Val Gly Gly Arg Asp Ile Glu Thr Ser Leu Asp Ala Val Arg Gln
305 310 315 320
Ser Leu Gly Met Cys Pro Gln His Asn Ile Leu Phe His His Leu Thr
325 330 335
Val Ala Glu His Met Leu Phe Tyr Ala Gln Leu Lys Gly Lys Ser Gln
340 345 350
Glu Glu Ala Gln Leu Glu Met Glu Ala Met Leu Glu Asp Thr Gly Leu
355 360 365
His His Lys Arg Asn Glu Glu Ala Gln Asp Leu Ser Gly Gly Met Gln
370 375 380
Arg Lys Leu Ser Val Ala Ile Ala Phe Val Gly Asp Ala Lys Val Val
385 390 395 400
Ile Leu Asp Glu Pro Thr Ser Gly Val Asp Pro Tyr Ser Arg Arg Ser
405 410 415
Ile Trp Asp Leu Leu Leu Lys Tyr Arg Ser Gly Arg Thr Ile Ile Met
420 425 430
Ser Thr His His Met Asp Glu Ala Asp Leu Leu Gly Asp Arg Ile Ala
435 440 445
Ile Ile Ala Gln Gly Arg Leu Tyr Cys Ser Gly Thr Pro Leu Phe Leu
450 455 460
Lys Asn Cys Phe Gly Thr Gly Leu Tyr Leu Thr Leu Val Gly Glu Tyr
465 470 475 480
Pro Ala Leu Thr Leu His Pro Trp Ile Tyr Gly Gln Gln Tyr Thr Phe
485 490 495
Phe Ser Met Asp Glu Pro Gly Ser Glu Gln Phe Thr Val Leu Ala Asp
500 505 510
Val Leu Leu Asn Lys Pro Gly Phe Gly Asn Arg Cys Leu Lys Glu Gly
515 520 525
Trp Leu Pro Glu Tyr Pro Cys Gly Asn Ser Thr Pro Trp Lys Thr Pro
530 535 540
Ser Val Ser Pro Asn Ile Thr Gln Leu Phe Gln Lys Gln Lys Trp Thr
545 550 555 560
Gln Val Asn Pro Ser Pro Ser Cys Arg Cys Ser Thr Arg Glu Lys Leu
565 570 575
Thr Met Leu Pro Glu Cys Pro Glu Gly Ala Gly Gly Leu Pro Pro Pro
580 585 590
Gln Arg Thr Gln Arg Ser Thr Glu Ile Leu Gln Asp Leu Thr Asp Arg
595 600 605
Asn Ile Ser Asp Phe Leu Val Lys Thr Tyr Pro Ala Leu Ile Arg Ser
610 615 620
Ser Leu Lys Ser Lys Phe Trp Val Asn Glu Gln Arg Tyr Gly Gly Ile
625 630 635 640
Ser Ile Gly Gly Lys Leu Pro Val Val Pro Ile Thr Gly Glu Ala Leu
645 650 655
Val Gly Phe Leu Ser Asp Leu Gly Arg Ile Met Asn Val Ser Gly Gly
660 665 670
Pro Ile Thr Arg Glu Ala Ser Lys Glu Ile Pro Asp Phe Leu Lys His
675 680 685
Leu Glu Thr Glu Asp Asn Ile Lys Val Trp Phe Asn Asn Lys Gly Trp
690 695 700
His Ala Leu Val Ser Phe Leu Asn Val Ala His Asn Ala Ile Leu Arg
705 710 715 720
Asn Phe Leu Trp Asp Ile Met Asn Tyr Ser Val Ser Ala Gly Leu Val
725 730 735
Val Gly Ile Phe Ile Gly Phe Gln Lys Lys Ala Tyr Thr Ser Pro Glu
740 745 750
Asn Leu Pro Ala Leu Val Ala Leu Leu Leu Leu Tyr Gly Trp Ala Val
755 760 765
Ile Pro Met Met Tyr Pro Ala Ser Phe Leu Phe Asp Val Pro Ser Thr
770 775 780
Ala Tyr Val Ala Leu Ser Cys Ala Asn Leu Phe Ile Gly Ile Asn Ser
785 790 795 800
Ser Ala Ile Thr Phe Ile Leu Glu Leu Phe Glu Asn Asn Arg Thr Leu
805 810 815
Leu Arg Phe Asn Ala Val Leu Arg Lys Leu Leu Ile Val Phe Pro His
820 825 830
Phe Cys Leu Gly Arg Gly Leu Ile Asp Leu Ala Leu Ser Gln Ala Val
835 840 845
Thr Asp Val Tyr Ala Arg Phe Gly Glu Glu His Ser Ala Asn Pro Phe
850 855 860
His Trp Asp Leu Ile Gly Lys Asn Leu Phe Ala Met Val Val Glu Gly
865 870 875 880
Val Val Tyr Phe Leu Leu Thr Leu Leu Val Gln Arg His Phe Phe Leu
885 890 895
Ser Gln Trp Ile Ala Glu Pro Thr Lys Glu Pro Ile Val Asp Glu Asp
900 905 910
Asp Asp Val Ala Glu Glu Arg Gln Arg Ile Ile Thr Gly Gly Asn Lys
915 920 925
Thr Asp Ile Leu Arg Leu His Glu Leu Thr Lys Ile Tyr Pro Gly Thr
930 935 940
Ser Ser Pro Ala Val Asp Arg Leu Cys Val Gly Val Arg Pro Gly Glu
945 950 955 960
Cys Phe Gly Leu Leu Gly Val Asn Gly Ala Gly Lys Thr Thr Thr Phe
965 970 975
Lys Met Leu Thr Gly Asp Thr Thr Val Thr Ser Gly Asp Ala Thr Val
980 985 990
Ala Gly Lys Ser Ile Leu Thr Asn Ile Ser Glu Val His Gln Asn Met
995 1000 1005
Gly Tyr Cys Pro Gln Phe Asp Ala Ile Asp Glu Leu Leu Thr Gly
1010 1015 1020
Arg Glu His Leu Tyr Leu Tyr Ala Arg Leu Arg Gly Val Pro Ala
1025 1030 1035
Glu Glu Ile Glu Lys Val Ala Asn Trp Ser Ile Lys Ser Leu Gly
1040 1045 1050
Leu Thr Val Tyr Ala Asp Cys Leu Ala Gly Thr Tyr Ser Gly Gly
1055 1060 1065
Asn Lys Arg Lys Leu Ser Thr Ala Ile Ala Leu Ile Gly Cys Pro
1070 1075 1080
Pro Leu Val Leu Leu Asp Glu Pro Thr Thr Gly Met Asp Pro Gln
1085 1090 1095
Ala Arg Arg Met Leu Trp Asn Val Ile Val Ser Ile Ile Arg Glu
1100 1105 1110
Gly Arg Ala Val Val Leu Thr Ser His Ser Met Glu Glu Cys Glu
1115 1120 1125
Ala Leu Cys Thr Arg Leu Ala Ile Met Val Lys Gly Ala Phe Arg
1130 1135 1140
Cys Met Gly Thr Ile Gln His Leu Lys Ser Lys Phe Gly Asp Gly
1145 1150 1155
Tyr Ile Val Thr Met Lys Ile Lys Ser Pro Lys Asp Asp Leu Leu
1160 1165 1170
Pro Asp Leu Asn Pro Val Glu Gln Phe Phe Gln Gly Asn Phe Pro
1175 1180 1185
Gly Ser Val Gln Arg Glu Arg His Tyr Asn Met Leu Gln Phe Gln
1190 1195 1200
Val Ser Ser Ser Ser Leu Ala Arg Ile Phe Gln Leu Leu Leu Ser
1205 1210 1215
His Lys Asp Ser Leu Leu Ile Glu Glu Tyr Ser Val Thr Gln Thr
1220 1225 1230
Thr Leu Asp Gln Val Phe Val Asn Phe Ala Lys Gln Gln Thr Glu
1235 1240 1245
Ser His Asp Leu Pro Leu His Pro Arg Ala Ala Gly Ala Ser Arg
1250 1255 1260
Gln Ala Gln Asp
1265
<210> 11
<211> 1353
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 11
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Ser His His Glu Cys His Phe Pro Asn Lys Ala Met Pro Ser Ala
50 55 60
Gly Met Leu Pro Trp Leu Gln Gly Ile Phe Cys Asn Val Asn Asn Pro
65 70 75 80
Cys Phe Gln Ser Pro Thr Pro Gly Glu Ser Pro Gly Ile Val Ser Asn
85 90 95
Tyr Asn Asn Ser Ile Leu Ala Arg Val Tyr Arg Asp Phe Gln Glu Leu
100 105 110
Leu Met Asn Ala Pro Glu Ser Gln His Leu Gly Arg Ile Trp Thr Glu
115 120 125
Leu His Ile Leu Ser Gln Phe Met Asp Thr Leu Arg Thr His Pro Glu
130 135 140
Arg Ile Ala Gly Arg Gly Ile Arg Ile Arg Asp Ile Leu Lys Asp Glu
145 150 155 160
Glu Thr Leu Thr Leu Phe Leu Ile Lys Asn Ile Gly Leu Ser Asp Ser
165 170 175
Val Val Tyr Leu Leu Ile Asn Ser Gln Val Arg Pro Glu Gln Phe Ala
180 185 190
His Gly Val Pro Asp Leu Ala Leu Lys Asp Ile Ala Cys Ser Glu Ala
195 200 205
Leu Leu Glu Arg Phe Ile Ile Phe Ser Gln Arg Arg Gly Ala Lys Thr
210 215 220
Val Arg Tyr Ala Leu Cys Ser Leu Ser Gln Gly Thr Leu Gln Trp Ile
225 230 235 240
Glu Asp Thr Leu Tyr Ala Asn Val Asp Phe Phe Lys Leu Phe Arg Val
245 250 255
Leu Pro Thr Leu Leu Asp Ser Arg Ser Gln Gly Ile Asn Leu Arg Ser
260 265 270
Trp Gly Gly Ile Leu Ser Asp Met Ser Pro Arg Ile Gln Glu Phe Ile
275 280 285
His Arg Pro Ser Met Gln Asp Leu Leu Trp Val Thr Arg Pro Leu Met
290 295 300
Gln Asn Gly Gly Pro Glu Thr Phe Thr Lys Leu Met Gly Ile Leu Ser
305 310 315 320
Asp Leu Leu Cys Gly Tyr Pro Glu Gly Gly Gly Ser Arg Val Leu Ser
325 330 335
Phe Asn Trp Tyr Glu Asp Asn Asn Tyr Lys Ala Phe Leu Gly Ile Asp
340 345 350
Ser Thr Arg Lys Asp Pro Ile Tyr Ser Tyr Asp Arg Arg Thr Thr Ser
355 360 365
Phe Cys Asn Ala Leu Ile Gln Ser Leu Glu Ser Asn Pro Leu Thr Lys
370 375 380
Ile Ala Trp Arg Ala Ala Lys Pro Leu Leu Met Gly Lys Ile Leu Tyr
385 390 395 400
Thr Pro Asp Ser Pro Ala Ala Arg Arg Ile Leu Lys Asn Ala Asn Ser
405 410 415
Thr Phe Glu Glu Leu Glu His Val Arg Lys Leu Val Lys Ala Trp Glu
420 425 430
Glu Val Gly Pro Gln Ile Trp Tyr Phe Phe Asp Asn Ser Thr Gln Met
435 440 445
Asn Met Ile Arg Asp Thr Leu Gly Asn Pro Thr Val Lys Asp Phe Leu
450 455 460
Asn Arg Gln Leu Gly Glu Glu Gly Ile Thr Ala Glu Ala Ile Leu Asn
465 470 475 480
Phe Leu Tyr Lys Gly Pro Arg Glu Ser Gln Ala Asp Asp Met Ala Asn
485 490 495
Phe Asp Trp Arg Asp Ile Phe Asn Ile Thr Asp Arg Thr Leu Arg Leu
500 505 510
Val Asn Gln Tyr Leu Glu Cys Leu Val Leu Asp Lys Phe Glu Ser Tyr
515 520 525
Asn Asp Glu Thr Gln Leu Thr Gln Arg Ala Leu Ser Leu Leu Glu Glu
530 535 540
Asn Met Phe Trp Ala Gly Val Val Phe Pro Asp Met Tyr Pro Trp Thr
545 550 555 560
Ser Ser Leu Pro Pro His Val Lys Tyr Lys Ile Arg Met Asp Ile Asp
565 570 575
Val Val Glu Lys Thr Asn Lys Ile Lys Asp Arg Tyr Trp Asp Ser Gly
580 585 590
Pro Arg Ala Asp Pro Val Glu Asp Phe Arg Tyr Ile Trp Gly Gly Phe
595 600 605
Ala Tyr Leu Gln Asp Met Val Glu Gln Gly Ile Thr Arg Ser Gln Val
610 615 620
Gln Ala Glu Ala Pro Val Gly Ile Tyr Leu Gln Gln Met Pro Tyr Pro
625 630 635 640
Cys Phe Val Asp Asp Ser Phe Met Ile Ile Leu Asn Arg Cys Phe Pro
645 650 655
Ile Phe Met Val Leu Ala Trp Ile Tyr Ser Val Ser Met Thr Val Lys
660 665 670
Ser Ile Val Leu Glu Lys Glu Leu Arg Leu Lys Glu Thr Leu Lys Asn
675 680 685
Gln Gly Val Ser Asn Ala Val Ile Trp Cys Thr Trp Phe Leu Asp Ser
690 695 700
Phe Ser Ile Met Ser Met Ser Ile Phe Leu Leu Thr Ile Phe Ile Met
705 710 715 720
His Gly Arg Ile Leu His Tyr Ser Asp Pro Phe Ile Leu Phe Leu Phe
725 730 735
Leu Leu Ala Phe Ser Thr Ala Thr Ile Met Leu Cys Phe Leu Leu Ser
740 745 750
Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala Ala Cys Ser Gly Val Ile
755 760 765
Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu Cys Phe Ala Trp Gln Asp
770 775 780
Arg Met Thr Ala Glu Leu Lys Lys Ala Val Ser Leu Leu Ser Pro Val
785 790 795 800
Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val Arg Phe Glu Glu Gln Gly
805 810 815
Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn Ser Pro Thr Glu Gly Asp
820 825 830
Glu Phe Ser Phe Leu Leu Ser Met Gln Met Met Leu Leu Asp Ala Ala
835 840 845
Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp Gln Val Leu Thr Glu Glu
850 855 860
Thr Glu Asp Pro Glu His Pro Glu Gly Ile His Asp Ser Phe Phe Glu
865 870 875 880
Arg Glu His Pro Gly Trp Val Pro Gly Val Cys Val Lys Asn Leu Val
885 890 895
Lys Ile Phe Glu Pro Cys Gly Arg Pro Ala Val Asp Arg Leu Asn Ile
900 905 910
Thr Phe Tyr Glu Asn Gln Ile Thr Ala Phe Leu Gly His Asn Gly Ala
915 920 925
Gly Lys Thr Thr Thr Leu Ser Ile Leu Thr Gly Leu Leu Pro Pro Thr
930 935 940
Ser Gly Thr Val Leu Val Gly Gly Arg Asp Ile Glu Thr Ser Leu Asp
945 950 955 960
Ala Gly Glu Tyr Pro Ala Leu Thr Leu His Pro Trp Ile Tyr Gly Gln
965 970 975
Gln Tyr Thr Phe Phe Ser Met Asp Glu Pro Gly Ser Glu Gln Phe Thr
980 985 990
Val Leu Ala Asp Val Leu Leu Asn Lys Pro Gly Phe Gly Asn Arg Cys
995 1000 1005
Leu Lys Glu Gly Trp Leu Pro Glu Tyr Pro Cys Gly Asn Ser Thr
1010 1015 1020
Pro Trp Lys Thr Pro Ser Val Ser Pro Asn Ile Thr Gln Leu Phe
1025 1030 1035
Gln Lys Gln Lys Trp Thr Gln Val Asn Pro Ser Pro Ser Cys Arg
1040 1045 1050
Cys Ser Thr Arg Glu Lys Leu Thr Met Leu Pro Leu Arg Leu His
1055 1060 1065
Glu Leu Thr Lys Ile Tyr Pro Gly Thr Ser Ser Pro Ala Val Asp
1070 1075 1080
Arg Leu Cys Val Gly Val Arg Pro Gly Glu Cys Phe Gly Leu Leu
1085 1090 1095
Gly Val Asn Gly Ala Gly Lys Thr Thr Thr Phe Lys Met Leu Thr
1100 1105 1110
Gly Asp Thr Thr Val Thr Ser Gly Asp Ala Thr Val Ala Gly Lys
1115 1120 1125
Ser Ile Leu Thr Asn Ile Ser Glu Val His Gln Asn Met Gly Tyr
1130 1135 1140
Cys Pro Gln Phe Asp Ala Ile Asp Glu Leu Leu Thr Gly Arg Glu
1145 1150 1155
His Leu Tyr Leu Tyr Ala Arg Leu Arg Gly Val Pro Ala Glu Glu
1160 1165 1170
Ile Glu Lys Val Ala Asn Trp Ser Ile Lys Ser Leu Gly Leu Thr
1175 1180 1185
Val Tyr Ala Asp Cys Leu Ala Gly Thr Tyr Ser Gly Gly Asn Lys
1190 1195 1200
Arg Lys Leu Ser Thr Ala Ile Ala Leu Ile Gly Cys Pro Pro Leu
1205 1210 1215
Val Leu Leu Asp Glu Pro Thr Thr Gly Met Asp Pro Gln Ala Arg
1220 1225 1230
Arg Met Leu Trp Asn Val Ile Val Ser Ile Ile Arg Glu Gly Arg
1235 1240 1245
Ala Val Val Leu Thr Ser His Ser Met Glu Glu Cys Glu Ala Leu
1250 1255 1260
Cys Thr Arg Leu Ala Ile Met Val Lys Gly Ala Phe Arg Cys Met
1265 1270 1275
Gly Thr Ile Gln His Leu Lys Ser Lys Phe Gly Asp Gly Tyr Ile
1280 1285 1290
Val Thr Met Lys Ile Lys Ser Pro Lys Asp Asp Leu Leu Pro Asp
1295 1300 1305
Leu Asn Pro Val Glu Gln Phe Phe Gln Gly Asn Phe Pro Gly Ser
1310 1315 1320
Val Gln Arg Glu Arg His Tyr Asn Met Leu Gln Phe Gln Val Ser
1325 1330 1335
Ser Ser Ser Leu Ala Arg Ile Phe Gln Val Phe Val Asn Phe Ala
1340 1345 1350
<210> 12
<211> 1222
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 12
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Ser His His Glu Cys His Phe Pro Asn Lys Ala Met Pro Ser Ala
50 55 60
Gly Met Leu Pro Trp Leu Gln Gly Ile Phe Cys Asn Val Asn Asn Pro
65 70 75 80
Cys Phe Gln Ser Pro Thr Pro Gly Glu Ser Pro Gly Ile Val Ser Asn
85 90 95
Tyr Asn Asn Ser Ile Leu Ala Arg Val Tyr Arg Asp Phe Gln Glu Leu
100 105 110
Leu Met Asn Ala Pro Glu Ser Gln His Leu Gly Arg Ile Trp Thr Glu
115 120 125
Leu His Ile Leu Ser Gln Phe Met Asp Thr Leu Arg Thr His Pro Glu
130 135 140
Arg Ile Ala Gly Arg Gly Ile Arg Ile Arg Asp Ile Leu Lys Asp Glu
145 150 155 160
Glu Thr Leu Thr Leu Phe Leu Ile Lys Asn Ile Gly Leu Ser Asp Ser
165 170 175
Val Val Tyr Leu Leu Ile Asn Ser Gln Val Arg Pro Glu Gln Phe Ala
180 185 190
His Gly Val Pro Asp Leu Ala Leu Lys Asp Ile Ala Cys Ser Glu Ala
195 200 205
Leu Leu Glu Arg Phe Ile Ile Phe Ser Gln Arg Arg Gly Ala Lys Thr
210 215 220
Val Arg Tyr Ala Leu Cys Ser Leu Ser Gln Gly Thr Leu Gln Trp Ile
225 230 235 240
Glu Asp Thr Leu Tyr Ala Asn Val Asp Phe Phe Lys Leu Phe Arg Val
245 250 255
Leu Pro Thr Leu Leu Asp Ser Arg Ser Gln Gly Ile Asn Leu Arg Ser
260 265 270
Trp Gly Gly Ile Leu Ser Asp Met Ser Pro Arg Ile Gln Glu Phe Ile
275 280 285
His Arg Pro Ser Met Gln Asp Leu Leu Trp Val Thr Arg Pro Leu Met
290 295 300
Gln Asn Gly Gly Pro Glu Thr Phe Thr Lys Leu Met Gly Ile Leu Ser
305 310 315 320
Asp Leu Leu Cys Gly Tyr Pro Glu Gly Gly Gly Ser Arg Val Leu Ser
325 330 335
Phe Asn Trp Tyr Glu Asp Asn Asn Tyr Lys Ala Phe Leu Gly Ile Asp
340 345 350
Ser Thr Arg Lys Asp Pro Ile Tyr Ser Tyr Asp Arg Arg Thr Thr Ser
355 360 365
Phe Cys Asn Ala Leu Ile Gln Ser Leu Glu Ser Asn Pro Leu Thr Lys
370 375 380
Ile Ala Trp Arg Ala Ala Lys Pro Leu Leu Met Gly Lys Ile Leu Tyr
385 390 395 400
Thr Pro Asp Ser Pro Ala Ala Arg Arg Ile Leu Lys Asn Ala Asn Ser
405 410 415
Thr Phe Glu Glu Leu Glu His Val Arg Lys Leu Val Lys Ala Trp Glu
420 425 430
Glu Val Gly Pro Gln Ile Trp Tyr Phe Phe Asp Asn Ser Thr Gln Met
435 440 445
Asn Met Ile Arg Asp Thr Leu Gly Asn Pro Thr Val Lys Asp Phe Leu
450 455 460
Asn Arg Gln Leu Gly Glu Glu Gly Ile Thr Ala Glu Ala Ile Leu Asn
465 470 475 480
Phe Leu Tyr Lys Gly Pro Arg Glu Ser Gln Ala Asp Asp Met Ala Asn
485 490 495
Phe Asp Trp Arg Asp Ile Phe Asn Ile Thr Asp Arg Thr Leu Arg Leu
500 505 510
Val Asn Gln Tyr Leu Glu Cys Leu Val Leu Asp Lys Phe Glu Ser Tyr
515 520 525
Asn Asp Glu Thr Gln Leu Thr Gln Arg Ala Leu Ser Leu Leu Glu Glu
530 535 540
Asn Met Phe Trp Ala Gly Val Val Phe Pro Asp Met Tyr Pro Trp Thr
545 550 555 560
Ser Ser Leu Pro Pro His Val Lys Tyr Lys Ile Arg Met Asp Ile Asp
565 570 575
Val Val Glu Lys Thr Asn Lys Ile Lys Asp Arg Tyr Trp Asp Ser Gly
580 585 590
Pro Arg Ala Asp Pro Val Glu Asp Phe Arg Tyr Ile Trp Gly Gly Phe
595 600 605
Ala Tyr Leu Gln Asp Met Val Glu Gln Gly Ile Thr Arg Ser Gln Val
610 615 620
Gln Ala Glu Ala Pro Val Gly Ile Tyr Leu Gln Gln Met Pro Tyr Pro
625 630 635 640
Cys Phe Val Asp Asp Ser Phe Met Ile Ile Leu Asn Arg Cys Phe Pro
645 650 655
Ile Phe Met Val Leu Ala Trp Ile Tyr Ser Val Ser Met Thr Val Lys
660 665 670
Ser Ile Val Leu Glu Lys Glu Leu Arg Leu Lys Glu Thr Leu Lys Asn
675 680 685
Gln Gly Val Ser Asn Ala Val Ile Trp Cys Thr Trp Phe Leu Asp Ser
690 695 700
Phe Ser Ile Met Ser Met Ser Ile Phe Leu Leu Thr Ile Phe Ile Met
705 710 715 720
His Gly Arg Ile Leu His Tyr Ser Asp Pro Phe Ile Leu Phe Leu Phe
725 730 735
Leu Leu Ala Phe Ser Thr Ala Thr Ile Met Leu Cys Phe Leu Leu Ser
740 745 750
Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala Ala Cys Ser Gly Val Ile
755 760 765
Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu Cys Phe Ala Trp Gln Asp
770 775 780
Arg Met Thr Ala Glu Leu Lys Lys Ala Val Ser Leu Leu Ser Pro Val
785 790 795 800
Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val Arg Phe Glu Glu Gln Gly
805 810 815
Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn Ser Pro Thr Glu Gly Asp
820 825 830
Glu Phe Ser Phe Leu Leu Ser Met Gln Met Met Leu Leu Asp Ala Ala
835 840 845
Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp Gln Val Val Arg Gln Ser
850 855 860
Leu Gly Met Cys Pro Gln His Asn Ile Leu Phe His His Leu Thr Val
865 870 875 880
Ala Glu His Met Leu Phe Tyr Ala Gln Leu Lys Gly Lys Ser Gln Glu
885 890 895
Glu Ala Gln Leu Glu Met Glu Ala Met Leu Glu Asp Thr Gly Leu His
900 905 910
His Lys Arg Asn Glu Glu Ala Gln Asp Leu Ser Gly Gly Met Gln Arg
915 920 925
Lys Leu Ser Val Ala Ile Ala Phe Val Gly Asp Ala Lys Val Val Ile
930 935 940
Leu Asp Glu Pro Thr Ser Gly Val Asp Pro Tyr Ser Arg Arg Ser Ile
945 950 955 960
Trp Asp Leu Leu Leu Lys Tyr Arg Ser Gly Arg Thr Ile Ile Met Ser
965 970 975
Thr His His Met Asp Glu Ala Asp Leu Leu Gly Asp Arg Ile Ala Ile
980 985 990
Ile Ala Gln Gly Arg Leu Tyr Cys Ser Gly Thr Pro Leu Phe Leu Lys
995 1000 1005
Asn Cys Phe Gly Thr Gly Leu Tyr Leu Thr Leu Val Gly Glu Tyr
1010 1015 1020
Pro Ala Leu Thr Leu His Pro Trp Ile Tyr Gly Gln Gln Tyr Thr
1025 1030 1035
Phe Phe Ser Met Asp Glu Pro Gly Ser Glu Gln Phe Thr Val Leu
1040 1045 1050
Ala Asp Val Leu Leu Asn Lys Pro Gly Phe Gly Asn Arg Cys Leu
1055 1060 1065
Lys Glu Gly Trp Leu Pro Glu Tyr Pro Cys Gly Asn Ser Thr Pro
1070 1075 1080
Trp Lys Thr Pro Ser Val Ser Pro Asn Ile Thr Gln Leu Phe Gln
1085 1090 1095
Lys Gln Lys Trp Thr Gln Val Asn Pro Ser Pro Ser Cys Arg Cys
1100 1105 1110
Ser Thr Arg Glu Lys Leu Thr Met Leu Pro Leu Arg Leu His Glu
1115 1120 1125
Leu Thr Lys Ile Tyr Pro Gly Thr Ser Ser Pro Ala Val Asp Arg
1130 1135 1140
Leu Cys Val Gly Val Arg Pro Gly Glu Cys Phe Gly Leu Leu Gly
1145 1150 1155
Val Asn Gly Ala Gly Lys Thr Thr Thr Phe Lys Met Leu Thr Gly
1160 1165 1170
Asp Thr Thr Val Thr Ser Gly Asp Ala Thr Val Ala Gly Ile Lys
1175 1180 1185
Ser Pro Lys Asp Asp Leu Leu Pro Asp Leu Asn Pro Val Glu Gln
1190 1195 1200
Phe Phe Gln Gly Asn Phe Pro Gly Ser Val Gln Arg Glu Val Phe
1205 1210 1215
Val Asn Phe Ala
1220
<210> 13
<211> 1022
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 13
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Ser His His Glu Cys His Phe Pro Asn Lys Ala Met Pro Ser Ala
50 55 60
Gly Met Leu Pro Trp Leu Gln Gly Ile Phe Cys Asn Val Asn Asn Pro
65 70 75 80
Cys Phe Gln Ser Pro Thr Pro Gly Glu Ser Pro Gly Ile Val Ser Asn
85 90 95
Tyr Asn Asn Ser Ile Leu Ala Arg Val Tyr Arg Asp Phe Gln Glu Leu
100 105 110
Leu Met Asn Ala Pro Glu Ser Gln His Leu Gly Arg Ile Trp Thr Glu
115 120 125
Leu His Ile Leu Ser Gln Phe Met Asp Thr Leu Arg Thr His Pro Glu
130 135 140
Arg Ile Ala Gly Arg Gly Ile Arg Ile Arg Asp Ile Leu Lys Asp Glu
145 150 155 160
Glu Thr Leu Thr Leu Phe Leu Ile Lys Asn Ile Gly Leu Ser Asp Ser
165 170 175
Val Val Tyr Leu Leu Ile Asn Ser Gln Val Arg Pro Glu Gln Phe Ala
180 185 190
His Gly Val Pro Asp Leu Ala Leu Lys Asp Ile Ala Cys Ser Glu Ala
195 200 205
Leu Leu Glu Arg Phe Ile Ile Phe Ser Gln Arg Arg Gly Ala Lys Thr
210 215 220
Val Arg Tyr Ala Leu Cys Ser Leu Ser Gln Gly Thr Leu Gln Trp Ile
225 230 235 240
Glu Asp Thr Leu Tyr Ser Phe Met Ile Ile Leu Asn Arg Cys Phe Pro
245 250 255
Ile Phe Met Val Leu Ala Trp Ile Tyr Ser Val Ser Met Thr Val Lys
260 265 270
Ser Ile Val Leu Glu Lys Glu Leu Arg Leu Lys Glu Thr Leu Lys Asn
275 280 285
Gln Gly Val Ser Asn Ala Val Ile Trp Cys Thr Trp Phe Leu Asp Ser
290 295 300
Phe Ser Ile Met Ser Met Ser Ile Phe Leu Leu Thr Ile Phe Ile Met
305 310 315 320
His Gly Arg Ile Leu His Tyr Ser Asp Pro Phe Ile Leu Phe Leu Phe
325 330 335
Leu Leu Ala Phe Ser Thr Ala Thr Ile Met Leu Cys Phe Leu Leu Ser
340 345 350
Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala Ala Cys Ser Gly Val Ile
355 360 365
Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu Cys Phe Ala Trp Gln Asp
370 375 380
Arg Met Thr Ala Glu Leu Lys Lys Ala Val Ser Leu Leu Ser Pro Val
385 390 395 400
Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val Arg Phe Glu Glu Gln Gly
405 410 415
Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn Ser Pro Thr Glu Gly Asp
420 425 430
Glu Phe Ser Phe Leu Leu Ser Met Gln Met Met Leu Leu Asp Ala Ala
435 440 445
Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp Gln Val Leu Thr Glu Glu
450 455 460
Thr Glu Asp Pro Glu His Pro Glu Gly Ile His Asp Ser Phe Phe Glu
465 470 475 480
Arg Glu His Pro Gly Trp Val Pro Gly Val Cys Val Lys Asn Leu Val
485 490 495
Lys Ile Phe Glu Pro Cys Gly Arg Pro Ala Val Asp Arg Leu Asn Ile
500 505 510
Thr Phe Tyr Glu Asn Gln Ile Thr Ala Phe Leu Gly His Asn Gly Ala
515 520 525
Gly Lys Thr Thr Thr Leu Ser Ile Leu Thr Gly Leu Leu Pro Pro Thr
530 535 540
Ser Gly Thr Val Leu Val Gly Gly Arg Asp Ile Glu Thr Ser Leu Asp
545 550 555 560
Ala His Lys Asp Phe Leu Ala Gln Ile Val Leu Pro Ala Thr Phe Val
565 570 575
Phe Leu Ala Leu Met Leu Ser Ile Val Ile Pro Pro Phe Gly Glu Tyr
580 585 590
Pro Ala Leu Thr Leu His Pro Trp Ile Tyr Gly Gln Gln Tyr Thr Phe
595 600 605
Phe Ser Met Asp Glu Pro Gly Ser Glu Gln Phe Thr Val Leu Ala Asp
610 615 620
Val Leu Leu Asn Lys Pro Gly Phe Gly Asn Arg Cys Leu Lys Glu Gly
625 630 635 640
Trp Leu Pro Glu Tyr Pro Cys Gly Asn Ser Thr Pro Trp Lys Thr Pro
645 650 655
Ser Val Ser Pro Asn Ile Thr Gln Leu Phe Gln Lys Gln Lys Trp Thr
660 665 670
Gln Val Asn Pro Ser Pro Ser Cys Arg Cys Ser Thr Arg Glu Lys Leu
675 680 685
Thr Met Leu Pro Asn Phe Leu Trp Asp Ile Met Asn Tyr Ser Val Ser
690 695 700
Ala Gly Leu Val Val Gly Ile Phe Ile Gly Phe Gln Lys Lys Ala Tyr
705 710 715 720
Thr Ser Pro Glu Asn Leu Pro Ala Leu Val Ala Leu Leu Leu Leu Tyr
725 730 735
Gly Trp Ala Val Ile Pro Met Met Tyr Pro Ala Ser Phe Leu Phe Asp
740 745 750
Val Pro Ser Thr Ala Tyr Val Ala Leu Ser Cys Ala Asn Leu Phe Ile
755 760 765
Gly Ile Asn Ser Ser Ala Ile Thr Phe Ile Leu Glu Leu Phe Glu Asn
770 775 780
Asn Arg Thr Leu Leu Arg Phe Asn Ala Val Leu Arg Lys Leu Leu Ile
785 790 795 800
Val Phe Pro His Phe Cys Leu Gly Arg Gly Leu Ile Asp Leu Ala Leu
805 810 815
Ser Gln Ala Val Thr Asp Val Tyr Ala Arg Phe Gly Glu Glu His Ser
820 825 830
Ala Asn Pro Phe His Trp Asp Leu Ile Gly Lys Asn Leu Phe Ala Met
835 840 845
Val Val Glu Gly Val Val Tyr Phe Leu Leu Thr Leu Leu Val Gln Arg
850 855 860
His Phe Phe Leu Ser Gln Trp Ile Ala Glu Pro Thr Lys Glu Pro Ile
865 870 875 880
Val Asp Glu Asp Asp Asp Val Ala Glu Glu Arg Gln Arg Ile Ile Thr
885 890 895
Gly Gly Asn Lys Thr Asp Ile Leu Arg Leu His Glu Leu Thr Lys Ile
900 905 910
Tyr Pro Gly Thr Ser Ser Pro Ala Val Asp Arg Leu Cys Val Gly Val
915 920 925
Arg Pro Gly Glu Cys Phe Gly Leu Leu Gly Val Asn Gly Ala Gly Lys
930 935 940
Thr Thr Thr Phe Lys Met Leu Thr Gly Asp Thr Thr Val Thr Ser Gly
945 950 955 960
Asp Ala Thr Val Ala Gly Ile Lys Ser Pro Lys Asp Asp Leu Leu Pro
965 970 975
Asp Leu Asn Pro Val Glu Gln Phe Phe Gln Gly Asn Phe Pro Gly Ser
980 985 990
Val Gln Arg Glu Arg His Tyr Asn Met Leu Gln Phe Gln Val Ser Ser
995 1000 1005
Ser Ser Leu Ala Arg Ile Phe Gln Val Phe Val Asn Phe Ala
1010 1015 1020
<210> 14
<211> 1466
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 14
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Ala Asn Val Asp Phe
35 40 45
Phe Lys Leu Phe Arg Val Leu Pro Thr Leu Leu Asp Ser Arg Ser Gln
50 55 60
Gly Ile Asn Leu Arg Ser Trp Gly Gly Ile Leu Ser Asp Met Ser Pro
65 70 75 80
Arg Ile Gln Glu Phe Ile His Arg Pro Ser Met Gln Asp Leu Leu Trp
85 90 95
Val Thr Arg Pro Leu Met Gln Asn Gly Gly Pro Glu Thr Phe Thr Lys
100 105 110
Leu Met Gly Ile Leu Ser Asp Leu Leu Cys Gly Tyr Pro Glu Gly Gly
115 120 125
Gly Ser Arg Val Leu Ser Phe Asn Trp Tyr Glu Asp Asn Asn Tyr Lys
130 135 140
Ala Phe Leu Gly Ile Asp Ser Thr Arg Lys Asp Pro Ile Tyr Ser Tyr
145 150 155 160
Asp Arg Arg Thr Thr Ser Phe Cys Asn Ala Leu Ile Gln Ser Leu Glu
165 170 175
Ser Asn Pro Leu Thr Lys Ile Ala Trp Arg Ala Ala Lys Pro Leu Leu
180 185 190
Met Gly Lys Ile Leu Tyr Thr Pro Asp Ser Pro Ala Ala Arg Arg Ile
195 200 205
Leu Lys Asn Ala Asn Ser Thr Phe Glu Glu Leu Glu His Val Arg Lys
210 215 220
Leu Val Lys Ala Trp Glu Glu Val Gly Pro Gln Ile Trp Tyr Phe Phe
225 230 235 240
Asp Asn Ser Thr Gln Met Asn Met Ile Arg Asp Thr Leu Gly Asn Pro
245 250 255
Thr Val Lys Asp Phe Leu Asn Arg Gln Leu Gly Glu Glu Gly Ile Thr
260 265 270
Ala Glu Ala Ile Leu Asn Phe Leu Tyr Lys Gly Pro Arg Glu Ser Gln
275 280 285
Ala Asp Asp Met Ala Asn Phe Asp Trp Arg Asp Ile Phe Asn Ile Thr
290 295 300
Asp Arg Thr Leu Arg Leu Val Asn Gln Tyr Leu Glu Cys Leu Val Leu
305 310 315 320
Asp Lys Phe Glu Ser Tyr Asn Asp Glu Thr Gln Leu Thr Gln Arg Ala
325 330 335
Leu Ser Leu Leu Glu Glu Asn Met Phe Trp Ala Gly Val Val Phe Pro
340 345 350
Asp Met Tyr Pro Trp Thr Ser Ser Leu Pro Pro His Val Lys Tyr Lys
355 360 365
Ile Arg Met Asp Ile Asp Val Val Glu Lys Thr Asn Lys Ile Lys Asp
370 375 380
Arg Tyr Trp Asp Ser Gly Pro Arg Ala Asp Pro Val Glu Asp Phe Arg
385 390 395 400
Tyr Ile Trp Gly Gly Phe Ala Tyr Leu Gln Asp Met Val Glu Gln Gly
405 410 415
Ile Thr Arg Ser Gln Val Gln Ala Glu Ala Pro Val Gly Ile Tyr Leu
420 425 430
Gln Gln Met Pro Tyr Pro Cys Phe Val Asp Asp Ser Phe Met Ile Ile
435 440 445
Leu Asn Arg Cys Phe Pro Ile Phe Met Val Leu Ala Trp Ile Tyr Ser
450 455 460
Val Ser Met Thr Val Lys Ser Ile Val Leu Glu Lys Glu Leu Arg Leu
465 470 475 480
Lys Glu Thr Leu Lys Asn Gln Gly Val Ser Asn Ala Val Ile Trp Cys
485 490 495
Thr Trp Phe Leu Asp Ser Phe Ser Ile Met Ser Met Ser Ile Phe Leu
500 505 510
Leu Thr Ile Phe Ile Met His Gly Arg Ile Leu His Tyr Ser Asp Pro
515 520 525
Phe Ile Leu Phe Leu Phe Leu Leu Ala Phe Ser Thr Ala Thr Ile Met
530 535 540
Leu Cys Phe Leu Leu Ser Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala
545 550 555 560
Ala Cys Ser Gly Val Ile Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu
565 570 575
Cys Phe Ala Trp Gln Asp Arg Met Thr Ala Glu Leu Lys Lys Ala Val
580 585 590
Ser Leu Leu Ser Pro Val Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val
595 600 605
Arg Phe Glu Glu Gln Gly Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn
610 615 620
Ser Pro Thr Glu Gly Asp Glu Phe Ser Phe Leu Leu Ser Met Gln Met
625 630 635 640
Met Leu Leu Asp Ala Ala Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp
645 650 655
Gln Val Val Arg Gln Ser Leu Gly Met Cys Pro Gln His Asn Ile Leu
660 665 670
Phe His His Leu Thr Val Ala Glu His Met Leu Phe Tyr Ala Gln Leu
675 680 685
Lys Gly Lys Ser Gln Glu Glu Ala Gln Leu Glu Met Glu Ala Met Leu
690 695 700
Glu Asp Thr Gly Leu His His Lys Arg Asn Glu Glu Ala Gln Asp Leu
705 710 715 720
Ser Gly Gly Met Gln Arg Lys Leu Ser Val Ala Ile Ala Phe Val Gly
725 730 735
Asp Ala Lys Val Val Ile Leu Asp Glu Pro Thr Ser Gly Val Asp Pro
740 745 750
Tyr Ser Arg Arg Ser Ile Trp Asp Leu Leu Leu Lys Tyr Arg Ser Gly
755 760 765
Arg Thr Ile Ile Met Ser Thr His His Met Asp Glu Ala Asp Leu Leu
770 775 780
Gly Asp Arg Ile Ala Ile Ile Ala Gln Gly Arg Leu Tyr Cys Ser Gly
785 790 795 800
Thr Pro Leu Phe Leu Lys Asn Cys Phe Gly Thr Gly Leu Tyr Leu Thr
805 810 815
Leu Val Arg Lys Met Lys Asn Ile Gln Ser Gln Arg Lys Gly Ser Glu
820 825 830
Gly Thr Cys Ser Cys Ser Ser Lys Gly Phe Ser Thr Thr Cys Pro Ala
835 840 845
His Val Asp Asp Leu Thr Pro Glu Gln Val His Lys Asp Phe Leu Ala
850 855 860
Gln Ile Val Leu Pro Ala Thr Phe Val Phe Leu Ala Leu Met Leu Ser
865 870 875 880
Ile Glu Cys Pro Glu Gly Ala Gly Gly Leu Pro Pro Pro Gln Arg Thr
885 890 895
Gln Arg Ser Thr Glu Ile Leu Gln Asp Leu Thr Asp Arg Asn Ile Ser
900 905 910
Asp Phe Leu Val Lys Thr Tyr Pro Ala Leu Ile Arg Ser Ser Leu Lys
915 920 925
Ser Lys Phe Trp Val Asn Glu Gln Arg Tyr Gly Gly Ile Ser Ile Gly
930 935 940
Gly Lys Leu Pro Val Val Pro Ile Thr Gly Glu Ala Leu Val Gly Phe
945 950 955 960
Leu Ser Asp Leu Gly Arg Ile Met Asn Val Ser Gly Gly Pro Ile Thr
965 970 975
Arg Glu Ala Ser Lys Glu Ile Pro Asp Phe Leu Lys His Leu Glu Thr
980 985 990
Glu Asp Asn Ile Lys Val Trp Phe Asn Asn Lys Gly Trp His Ala Leu
995 1000 1005
Val Ser Phe Leu Asn Val Ala His Asn Ala Ile Leu Arg Ala Ser
1010 1015 1020
Leu Pro Lys Asp Arg Ser Pro Glu Asn Phe Leu Trp Asp Ile Met
1025 1030 1035
Asn Tyr Ser Val Ser Ala Gly Leu Val Val Gly Ile Phe Ile Gly
1040 1045 1050
Phe Gln Lys Lys Ala Tyr Thr Ser Pro Glu Asn Leu Pro Ala Leu
1055 1060 1065
Val Ala Leu Leu Leu Leu Tyr Gly Trp Ala Val Ile Pro Met Met
1070 1075 1080
Tyr Pro Ala Ser Phe Leu Phe Asp Val Pro Ser Thr Ala Tyr Val
1085 1090 1095
Ala Leu Ser Cys Ala Asn Leu Phe Ile Gly Ile Asn Ser Ser Ala
1100 1105 1110
Ile Thr Phe Ile Leu Glu Leu Phe Glu Asn Asn Arg Thr Leu Leu
1115 1120 1125
Arg Phe Asn Ala Val Leu Arg Lys Leu Leu Ile Val Phe Pro His
1130 1135 1140
Phe Cys Leu Gly Arg Gly Leu Ile Asp Leu Ala Leu Ser Gln Ala
1145 1150 1155
Val Thr Asp Val Tyr Ala Arg Phe Gly Glu Glu His Ser Ala Asn
1160 1165 1170
Pro Phe His Trp Asp Leu Ile Gly Lys Asn Leu Phe Ala Met Val
1175 1180 1185
Val Glu Gly Val Val Tyr Phe Leu Leu Thr Leu Leu Val Gln Arg
1190 1195 1200
His Phe Phe Leu Ser Gln Trp Ile Ala Glu Pro Thr Lys Glu Pro
1205 1210 1215
Ile Val Asp Glu Asp Asp Asp Val Ala Glu Glu Arg Gln Arg Ile
1220 1225 1230
Ile Thr Gly Gly Asn Lys Thr Asp Ile Leu Lys Ser Ile Leu Thr
1235 1240 1245
Asn Ile Ser Glu Val His Gln Asn Met Gly Tyr Cys Pro Gln Phe
1250 1255 1260
Asp Ala Ile Asp Glu Leu Leu Thr Gly Arg Glu His Leu Tyr Leu
1265 1270 1275
Tyr Ala Arg Leu Arg Gly Val Pro Ala Glu Glu Ile Glu Lys Val
1280 1285 1290
Ala Asn Trp Ser Ile Lys Ser Leu Gly Leu Thr Val Tyr Ala Asp
1295 1300 1305
Cys Leu Ala Gly Thr Tyr Ser Gly Gly Asn Lys Arg Lys Leu Ser
1310 1315 1320
Thr Ala Ile Ala Leu Ile Gly Cys Pro Pro Leu Val Leu Leu Asp
1325 1330 1335
Glu Pro Thr Thr Gly Met Asp Pro Gln Ala Arg Arg Met Leu Trp
1340 1345 1350
Asn Val Ile Val Ser Ile Ile Arg Glu Gly Arg Ala Val Val Leu
1355 1360 1365
Thr Ser His Ser Met Glu Glu Cys Glu Ala Leu Cys Thr Arg Leu
1370 1375 1380
Ala Ile Met Val Lys Gly Ala Phe Arg Cys Met Gly Thr Ile Gln
1385 1390 1395
His Leu Lys Ser Lys Phe Gly Asp Gly Tyr Ile Val Thr Met Lys
1400 1405 1410
Leu Leu Leu Ser His Lys Asp Ser Leu Leu Ile Glu Glu Tyr Ser
1415 1420 1425
Val Thr Gln Thr Thr Leu Asp Gln Val Phe Val Asn Phe Ala Lys
1430 1435 1440
Gln Gln Thr Glu Ser His Asp Leu Pro Leu His Pro Arg Ala Ala
1445 1450 1455
Gly Ala Ser Arg Gln Ala Gln Asp
1460 1465
<210> 15
<211> 3483
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 15
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaaccc actctacagc catcatgaat gccatttccc caacaaggcg 180
atgccctcag caggaatgct gccgtggctc caggggatct tctgcaatgt gaacaatccc 240
tgttttcaaa gccccacccc aggagaatct cctggaattg tgtcaaacta taacaactcc 300
atcttggcaa gggtatatcg agattttcaa gaactcctca tgaatgcacc agagagccag 360
caccttggcc gtatttggac agagctacac atcttgtccc aattcatgga caccctccgg 420
actcacccgg agagaattgc aggaagagga atacgaataa gggatatctt gaaagatgaa 480
gaaacactga cactatttct cattaaaaac atcggcctgt ctgactcagt ggtctacctt 540
ctgatcaact ctcaagtccg tccagagcag ttcgctcatg gagtcccgga cctggcgctg 600
aaggacatcg cctgcagcga ggccctcctg gagcgcttca tcatcttcag ccagagacgc 660
ggggcaaaga cggtgcgcta tgccctgtgc tccctctccc agggcaccct acagtggata 720
gaagacactc tgtatgccaa cgtggacttc ttcaagctct tccgtgtgct tcccacactc 780
ctagacagcc gttctcaagg tatcaatctg agatcttggg gaggaatatt atctgatatg 840
tcaccaagaa ttcaagagtt tatccatcgg ccgagtatgc aggacttgct gtgggtgacc 900
aggcccctca tgcagaatgg tggtccagag acctttacaa agctgatggg catcctgtct 960
gacctcctgt gtggctaccc cgagggaggt ggctctcggg tgctctcctt caactggtat 1020
gaagacaata actataaggc ctttctgggg attgactcca caaggaagga tcctatctat 1080
tcttatgaca gaagaacaac atccttttgt aatgcattga tccagagcct ggagtcaaat 1140
cctttaacca aaatcgcttg gagggcggca aagcctttgc tgatgggaaa aatcctgtac 1200
actcctgatt cacctgcagc acgaaggata ctgaagaatg ccaactcaac ttttgaagaa 1260
ctggaacacg ttaggaagtt ggtcaaagcc tgggaagaag tagggcccca gatctggtac 1320
ttctttgaca acagcacaca gatgaacatg atcagagata ccctggggaa cccaacagta 1380
aaagactttt tgaataggca gcttggtgaa gaaggtatta ctgctgaagc catcctaaac 1440
ttcctctaca agggccctcg ggaaagccag gctgacgaca tggccaactt cgactggagg 1500
gacatattta acatcactga tcgcaccctc cgcctggtca atcaatacct ggagtgcttg 1560
gtcctggata agtttgaaag ctacaatgat gaaactcagc tcacccaacg tgccctctct 1620
ctactggagg aaaacatgtt ctgggccgga gtggtattcc ctgacatgta tccctggacc 1680
agctctctac caccccacgt gaagtataag atccgaatgg acatagacgt ggtggagaaa 1740
accaataaga ttaaagacag gtattgggat tctggtccca gagctgatcc cgtggaagat 1800
ttccggtaca tctggggcgg gtttgcctat ctgcaggaca tggttgaaca ggggatcaca 1860
aggagccagg tgcaggcgga ggctccagtt ggaatctacc tccagcagat gccctacccc 1920
tgcttcgtgg acgattcttt catgatcatc ctgaaccgct gtttccctat cttcatggtg 1980
ctggcatgga tctactctgt ctccatgact gtgaagagca tcgtcttgga gaaggagttg 2040
cgactgaagg agaccttgaa aaatcagggt gtctccaatg cagtgatttg gtgtacctgg 2100
ttcctggaca gcttctccat catgtcgatg agcatcttcc tcctgacgat attcatcatg 2160
catggaagaa tcctacatta cagcgaccca ttcatcctct tcctgttctt gttggctttc 2220
tccactgcca ccatcatgct gtgctttctg ctcagcacct tcttctccaa ggccagtctg 2280
gcagcagcct gtagtggtgt catctatttc accctctacc tgccacacat cctgtgcttc 2340
gcctggcagg accgcatgac cgctgagctg aagaaggctg tgagcttact gtctccggtg 2400
gcatttggat ttggcactga gtacctggtt cgctttgaag agcaaggcct ggggctgcag 2460
tggagcaaca tcgggaacag tcccacggaa ggggacgaat tcagcttcct gctgtccatg 2520
cagatgatgc tccttgatgc tgctgtctat ggcttactcg cttggtacct tgatcaggtg 2580
tttccaggag actatggaac cccacttcct tggtactttc ttctacaaga gtcgtattgg 2640
cttggcggtg aagggtgttc aaccagagaa gaaagagccc tggaaaagac cgagccccta 2700
acagaggaaa cggaggatcc agagcaccca gaaggaatac acgactcctt ctttgaacgt 2760
gagcatccag ggtgggttcc tggggtatgc gtgaagaatc tggtaaagat ttttgagccc 2820
tgtggccggc cagctgtgga ccgtctgaac atcaccttct acgagaacca gatcaccgca 2880
ttcctgggcc acaatggagc tgggaaaacc accaccttgt ccatcctgac gggtctgttg 2940
ccaccaacct ctgggactgt gctcgttggg ggaagggaca ttgaaaccag cctggatgca 3000
gtccggcaga gccttggcat gtgtccacag cacaacatcc tgttccacca cctcacggtg 3060
gctgagcaca tgctgttcta tgcccagctg aaaggaaagt cccaggagga ggcccagctg 3120
gagatggaag ccatgttgga ggacacaggc ctccaccaca agcggaatga agaggctcag 3180
gacctatcag gtggcatgca gagaaagctg tcggttgcca ttgcctttgt gggagatgcc 3240
aaggtggtga ttctggacga acccacctct ggggtggacc cttactcgag acgctcaatc 3300
tgggatctgc tcctgaagta tcgctcaggc agaaccatca tcatgtccac tcaccacatg 3360
gacgaggccg acctccttgg ggaccgcatt gccatcattg cccagggaag gctctactgc 3420
tcaggcaccc cactcttcct gaagaactgc tttggcacag gcttgtactt aaccttggtg 3480
tga 3483
<210> 16
<211> 2754
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 16
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
atcgtgctcc cggctacctt tgtgtttttg gctctgatgc tttctattgt tatccctcct 120
tttggcgaat accccgcttt gacccttcac ccctggatat atgggcagca gtacaccttc 180
ttcagcatgg atgaaccagg cagtgagcag ttcacggtac ttgcagacgt cctcctgaat 240
aagccaggct ttggcaaccg ctgcctgaag gaagggtggc ttccggagta cccctgtggc 300
aactcaacac cctggaagac tccttctgtg tccccaaaca tcacccagct gttccagaag 360
cagaaatgga cacaggtcaa cccttcacca tcctgcaggt gcagcaccag ggagaagctc 420
accatgctgc cagagtgccc cgagggtgcc gggggcctcc cgccccccca gagaacacag 480
cgcagcacgg aaattctaca agacctgacg gacaggaaca tctccgactt cttggtaaaa 540
acgtatcctg ctcttataag aagcagctta aagagcaaat tctgggtcaa tgaacagagg 600
tatggaggaa tttccattgg aggaaagctc ccagtcgtcc ccatcacggg ggaagcactt 660
gttgggtttt taagcgacct tggccggatc atgaatgtga gcgggggccc tatcactaga 720
gaggcctcta aagaaatacc tgatttcctt aaacatctag aaactgaaga caacattaag 780
gtgtggttta ataacaaagg ctggcatgcc ctggtcagct ttctcaatgt ggcccacaac 840
gccatcttac gggccagcct gcctaaggac aggagccccg aggagtatgg aatcaccgtc 900
attagccaac ccctgaacct gaccaaggag cagctctcag agattacagt gctgaccact 960
tcagtggatg ctgtggttgc catctgcgtg attttctcca tgtccttcgt cccagccagc 1020
tttgtccttt atttgatcca ggagcgggtg aacaaatcca agcacctcca gtttatcagt 1080
ggagtgagcc ccaccaccta ctgggtgacc aacttcctct gggacatcat gaattattcc 1140
gtgagtgctg ggctggtggt gggcatcttc atcgggtttc agaagaaagc ctacacttct 1200
ccagaaaacc ttcctgccct tgtggcactg ctcctgctgt atggatgggc ggtcattccc 1260
atgatgtacc cagcatcctt cctgtttgat gtccccagca cagcctatgt ggctttatct 1320
tgtgctaatc tgttcatcgg catcaacagc agtgctatta ccttcatctt ggaattattt 1380
gagaataacc ggacgctgct caggttcaac gccgtgctga ggaagctgct cattgtcttc 1440
ccccacttct gcctgggccg gggcctcatt gaccttgcac tgagccaggc tgtgacagat 1500
gtctatgccc ggtttggtga ggagcactct gcaaatccgt tccactggga cctgattggg 1560
aagaacctgt ttgccatggt ggtggaaggg gtggtgtact tcctcctgac cctgctggtc 1620
cagcgccact tcttcctctc ccaatggatt gccgagccca ctaaggagcc cattgttgat 1680
gaagatgatg atgtggctga agaaagacaa agaattatta ctggtggaaa taaaactgac 1740
atcttaaggc tacatgaact aaccaagatt tatccaggca cctccagccc agcagtggac 1800
aggctgtgtg tcggagttcg ccctggagag tgctttggcc tcctgggagt gaatggtgcc 1860
ggcaaaacaa ccacattcaa gatgctcact ggggacacca cagtgacctc aggggatgcc 1920
accgtagcag gcaagagtat tttaaccaat atttctgaag tccatcaaaa tatgggctac 1980
tgtcctcagt ttgatgcaat tgatgagctg ctcacaggac gagaacatct ttacctttat 2040
gcccggcttc gaggtgtacc agcagaagaa atcgaaaagg ttgcaaactg gagtattaag 2100
agcctgggcc tgactgtcta cgccgactgc ctggctggca cgtacagtgg gggcaacaag 2160
cggaaactct ccacagccat cgcactcatt ggctgcccac cgctggtgct gctggatgag 2220
cccaccacag ggatggaccc ccaggcacgc cgcatgctgt ggaacgtcat cgtgagcatc 2280
atcagagaag ggagggctgt ggtcctcaca tcccacagca tggaagaatg tgaggcactg 2340
tgtacccggc tggccatcat ggtaaagggc gcctttcgat gtatgggcac cattcagcat 2400
ctcaagtcca aatttggaga tggctatatc gtcacaatga agatcaaatc cccgaaggac 2460
gacctgcttc ctgacctgaa ccctgtggag cagttcttcc aggggaactt cccaggcagt 2520
gtgcagaggg agaggcacta caacatgctc cagttccagg tctcctcctc ctccctggcg 2580
aggatcttcc agctcctcct ctcccacaag gacagcctgc tcatcgagga gtactcagtc 2640
acacagacca cactggacca ggtgtttgta aattttgcta aacagcagac tgaaagtcat 2700
gacctccctc tgcaccctcg agctgctgga gccagtcgac aagcccagga ctga 2754
<210> 17
<211> 3459
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 17
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaaccc actctacatg ccctacccct gcttcgtgga cgattctttc 180
atgatcatcc tgaaccgctg tttccctatc ttcatggtgc tggcatggat ctactctgtc 240
tccatgactg tgaagagcat cgtcttggag aaggagttgc gactgaagga gaccttgaaa 300
aatcagggtg tctccaatgc agtgatttgg tgtacctggt tcctggacag cttctccatc 360
atgtcgatga gcatcttcct cctgacgata ttcatcatgc atggaagaat cctacattac 420
agcgacccat tcatcctctt cctgttcttg ttggctttct ccactgccac catcatgctg 480
tgctttctgc tcagcacctt cttctccaag gccagtctgg cagcagcctg tagtggtgtc 540
atctatttca ccctctacct gccacacatc ctgtgcttcg cctggcagga ccgcatgacc 600
gctgagctga agaaggctgt gagcttactg tctccggtgg catttggatt tggcactgag 660
tacctggttc gctttgaaga gcaaggcctg gggctgcagt ggagcaacat cgggaacagt 720
cccacggaag gggacgaatt cagcttcctg ctgtccatgc agatgatgct ccttgatgct 780
gctgtctatg gcttactcgc ttggtacctt gatcaggtgt ttccaggaga ctatggaacc 840
ccacttcctt ggtactttct tctacaagag tcgtattggc ttggcggtga agggtgttca 900
accagagaag aaagagccct ggaaaagacc gagcccctaa cagaggaaac ggaggatcca 960
gagcacccag aaggaataca cgactccttc tttgaacgtg agcatccagg gtgggttcct 1020
ggggtatgcg tgaagaatct ggtaaagatt tttgagccct gtggccggcc agctgtggac 1080
cgtctgaaca tcaccttcta cgagaaccag atcaccgcat tcctgggcca caatggagct 1140
gggaaaacca ccaccttgtc catcctgacg ggtctgttgc caccaacctc tgggactgtg 1200
ctcgttgggg gaagggacat tgaaaccagc ctggatgcag tccggcagag ccttggcatg 1260
tgtccacagc acaacatcct gttccaccac ctcacggtgg ctgagcacat gctgttctat 1320
gcccagctga aaggaaagtc ccaggaggag gcccagctgg agatggaagc catgttggag 1380
gacacaggcc tccaccacaa gcggaatgaa gaggctcagg acctatcagg tggcatgcag 1440
agaaagctgt cggttgccat tgcctttgtg ggagatgcca aggtggtgat tctggacgaa 1500
cccacctctg gggtggaccc ttactcgaga cgctcaatct gggatctgct cctgaagtat 1560
cgctcaggca gaaccatcat catgtccact caccacatgg acgaggccga cctccttggg 1620
gaccgcattg ccatcattgc ccagggaagg ctctactgct caggcacccc actcttcctg 1680
aagaactgct ttggcacagg cttggacttc ctggcgcaga tcgtgctccc ggctaccttt 1740
gtgtttttgg ctctgatgct ttctattgtt atccctcctt ttggcgaata ccccgctacc 1800
acctactggg tgaccaactt cctctgggac atcatgaatt attccgtgag tgctgggctg 1860
gtggtgggca tcttcatcgg gtttcagaag aaagcctaca cttctccaga aaaccttcct 1920
gcccttgtgg cactgctcct gctgtatgga tgggcggtca ttcccatgat gtacccagca 1980
tccttcctgt ttgatgtccc cagcacagcc tatgtggctt tatcttgtgc taatctgttc 2040
atcggcatca acagcagtgc tattaccttc atcttggaat tatttgagaa taaccggacg 2100
ctgctcaggt tcaacgccgt gctgaggaag ctgctcattg tcttccccca cttctgcctg 2160
ggccggggcc tcattgacct tgcactgagc caggctgtga cagatgtcta tgcccggttt 2220
ggtgaggagc actctgcaaa tccgttccac tgggacctga ttgggaagaa cctgtttgcc 2280
atggtggtgg aaggggtggt gtacttcctc ctgaccctgc tggtccagcg ccacttcttc 2340
ctctcccaat ggattgccga gcccactaag gagcccattg ttgatgaaga tgatgatgtg 2400
gctgaagaaa gacaaagaat tattactggt ggaaataaaa ctgacatctt aaggctacat 2460
gaactaacca agatttatcc aggcacctcc agcccagcag tggacaggct gtgtgtcgga 2520
gttcgccctg gagagtgctt tggcctcctg ggagtgaatg gtgccggcaa aacaaccaca 2580
ttcaagatgc tcactgggga caccacagtg acctcagggg atgccaccgt agcaggcaag 2640
agtattttaa ccaatatttc tgaagtccat caaaatatgg gctactgtcc tcagtttgat 2700
gcaattgatg agctgctcac aggacgagaa catctttacc tttatgcccg gcttcgaggt 2760
gtaccagcag aagaaatcga aaaggttgca aactggagta ttaagagcct gggcctgact 2820
gtctacgccg actgcctggc tggcacgtac agtgggggca acaagcggaa actctccaca 2880
gccatcgcac tcattggctg cccaccgctg gtgctgctgg atgagcccac cacagggatg 2940
gacccccagg cacgccgcat gctgtggaac gtcatcgtga gcatcatcag agaagggagg 3000
gctgtggtcc tcacatccca cagcatggaa gaatgtgagg cactgtgtac ccggctggcc 3060
atcatggtaa agggcgcctt tcgatgtatg ggcaccattc agcatctcaa gtccaaattt 3120
ggagatggct atatcgtcac aatgaagatc aaatccccga aggacgacct gcttcctgac 3180
ctgaaccctg tggagcagtt cttccagggg aacttcccag gcagtgtgca gagggagagg 3240
cactacaaca tgctccagtt ccaggtctcc tcctcctccc tggcgaggat cttccagctc 3300
ctcctctccc acaaggacag cctgctcatc gaggagtact cagtcacaca gaccacactg 3360
gaccaggtgt ttgtaaattt tgctaaacag cagactgaaa gtcatgacct ccctctgcac 3420
cctcgagctg ctggagccag tcgacaagcc caggactga 3459
<210> 18
<211> 3780
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 18
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaaccc actctacagc catcatgaat gccatttccc caacaaggcg 180
atgccctcag caggaatgct gccgtggctc caggggatct tctgcaatgt gaacaatccc 240
tgttttcaaa gccccacccc aggagaatct cctggaattg tgtcaaacta taacaactcc 300
atcttggcaa gggtatatcg agattttcaa gaactcctca tgaatgcacc agagagccag 360
caccttggcc gtatttggac agagctacac atcttgtccc aattcatgga caccctccgg 420
actcacccgg agagaattgc aggaagagga atacgaataa gggatatctt gaaagatgaa 480
gaaacactga cactatttct cattaaaaac atcggcctgt ctgactcagt ggtctacctt 540
ctgatcaact ctcaagtccg tccagagcag ttcgctcatg gagtcccgga cctggcgctg 600
aaggacatcg cctgcagcga ggccctcctg gagcgcttca tcatcttcag ccagagacgc 660
ggggcaaaga cggtgcgcta tgccctgtgc tccctctccc agggcaccct acagtggata 720
gaagacactc tgtatgccaa cgtggacttc ttcaagctct tccgtgtgct tcccacactc 780
ctagacagcc gttctcaagg tatcaatctg agatcttggg gaggaatatt atctgatatg 840
tcaccaagaa ttcaagagtt tatccatcgg ccgagtatgc aggacttgct gtgggtgacc 900
aggcccctca tgcagaatgg tggtccagag acctttacaa agctgatggg catcctgtct 960
gacctcctgt gtggctaccc cgagggaggt ggctctcggg tgctctcctt caactggtat 1020
gaagacaata actataaggc ctttctgggg attgactcca caaggaagga tcctatctat 1080
tcttatgaca gaagaacaac atccttttgt aatgcattga tccagagcct ggagtcaaat 1140
cctttaacca aaatcgcttg gagggcggca aagcctttgc tgatgggaaa aatcctgtac 1200
actcctgatt cacctgcagc acgaaggata ctgaagaatg ccaactcaac ttttgaagaa 1260
ctggaacacg ttaggaagtt ggtcaaagcc tgggaagaag tagggcccca gatctggtac 1320
ttctttgaca acagcacaca gatgaacatg atcagagata ccctggggaa cccaacagta 1380
aaagactttt tgaataggca gcttggtgaa gaaggtatta ctgctgaagc catcctaaac 1440
ttcctctaca agggccctcg ggaaagccag gctgacgaca tggccaactt cgactggagg 1500
gacatattta acatcactga tcgcaccctc cgcctggtca atcaatacct ggagtgcttg 1560
gtcctggata agtttgaaag ctacaatgat gaaactcagc tcacccaacg tgccctctct 1620
ctactggagg aaaacatgtt ctgggccgga gtggtattcc ctgacatgta tccctggacc 1680
agctctctac caccccacgt gaagtataag atccgaatgg acatagacgt ggtggagaaa 1740
accaataaga ttaaagacag gtattgggat tctggtccca gagctgatcc cgtggaagat 1800
ttccggtaca tctggggcgg gtttgcctat ctgcaggaca tggttgaaca ggggatcaca 1860
aggagccagg tgcaggcgga ggctccagtt ggaatctacc tccagcagat gccctacccc 1920
tgcttcgtgg acgattcttt catgatcatc ctgaaccgct gtttccctat cttcatggtg 1980
ctggcatgga tctactctgt ctccatgact gtgaagagca tcgtcttgga gaaggagttg 2040
cgactgaagg agaccttgaa aaatcagggt gtctccaatg cagtgatttg gtgtacctgg 2100
ttcctggaca gcttctccat catgtcgatg agcatcttcc tcctgacgat attcatcatg 2160
catggaagaa tcctacatta cagcgaccca ttcatcctct tcctgttctt gttggctttc 2220
tccactgcca ccatcatgct gtgctttctg ctcagcacct tcttctccaa ggccagtctg 2280
gcagcagcct gtagtggtgt catctatttc accctctacc tgccacacat cctgtgcttc 2340
gcctggcagg accgcatgac cgctgagctg aagaaggctg tgagcttact gtctccggtg 2400
gcatttggat ttggcactga gtacctggtt cgctttgaag agcaaggcct ggggctgcag 2460
tggagcaaca tcgggaacag tcccacggaa ggggacgaat tcagcttcct gctgtccatg 2520
cagatgatgc tccttgatgc tgctgtctat ggcttactcg cttggtacct tgatcaggtg 2580
gttcctgggg tatgcgtgaa gaatctggta aagatttttg agccctgtgg ccggccagct 2640
gtggaccgtc tgaacatcac cttctacgag aaccagatca ccgcattcct gggccacaat 2700
ggagctggga aaaccaccac cttgtccatc ctgacgggtc tgttgccacc aacctctggg 2760
actgtgctcg ttgggggaag ggacattgaa accagcctgg atgcagtccg gcagagcctt 2820
ggcatgtgtc cacagcacaa catcctgttc caccacctca cggtggctga gcacatgctg 2880
ttctatgccc agctgaaagg aaagtcccag gaggaggccc agctggagat ggaagccatg 2940
ttggaggaca caggcctcca ccacaagcgg aatgaagagg ctcaggacct atcaggtggc 3000
atgcagagaa agctgtcggt tgccattgcc tttgtgggag atgccaaggt ggtgattctg 3060
gacgaaccca cctctggggt ggacccttac tcgagacgct caatctggga tctgctcctg 3120
aagtatcgct caggcagaac catcatcatg tccactcacc acatggacga ggccgacctc 3180
cttggggacc gcattgccat cattgcccag ggaaggctct actgctcagg caccccactc 3240
ttcctgaaga actgctttgt gaccaacttc ctctgggaca tcatgaatta ttccgtgagt 3300
gctgggctgg tggtgggcat cttcatcggg tttcagaaga aagcctacac ttctccagaa 3360
aaccttcctg cccttgtggc actgctcctg ctgtatggat gggcggtcat tcccatgatg 3420
tacccagcat ccttcctgtt tgatgtcccc agcacagcct atgtggcttt atcttgtgct 3480
aatctgttca tcggcatcaa cagcagtgct attaccttca tcttggaatt atttgagaat 3540
aaccggacgc tgctcaggtt caacgccgtg ctgaggaagc tgctcattgt cttcccccac 3600
ttctgcctgg gccggggcct cattgacctt gcactgagcc aggctgtgac agatgtctat 3660
gcccggtttg gtgaggagca ctctgcaaat ccgttccact gggacctgat tgggaagaac 3720
ctgtttgcca tggtggtgga aggggtggtg tacttcctcc tgaccctgct ggtccagtga 3780
<210> 19
<211> 3498
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多核苷酸
<400> 19
atgggcttcg tgagacagat acagcttttg ctctggaaga actggaccct gcggaaaagg 60
caaaagattc gctttgtggt ggaactcgtg tggcctttat ctttatttct ggtcttgatc 120
tggttaagga atgccaacgt ggacgattct ttcatgatca tcctgaaccg ctgtttccct 180
atcttcatgg tgctggcatg gatctactct gtctccatga ctgtgaagag catcgtcttg 240
gagaaggagt tgcgactgaa ggagaccttg aaaaatcagg gtgtctccaa tgcagtgatt 300
tggtgtacct ggttcctgga cagcttctcc atcatgtcga tgagcatctt cctcctgacg 360
atattcatca tgcatggaag aatcctacat tacagcgacc cattcatcct cttcctgttc 420
ttgttggctt tctccactgc caccatcatg ctgtgctttc tgctcagcac cttcttctcc 480
aaggccagtc tggcagcagc ctgtagtggt gtcatctatt tcaccctcta cctgccacac 540
atcctgtgct tcgcctggca ggaccgcatg accgctgagc tgaagaaggc tgtgagctta 600
ctgtctccgg tggcatttgg atttggcact gagtacctgg ttcgctttga agagcaaggc 660
ctggggctgc agtggagcaa catcgggaac agtcccacgg aaggggacga attcagcttc 720
ctgctgtcca tgcagatgat gctccttgat gctgctgtct atggcttact cgcttggtac 780
cttgatcagg tgttcctggc gcagatcgtg ctcccggcta cctttgtgtt tttggctctg 840
atgctttcta ttgttatccc tccttttggc gaataccccg ctttgaccct tcacccctgg 900
atatatgggc agcagtacac cttcttcagc atggatgaac caggcagtga gcagttcacg 960
gtacttgcag acgtcctcct gaataagcca ggctttggca accgctgcct gaaggaaggg 1020
tggcttccgg agtacccctg tggcaactca acaccctgga agactccttc tgtgtcccca 1080
aacatcaccc agctgttcca gaagcagaaa tggacacagg tcaacccttc accatcctgc 1140
aggtgcagca ccagggagaa gctcaccatg ctgccagagt gccccgaggg tgccgggggc 1200
ctcccgcccc cccagagaac acagcgcagc acggaaattc tacaagacct gacggacagg 1260
aacatctccg acttcttggt aaaaacgtat cctgctctta taagaagcag cttaaagagc 1320
aaattctggg tcaatgaaca gaggtatgga ggaatttcca ttggaggaaa gctcccagtc 1380
gtccccatca cgggggaagc acttgttggg tttttaagcg accttggccg gatcatgaat 1440
gtgagcgggg gccctatcac tagagaggcc tctaaagaaa tacctgattt ccttaaacat 1500
ctagaaactg aagacaacat taaggtgtgg tttaataaca aaggctggca tgccctggtc 1560
agctttctca atgtggccca caacgccatc ttacgggcca gcctgcctaa ggacaggagc 1620
cccgaggagt atggaatcac cgtcattagc caacccctga acctgaccaa ggagcagctc 1680
tcagagatta cagtgctgac cacttcagtg gatgctgtgg ttgccatctg cgtgattttc 1740
tccatgtcct tcgtcccagc cagctttgtc ctttatttga tccaggagcg ggtgaacaaa 1800
tccaagcacc tccagtttat cagtggagtg agccccacca cctactgggt gaccaacttc 1860
ctctgggaca tcatgaatta ttccgtgagt gctgggctgg tggtgggcat cttcatcggg 1920
tttcagaaga aagcctacac ttctccagaa aaccttcctg cccttgtggc actgctcctg 1980
ctgtatggat gggcggtcat tcccatgatg tacccagcat ccttcctgtt tgatgtcccc 2040
agcacagcct atgtggcttt atcttgtgct aatctgttca tcggcatcaa cagcagtgct 2100
attaccttca tcttggaatt atttgagaat aaccggacgc tgctcaggtt caacgccgtg 2160
ctgaggaagc tgctcattgt cttcccccac ttctgcctgg gccggggcct cattgacctt 2220
gcactgagcc aggctgtgac agatgtctat gcccggtttg gtgaggagca ctctgcaaat 2280
ccgttccact gggacctgat tgggaagaac ctgtttgcca tggtggtgga aggggtggtg 2340
tacttcctcc tgaccctgct ggtccagcgc cacttcttcc tctcccaatg gattgccgag 2400
cccactaagg agcccattgt tgatgaagat gatgatgtgg ctgaagaaag acaaagaatt 2460
attactggtg gaaataaaac tgacatctta aggctacatg aactaaccaa gatttatcca 2520
ggcacctcca gcccagcagt ggacaggctg tgtgtcggag ttcgccctgg agagtgcttt 2580
ggcctcctgg gagtgaatgg tgccggcaaa acaaccacat tcaagatgct cactggggac 2640
accacagtga cctcagggga tgccaccgta gcaggcaaga gtattttaac caatatttct 2700
gaagtccatc aaaatatggg ctactgtcct cagtttgatg caattgatga gctgctcaca 2760
ggacgagaac atctttacct ttatgcccgg cttcgaggtg taccagcaga agaaatcgaa 2820
aaggttgcaa actggagtat taagagcctg ggcctgactg tctacgccga ctgcctggct 2880
ggcacgtaca gtgggggcaa caagcggaaa ctctccacag ccatcgcact cattggctgc 2940
ccaccgctgg tgctgctgga tgagcccacc acagggatgg acccccaggc acgccgcatg 3000
ctgtggaacg tcatcgtgag catcatcaga gaagggaggg ctgtggtcct cacatcccac 3060
agcatggaag aatgtgaggc actgtgtacc cggctggcca tcatggtaaa gggcgccttt 3120
cgatgtatgg gcaccattca gcatctcaag tccaaatttg gagatggcta tatcgtcaca 3180
atgaagatca aatccccgaa ggacgacctg cttcctgacc tgaaccctgt ggagcagttc 3240
ttccagggga acttcccagg cagtgtgcag agggagaggc actacaacat gctccagttc 3300
caggtctcct cctcctccct ggcgaggatc ttccagctcc tcctctccca caaggacagc 3360
ctgctcatcg aggagtactc agtcacacag accacactgg accaggtgtt tgtaaatttt 3420
gctaaacagc agactgaaag tcatgacctc cctctgcacc ctcgagctgc tggagccagt 3480
cgacaagccc aggactga 3498
<210> 20
<211> 1160
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 20
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Ser His His Glu Cys His Phe Pro Asn Lys Ala Met Pro Ser Ala
50 55 60
Gly Met Leu Pro Trp Leu Gln Gly Ile Phe Cys Asn Val Asn Asn Pro
65 70 75 80
Cys Phe Gln Ser Pro Thr Pro Gly Glu Ser Pro Gly Ile Val Ser Asn
85 90 95
Tyr Asn Asn Ser Ile Leu Ala Arg Val Tyr Arg Asp Phe Gln Glu Leu
100 105 110
Leu Met Asn Ala Pro Glu Ser Gln His Leu Gly Arg Ile Trp Thr Glu
115 120 125
Leu His Ile Leu Ser Gln Phe Met Asp Thr Leu Arg Thr His Pro Glu
130 135 140
Arg Ile Ala Gly Arg Gly Ile Arg Ile Arg Asp Ile Leu Lys Asp Glu
145 150 155 160
Glu Thr Leu Thr Leu Phe Leu Ile Lys Asn Ile Gly Leu Ser Asp Ser
165 170 175
Val Val Tyr Leu Leu Ile Asn Ser Gln Val Arg Pro Glu Gln Phe Ala
180 185 190
His Gly Val Pro Asp Leu Ala Leu Lys Asp Ile Ala Cys Ser Glu Ala
195 200 205
Leu Leu Glu Arg Phe Ile Ile Phe Ser Gln Arg Arg Gly Ala Lys Thr
210 215 220
Val Arg Tyr Ala Leu Cys Ser Leu Ser Gln Gly Thr Leu Gln Trp Ile
225 230 235 240
Glu Asp Thr Leu Tyr Ala Asn Val Asp Phe Phe Lys Leu Phe Arg Val
245 250 255
Leu Pro Thr Leu Leu Asp Ser Arg Ser Gln Gly Ile Asn Leu Arg Ser
260 265 270
Trp Gly Gly Ile Leu Ser Asp Met Ser Pro Arg Ile Gln Glu Phe Ile
275 280 285
His Arg Pro Ser Met Gln Asp Leu Leu Trp Val Thr Arg Pro Leu Met
290 295 300
Gln Asn Gly Gly Pro Glu Thr Phe Thr Lys Leu Met Gly Ile Leu Ser
305 310 315 320
Asp Leu Leu Cys Gly Tyr Pro Glu Gly Gly Gly Ser Arg Val Leu Ser
325 330 335
Phe Asn Trp Tyr Glu Asp Asn Asn Tyr Lys Ala Phe Leu Gly Ile Asp
340 345 350
Ser Thr Arg Lys Asp Pro Ile Tyr Ser Tyr Asp Arg Arg Thr Thr Ser
355 360 365
Phe Cys Asn Ala Leu Ile Gln Ser Leu Glu Ser Asn Pro Leu Thr Lys
370 375 380
Ile Ala Trp Arg Ala Ala Lys Pro Leu Leu Met Gly Lys Ile Leu Tyr
385 390 395 400
Thr Pro Asp Ser Pro Ala Ala Arg Arg Ile Leu Lys Asn Ala Asn Ser
405 410 415
Thr Phe Glu Glu Leu Glu His Val Arg Lys Leu Val Lys Ala Trp Glu
420 425 430
Glu Val Gly Pro Gln Ile Trp Tyr Phe Phe Asp Asn Ser Thr Gln Met
435 440 445
Asn Met Ile Arg Asp Thr Leu Gly Asn Pro Thr Val Lys Asp Phe Leu
450 455 460
Asn Arg Gln Leu Gly Glu Glu Gly Ile Thr Ala Glu Ala Ile Leu Asn
465 470 475 480
Phe Leu Tyr Lys Gly Pro Arg Glu Ser Gln Ala Asp Asp Met Ala Asn
485 490 495
Phe Asp Trp Arg Asp Ile Phe Asn Ile Thr Asp Arg Thr Leu Arg Leu
500 505 510
Val Asn Gln Tyr Leu Glu Cys Leu Val Leu Asp Lys Phe Glu Ser Tyr
515 520 525
Asn Asp Glu Thr Gln Leu Thr Gln Arg Ala Leu Ser Leu Leu Glu Glu
530 535 540
Asn Met Phe Trp Ala Gly Val Val Phe Pro Asp Met Tyr Pro Trp Thr
545 550 555 560
Ser Ser Leu Pro Pro His Val Lys Tyr Lys Ile Arg Met Asp Ile Asp
565 570 575
Val Val Glu Lys Thr Asn Lys Ile Lys Asp Arg Tyr Trp Asp Ser Gly
580 585 590
Pro Arg Ala Asp Pro Val Glu Asp Phe Arg Tyr Ile Trp Gly Gly Phe
595 600 605
Ala Tyr Leu Gln Asp Met Val Glu Gln Gly Ile Thr Arg Ser Gln Val
610 615 620
Gln Ala Glu Ala Pro Val Gly Ile Tyr Leu Gln Gln Met Pro Tyr Pro
625 630 635 640
Cys Phe Val Asp Asp Ser Phe Met Ile Ile Leu Asn Arg Cys Phe Pro
645 650 655
Ile Phe Met Val Leu Ala Trp Ile Tyr Ser Val Ser Met Thr Val Lys
660 665 670
Ser Ile Val Leu Glu Lys Glu Leu Arg Leu Lys Glu Thr Leu Lys Asn
675 680 685
Gln Gly Val Ser Asn Ala Val Ile Trp Cys Thr Trp Phe Leu Asp Ser
690 695 700
Phe Ser Ile Met Ser Met Ser Ile Phe Leu Leu Thr Ile Phe Ile Met
705 710 715 720
His Gly Arg Ile Leu His Tyr Ser Asp Pro Phe Ile Leu Phe Leu Phe
725 730 735
Leu Leu Ala Phe Ser Thr Ala Thr Ile Met Leu Cys Phe Leu Leu Ser
740 745 750
Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala Ala Cys Ser Gly Val Ile
755 760 765
Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu Cys Phe Ala Trp Gln Asp
770 775 780
Arg Met Thr Ala Glu Leu Lys Lys Ala Val Ser Leu Leu Ser Pro Val
785 790 795 800
Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val Arg Phe Glu Glu Gln Gly
805 810 815
Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn Ser Pro Thr Glu Gly Asp
820 825 830
Glu Phe Ser Phe Leu Leu Ser Met Gln Met Met Leu Leu Asp Ala Ala
835 840 845
Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp Gln Val Phe Pro Gly Asp
850 855 860
Tyr Gly Thr Pro Leu Pro Trp Tyr Phe Leu Leu Gln Glu Ser Tyr Trp
865 870 875 880
Leu Gly Gly Glu Gly Cys Ser Thr Arg Glu Glu Arg Ala Leu Glu Lys
885 890 895
Thr Glu Pro Leu Thr Glu Glu Thr Glu Asp Pro Glu His Pro Glu Gly
900 905 910
Ile His Asp Ser Phe Phe Glu Arg Glu His Pro Gly Trp Val Pro Gly
915 920 925
Val Cys Val Lys Asn Leu Val Lys Ile Phe Glu Pro Cys Gly Arg Pro
930 935 940
Ala Val Asp Arg Leu Asn Ile Thr Phe Tyr Glu Asn Gln Ile Thr Ala
945 950 955 960
Phe Leu Gly His Asn Gly Ala Gly Lys Thr Thr Thr Leu Ser Ile Leu
965 970 975
Thr Gly Leu Leu Pro Pro Thr Ser Gly Thr Val Leu Val Gly Gly Arg
980 985 990
Asp Ile Glu Thr Ser Leu Asp Ala Val Arg Gln Ser Leu Gly Met Cys
995 1000 1005
Pro Gln His Asn Ile Leu Phe His His Leu Thr Val Ala Glu His
1010 1015 1020
Met Leu Phe Tyr Ala Gln Leu Lys Gly Lys Ser Gln Glu Glu Ala
1025 1030 1035
Gln Leu Glu Met Glu Ala Met Leu Glu Asp Thr Gly Leu His His
1040 1045 1050
Lys Arg Asn Glu Glu Ala Gln Asp Leu Ser Gly Gly Met Gln Arg
1055 1060 1065
Lys Leu Ser Val Ala Ile Ala Phe Val Gly Asp Ala Lys Val Val
1070 1075 1080
Ile Leu Asp Glu Pro Thr Ser Gly Val Asp Pro Tyr Ser Arg Arg
1085 1090 1095
Ser Ile Trp Asp Leu Leu Leu Lys Tyr Arg Ser Gly Arg Thr Ile
1100 1105 1110
Ile Met Ser Thr His His Met Asp Glu Ala Asp Leu Leu Gly Asp
1115 1120 1125
Arg Ile Ala Ile Ile Ala Gln Gly Arg Leu Tyr Cys Ser Gly Thr
1130 1135 1140
Pro Leu Phe Leu Lys Asn Cys Phe Gly Thr Gly Leu Tyr Leu Thr
1145 1150 1155
Leu Val
1160
<210> 21
<211> 917
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 21
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Ile Val Leu Pro Ala Thr Phe Val Phe Leu Ala Leu
20 25 30
Met Leu Ser Ile Val Ile Pro Pro Phe Gly Glu Tyr Pro Ala Leu Thr
35 40 45
Leu His Pro Trp Ile Tyr Gly Gln Gln Tyr Thr Phe Phe Ser Met Asp
50 55 60
Glu Pro Gly Ser Glu Gln Phe Thr Val Leu Ala Asp Val Leu Leu Asn
65 70 75 80
Lys Pro Gly Phe Gly Asn Arg Cys Leu Lys Glu Gly Trp Leu Pro Glu
85 90 95
Tyr Pro Cys Gly Asn Ser Thr Pro Trp Lys Thr Pro Ser Val Ser Pro
100 105 110
Asn Ile Thr Gln Leu Phe Gln Lys Gln Lys Trp Thr Gln Val Asn Pro
115 120 125
Ser Pro Ser Cys Arg Cys Ser Thr Arg Glu Lys Leu Thr Met Leu Pro
130 135 140
Glu Cys Pro Glu Gly Ala Gly Gly Leu Pro Pro Pro Gln Arg Thr Gln
145 150 155 160
Arg Ser Thr Glu Ile Leu Gln Asp Leu Thr Asp Arg Asn Ile Ser Asp
165 170 175
Phe Leu Val Lys Thr Tyr Pro Ala Leu Ile Arg Ser Ser Leu Lys Ser
180 185 190
Lys Phe Trp Val Asn Glu Gln Arg Tyr Gly Gly Ile Ser Ile Gly Gly
195 200 205
Lys Leu Pro Val Val Pro Ile Thr Gly Glu Ala Leu Val Gly Phe Leu
210 215 220
Ser Asp Leu Gly Arg Ile Met Asn Val Ser Gly Gly Pro Ile Thr Arg
225 230 235 240
Glu Ala Ser Lys Glu Ile Pro Asp Phe Leu Lys His Leu Glu Thr Glu
245 250 255
Asp Asn Ile Lys Val Trp Phe Asn Asn Lys Gly Trp His Ala Leu Val
260 265 270
Ser Phe Leu Asn Val Ala His Asn Ala Ile Leu Arg Ala Ser Leu Pro
275 280 285
Lys Asp Arg Ser Pro Glu Glu Tyr Gly Ile Thr Val Ile Ser Gln Pro
290 295 300
Leu Asn Leu Thr Lys Glu Gln Leu Ser Glu Ile Thr Val Leu Thr Thr
305 310 315 320
Ser Val Asp Ala Val Val Ala Ile Cys Val Ile Phe Ser Met Ser Phe
325 330 335
Val Pro Ala Ser Phe Val Leu Tyr Leu Ile Gln Glu Arg Val Asn Lys
340 345 350
Ser Lys His Leu Gln Phe Ile Ser Gly Val Ser Pro Thr Thr Tyr Trp
355 360 365
Val Thr Asn Phe Leu Trp Asp Ile Met Asn Tyr Ser Val Ser Ala Gly
370 375 380
Leu Val Val Gly Ile Phe Ile Gly Phe Gln Lys Lys Ala Tyr Thr Ser
385 390 395 400
Pro Glu Asn Leu Pro Ala Leu Val Ala Leu Leu Leu Leu Tyr Gly Trp
405 410 415
Ala Val Ile Pro Met Met Tyr Pro Ala Ser Phe Leu Phe Asp Val Pro
420 425 430
Ser Thr Ala Tyr Val Ala Leu Ser Cys Ala Asn Leu Phe Ile Gly Ile
435 440 445
Asn Ser Ser Ala Ile Thr Phe Ile Leu Glu Leu Phe Glu Asn Asn Arg
450 455 460
Thr Leu Leu Arg Phe Asn Ala Val Leu Arg Lys Leu Leu Ile Val Phe
465 470 475 480
Pro His Phe Cys Leu Gly Arg Gly Leu Ile Asp Leu Ala Leu Ser Gln
485 490 495
Ala Val Thr Asp Val Tyr Ala Arg Phe Gly Glu Glu His Ser Ala Asn
500 505 510
Pro Phe His Trp Asp Leu Ile Gly Lys Asn Leu Phe Ala Met Val Val
515 520 525
Glu Gly Val Val Tyr Phe Leu Leu Thr Leu Leu Val Gln Arg His Phe
530 535 540
Phe Leu Ser Gln Trp Ile Ala Glu Pro Thr Lys Glu Pro Ile Val Asp
545 550 555 560
Glu Asp Asp Asp Val Ala Glu Glu Arg Gln Arg Ile Ile Thr Gly Gly
565 570 575
Asn Lys Thr Asp Ile Leu Arg Leu His Glu Leu Thr Lys Ile Tyr Pro
580 585 590
Gly Thr Ser Ser Pro Ala Val Asp Arg Leu Cys Val Gly Val Arg Pro
595 600 605
Gly Glu Cys Phe Gly Leu Leu Gly Val Asn Gly Ala Gly Lys Thr Thr
610 615 620
Thr Phe Lys Met Leu Thr Gly Asp Thr Thr Val Thr Ser Gly Asp Ala
625 630 635 640
Thr Val Ala Gly Lys Ser Ile Leu Thr Asn Ile Ser Glu Val His Gln
645 650 655
Asn Met Gly Tyr Cys Pro Gln Phe Asp Ala Ile Asp Glu Leu Leu Thr
660 665 670
Gly Arg Glu His Leu Tyr Leu Tyr Ala Arg Leu Arg Gly Val Pro Ala
675 680 685
Glu Glu Ile Glu Lys Val Ala Asn Trp Ser Ile Lys Ser Leu Gly Leu
690 695 700
Thr Val Tyr Ala Asp Cys Leu Ala Gly Thr Tyr Ser Gly Gly Asn Lys
705 710 715 720
Arg Lys Leu Ser Thr Ala Ile Ala Leu Ile Gly Cys Pro Pro Leu Val
725 730 735
Leu Leu Asp Glu Pro Thr Thr Gly Met Asp Pro Gln Ala Arg Arg Met
740 745 750
Leu Trp Asn Val Ile Val Ser Ile Ile Arg Glu Gly Arg Ala Val Val
755 760 765
Leu Thr Ser His Ser Met Glu Glu Cys Glu Ala Leu Cys Thr Arg Leu
770 775 780
Ala Ile Met Val Lys Gly Ala Phe Arg Cys Met Gly Thr Ile Gln His
785 790 795 800
Leu Lys Ser Lys Phe Gly Asp Gly Tyr Ile Val Thr Met Lys Ile Lys
805 810 815
Ser Pro Lys Asp Asp Leu Leu Pro Asp Leu Asn Pro Val Glu Gln Phe
820 825 830
Phe Gln Gly Asn Phe Pro Gly Ser Val Gln Arg Glu Arg His Tyr Asn
835 840 845
Met Leu Gln Phe Gln Val Ser Ser Ser Ser Leu Ala Arg Ile Phe Gln
850 855 860
Leu Leu Leu Ser His Lys Asp Ser Leu Leu Ile Glu Glu Tyr Ser Val
865 870 875 880
Thr Gln Thr Thr Leu Asp Gln Val Phe Val Asn Phe Ala Lys Gln Gln
885 890 895
Thr Glu Ser His Asp Leu Pro Leu His Pro Arg Ala Ala Gly Ala Ser
900 905 910
Arg Gln Ala Gln Asp
915
<210> 22
<211> 1152
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 22
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Met Pro Tyr Pro Cys Phe Val Asp Asp Ser Phe Met Ile Ile Leu
50 55 60
Asn Arg Cys Phe Pro Ile Phe Met Val Leu Ala Trp Ile Tyr Ser Val
65 70 75 80
Ser Met Thr Val Lys Ser Ile Val Leu Glu Lys Glu Leu Arg Leu Lys
85 90 95
Glu Thr Leu Lys Asn Gln Gly Val Ser Asn Ala Val Ile Trp Cys Thr
100 105 110
Trp Phe Leu Asp Ser Phe Ser Ile Met Ser Met Ser Ile Phe Leu Leu
115 120 125
Thr Ile Phe Ile Met His Gly Arg Ile Leu His Tyr Ser Asp Pro Phe
130 135 140
Ile Leu Phe Leu Phe Leu Leu Ala Phe Ser Thr Ala Thr Ile Met Leu
145 150 155 160
Cys Phe Leu Leu Ser Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala Ala
165 170 175
Cys Ser Gly Val Ile Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu Cys
180 185 190
Phe Ala Trp Gln Asp Arg Met Thr Ala Glu Leu Lys Lys Ala Val Ser
195 200 205
Leu Leu Ser Pro Val Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val Arg
210 215 220
Phe Glu Glu Gln Gly Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn Ser
225 230 235 240
Pro Thr Glu Gly Asp Glu Phe Ser Phe Leu Leu Ser Met Gln Met Met
245 250 255
Leu Leu Asp Ala Ala Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp Gln
260 265 270
Val Phe Pro Gly Asp Tyr Gly Thr Pro Leu Pro Trp Tyr Phe Leu Leu
275 280 285
Gln Glu Ser Tyr Trp Leu Gly Gly Glu Gly Cys Ser Thr Arg Glu Glu
290 295 300
Arg Ala Leu Glu Lys Thr Glu Pro Leu Thr Glu Glu Thr Glu Asp Pro
305 310 315 320
Glu His Pro Glu Gly Ile His Asp Ser Phe Phe Glu Arg Glu His Pro
325 330 335
Gly Trp Val Pro Gly Val Cys Val Lys Asn Leu Val Lys Ile Phe Glu
340 345 350
Pro Cys Gly Arg Pro Ala Val Asp Arg Leu Asn Ile Thr Phe Tyr Glu
355 360 365
Asn Gln Ile Thr Ala Phe Leu Gly His Asn Gly Ala Gly Lys Thr Thr
370 375 380
Thr Leu Ser Ile Leu Thr Gly Leu Leu Pro Pro Thr Ser Gly Thr Val
385 390 395 400
Leu Val Gly Gly Arg Asp Ile Glu Thr Ser Leu Asp Ala Val Arg Gln
405 410 415
Ser Leu Gly Met Cys Pro Gln His Asn Ile Leu Phe His His Leu Thr
420 425 430
Val Ala Glu His Met Leu Phe Tyr Ala Gln Leu Lys Gly Lys Ser Gln
435 440 445
Glu Glu Ala Gln Leu Glu Met Glu Ala Met Leu Glu Asp Thr Gly Leu
450 455 460
His His Lys Arg Asn Glu Glu Ala Gln Asp Leu Ser Gly Gly Met Gln
465 470 475 480
Arg Lys Leu Ser Val Ala Ile Ala Phe Val Gly Asp Ala Lys Val Val
485 490 495
Ile Leu Asp Glu Pro Thr Ser Gly Val Asp Pro Tyr Ser Arg Arg Ser
500 505 510
Ile Trp Asp Leu Leu Leu Lys Tyr Arg Ser Gly Arg Thr Ile Ile Met
515 520 525
Ser Thr His His Met Asp Glu Ala Asp Leu Leu Gly Asp Arg Ile Ala
530 535 540
Ile Ile Ala Gln Gly Arg Leu Tyr Cys Ser Gly Thr Pro Leu Phe Leu
545 550 555 560
Lys Asn Cys Phe Gly Thr Gly Leu Asp Phe Leu Ala Gln Ile Val Leu
565 570 575
Pro Ala Thr Phe Val Phe Leu Ala Leu Met Leu Ser Ile Val Ile Pro
580 585 590
Pro Phe Gly Glu Tyr Pro Ala Thr Thr Tyr Trp Val Thr Asn Phe Leu
595 600 605
Trp Asp Ile Met Asn Tyr Ser Val Ser Ala Gly Leu Val Val Gly Ile
610 615 620
Phe Ile Gly Phe Gln Lys Lys Ala Tyr Thr Ser Pro Glu Asn Leu Pro
625 630 635 640
Ala Leu Val Ala Leu Leu Leu Leu Tyr Gly Trp Ala Val Ile Pro Met
645 650 655
Met Tyr Pro Ala Ser Phe Leu Phe Asp Val Pro Ser Thr Ala Tyr Val
660 665 670
Ala Leu Ser Cys Ala Asn Leu Phe Ile Gly Ile Asn Ser Ser Ala Ile
675 680 685
Thr Phe Ile Leu Glu Leu Phe Glu Asn Asn Arg Thr Leu Leu Arg Phe
690 695 700
Asn Ala Val Leu Arg Lys Leu Leu Ile Val Phe Pro His Phe Cys Leu
705 710 715 720
Gly Arg Gly Leu Ile Asp Leu Ala Leu Ser Gln Ala Val Thr Asp Val
725 730 735
Tyr Ala Arg Phe Gly Glu Glu His Ser Ala Asn Pro Phe His Trp Asp
740 745 750
Leu Ile Gly Lys Asn Leu Phe Ala Met Val Val Glu Gly Val Val Tyr
755 760 765
Phe Leu Leu Thr Leu Leu Val Gln Arg His Phe Phe Leu Ser Gln Trp
770 775 780
Ile Ala Glu Pro Thr Lys Glu Pro Ile Val Asp Glu Asp Asp Asp Val
785 790 795 800
Ala Glu Glu Arg Gln Arg Ile Ile Thr Gly Gly Asn Lys Thr Asp Ile
805 810 815
Leu Arg Leu His Glu Leu Thr Lys Ile Tyr Pro Gly Thr Ser Ser Pro
820 825 830
Ala Val Asp Arg Leu Cys Val Gly Val Arg Pro Gly Glu Cys Phe Gly
835 840 845
Leu Leu Gly Val Asn Gly Ala Gly Lys Thr Thr Thr Phe Lys Met Leu
850 855 860
Thr Gly Asp Thr Thr Val Thr Ser Gly Asp Ala Thr Val Ala Gly Lys
865 870 875 880
Ser Ile Leu Thr Asn Ile Ser Glu Val His Gln Asn Met Gly Tyr Cys
885 890 895
Pro Gln Phe Asp Ala Ile Asp Glu Leu Leu Thr Gly Arg Glu His Leu
900 905 910
Tyr Leu Tyr Ala Arg Leu Arg Gly Val Pro Ala Glu Glu Ile Glu Lys
915 920 925
Val Ala Asn Trp Ser Ile Lys Ser Leu Gly Leu Thr Val Tyr Ala Asp
930 935 940
Cys Leu Ala Gly Thr Tyr Ser Gly Gly Asn Lys Arg Lys Leu Ser Thr
945 950 955 960
Ala Ile Ala Leu Ile Gly Cys Pro Pro Leu Val Leu Leu Asp Glu Pro
965 970 975
Thr Thr Gly Met Asp Pro Gln Ala Arg Arg Met Leu Trp Asn Val Ile
980 985 990
Val Ser Ile Ile Arg Glu Gly Arg Ala Val Val Leu Thr Ser His Ser
995 1000 1005
Met Glu Glu Cys Glu Ala Leu Cys Thr Arg Leu Ala Ile Met Val
1010 1015 1020
Lys Gly Ala Phe Arg Cys Met Gly Thr Ile Gln His Leu Lys Ser
1025 1030 1035
Lys Phe Gly Asp Gly Tyr Ile Val Thr Met Lys Ile Lys Ser Pro
1040 1045 1050
Lys Asp Asp Leu Leu Pro Asp Leu Asn Pro Val Glu Gln Phe Phe
1055 1060 1065
Gln Gly Asn Phe Pro Gly Ser Val Gln Arg Glu Arg His Tyr Asn
1070 1075 1080
Met Leu Gln Phe Gln Val Ser Ser Ser Ser Leu Ala Arg Ile Phe
1085 1090 1095
Gln Leu Leu Leu Ser His Lys Asp Ser Leu Leu Ile Glu Glu Tyr
1100 1105 1110
Ser Val Thr Gln Thr Thr Leu Asp Gln Val Phe Val Asn Phe Ala
1115 1120 1125
Lys Gln Gln Thr Glu Ser His Asp Leu Pro Leu His Pro Arg Ala
1130 1135 1140
Ala Gly Ala Ser Arg Gln Ala Gln Asp
1145 1150
<210> 23
<211> 1259
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 23
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Pro Leu
35 40 45
Tyr Ser His His Glu Cys His Phe Pro Asn Lys Ala Met Pro Ser Ala
50 55 60
Gly Met Leu Pro Trp Leu Gln Gly Ile Phe Cys Asn Val Asn Asn Pro
65 70 75 80
Cys Phe Gln Ser Pro Thr Pro Gly Glu Ser Pro Gly Ile Val Ser Asn
85 90 95
Tyr Asn Asn Ser Ile Leu Ala Arg Val Tyr Arg Asp Phe Gln Glu Leu
100 105 110
Leu Met Asn Ala Pro Glu Ser Gln His Leu Gly Arg Ile Trp Thr Glu
115 120 125
Leu His Ile Leu Ser Gln Phe Met Asp Thr Leu Arg Thr His Pro Glu
130 135 140
Arg Ile Ala Gly Arg Gly Ile Arg Ile Arg Asp Ile Leu Lys Asp Glu
145 150 155 160
Glu Thr Leu Thr Leu Phe Leu Ile Lys Asn Ile Gly Leu Ser Asp Ser
165 170 175
Val Val Tyr Leu Leu Ile Asn Ser Gln Val Arg Pro Glu Gln Phe Ala
180 185 190
His Gly Val Pro Asp Leu Ala Leu Lys Asp Ile Ala Cys Ser Glu Ala
195 200 205
Leu Leu Glu Arg Phe Ile Ile Phe Ser Gln Arg Arg Gly Ala Lys Thr
210 215 220
Val Arg Tyr Ala Leu Cys Ser Leu Ser Gln Gly Thr Leu Gln Trp Ile
225 230 235 240
Glu Asp Thr Leu Tyr Ala Asn Val Asp Phe Phe Lys Leu Phe Arg Val
245 250 255
Leu Pro Thr Leu Leu Asp Ser Arg Ser Gln Gly Ile Asn Leu Arg Ser
260 265 270
Trp Gly Gly Ile Leu Ser Asp Met Ser Pro Arg Ile Gln Glu Phe Ile
275 280 285
His Arg Pro Ser Met Gln Asp Leu Leu Trp Val Thr Arg Pro Leu Met
290 295 300
Gln Asn Gly Gly Pro Glu Thr Phe Thr Lys Leu Met Gly Ile Leu Ser
305 310 315 320
Asp Leu Leu Cys Gly Tyr Pro Glu Gly Gly Gly Ser Arg Val Leu Ser
325 330 335
Phe Asn Trp Tyr Glu Asp Asn Asn Tyr Lys Ala Phe Leu Gly Ile Asp
340 345 350
Ser Thr Arg Lys Asp Pro Ile Tyr Ser Tyr Asp Arg Arg Thr Thr Ser
355 360 365
Phe Cys Asn Ala Leu Ile Gln Ser Leu Glu Ser Asn Pro Leu Thr Lys
370 375 380
Ile Ala Trp Arg Ala Ala Lys Pro Leu Leu Met Gly Lys Ile Leu Tyr
385 390 395 400
Thr Pro Asp Ser Pro Ala Ala Arg Arg Ile Leu Lys Asn Ala Asn Ser
405 410 415
Thr Phe Glu Glu Leu Glu His Val Arg Lys Leu Val Lys Ala Trp Glu
420 425 430
Glu Val Gly Pro Gln Ile Trp Tyr Phe Phe Asp Asn Ser Thr Gln Met
435 440 445
Asn Met Ile Arg Asp Thr Leu Gly Asn Pro Thr Val Lys Asp Phe Leu
450 455 460
Asn Arg Gln Leu Gly Glu Glu Gly Ile Thr Ala Glu Ala Ile Leu Asn
465 470 475 480
Phe Leu Tyr Lys Gly Pro Arg Glu Ser Gln Ala Asp Asp Met Ala Asn
485 490 495
Phe Asp Trp Arg Asp Ile Phe Asn Ile Thr Asp Arg Thr Leu Arg Leu
500 505 510
Val Asn Gln Tyr Leu Glu Cys Leu Val Leu Asp Lys Phe Glu Ser Tyr
515 520 525
Asn Asp Glu Thr Gln Leu Thr Gln Arg Ala Leu Ser Leu Leu Glu Glu
530 535 540
Asn Met Phe Trp Ala Gly Val Val Phe Pro Asp Met Tyr Pro Trp Thr
545 550 555 560
Ser Ser Leu Pro Pro His Val Lys Tyr Lys Ile Arg Met Asp Ile Asp
565 570 575
Val Val Glu Lys Thr Asn Lys Ile Lys Asp Arg Tyr Trp Asp Ser Gly
580 585 590
Pro Arg Ala Asp Pro Val Glu Asp Phe Arg Tyr Ile Trp Gly Gly Phe
595 600 605
Ala Tyr Leu Gln Asp Met Val Glu Gln Gly Ile Thr Arg Ser Gln Val
610 615 620
Gln Ala Glu Ala Pro Val Gly Ile Tyr Leu Gln Gln Met Pro Tyr Pro
625 630 635 640
Cys Phe Val Asp Asp Ser Phe Met Ile Ile Leu Asn Arg Cys Phe Pro
645 650 655
Ile Phe Met Val Leu Ala Trp Ile Tyr Ser Val Ser Met Thr Val Lys
660 665 670
Ser Ile Val Leu Glu Lys Glu Leu Arg Leu Lys Glu Thr Leu Lys Asn
675 680 685
Gln Gly Val Ser Asn Ala Val Ile Trp Cys Thr Trp Phe Leu Asp Ser
690 695 700
Phe Ser Ile Met Ser Met Ser Ile Phe Leu Leu Thr Ile Phe Ile Met
705 710 715 720
His Gly Arg Ile Leu His Tyr Ser Asp Pro Phe Ile Leu Phe Leu Phe
725 730 735
Leu Leu Ala Phe Ser Thr Ala Thr Ile Met Leu Cys Phe Leu Leu Ser
740 745 750
Thr Phe Phe Ser Lys Ala Ser Leu Ala Ala Ala Cys Ser Gly Val Ile
755 760 765
Tyr Phe Thr Leu Tyr Leu Pro His Ile Leu Cys Phe Ala Trp Gln Asp
770 775 780
Arg Met Thr Ala Glu Leu Lys Lys Ala Val Ser Leu Leu Ser Pro Val
785 790 795 800
Ala Phe Gly Phe Gly Thr Glu Tyr Leu Val Arg Phe Glu Glu Gln Gly
805 810 815
Leu Gly Leu Gln Trp Ser Asn Ile Gly Asn Ser Pro Thr Glu Gly Asp
820 825 830
Glu Phe Ser Phe Leu Leu Ser Met Gln Met Met Leu Leu Asp Ala Ala
835 840 845
Val Tyr Gly Leu Leu Ala Trp Tyr Leu Asp Gln Val Val Pro Gly Val
850 855 860
Cys Val Lys Asn Leu Val Lys Ile Phe Glu Pro Cys Gly Arg Pro Ala
865 870 875 880
Val Asp Arg Leu Asn Ile Thr Phe Tyr Glu Asn Gln Ile Thr Ala Phe
885 890 895
Leu Gly His Asn Gly Ala Gly Lys Thr Thr Thr Leu Ser Ile Leu Thr
900 905 910
Gly Leu Leu Pro Pro Thr Ser Gly Thr Val Leu Val Gly Gly Arg Asp
915 920 925
Ile Glu Thr Ser Leu Asp Ala Val Arg Gln Ser Leu Gly Met Cys Pro
930 935 940
Gln His Asn Ile Leu Phe His His Leu Thr Val Ala Glu His Met Leu
945 950 955 960
Phe Tyr Ala Gln Leu Lys Gly Lys Ser Gln Glu Glu Ala Gln Leu Glu
965 970 975
Met Glu Ala Met Leu Glu Asp Thr Gly Leu His His Lys Arg Asn Glu
980 985 990
Glu Ala Gln Asp Leu Ser Gly Gly Met Gln Arg Lys Leu Ser Val Ala
995 1000 1005
Ile Ala Phe Val Gly Asp Ala Lys Val Val Ile Leu Asp Glu Pro
1010 1015 1020
Thr Ser Gly Val Asp Pro Tyr Ser Arg Arg Ser Ile Trp Asp Leu
1025 1030 1035
Leu Leu Lys Tyr Arg Ser Gly Arg Thr Ile Ile Met Ser Thr His
1040 1045 1050
His Met Asp Glu Ala Asp Leu Leu Gly Asp Arg Ile Ala Ile Ile
1055 1060 1065
Ala Gln Gly Arg Leu Tyr Cys Ser Gly Thr Pro Leu Phe Leu Lys
1070 1075 1080
Asn Cys Phe Val Thr Asn Phe Leu Trp Asp Ile Met Asn Tyr Ser
1085 1090 1095
Val Ser Ala Gly Leu Val Val Gly Ile Phe Ile Gly Phe Gln Lys
1100 1105 1110
Lys Ala Tyr Thr Ser Pro Glu Asn Leu Pro Ala Leu Val Ala Leu
1115 1120 1125
Leu Leu Leu Tyr Gly Trp Ala Val Ile Pro Met Met Tyr Pro Ala
1130 1135 1140
Ser Phe Leu Phe Asp Val Pro Ser Thr Ala Tyr Val Ala Leu Ser
1145 1150 1155
Cys Ala Asn Leu Phe Ile Gly Ile Asn Ser Ser Ala Ile Thr Phe
1160 1165 1170
Ile Leu Glu Leu Phe Glu Asn Asn Arg Thr Leu Leu Arg Phe Asn
1175 1180 1185
Ala Val Leu Arg Lys Leu Leu Ile Val Phe Pro His Phe Cys Leu
1190 1195 1200
Gly Arg Gly Leu Ile Asp Leu Ala Leu Ser Gln Ala Val Thr Asp
1205 1210 1215
Val Tyr Ala Arg Phe Gly Glu Glu His Ser Ala Asn Pro Phe His
1220 1225 1230
Trp Asp Leu Ile Gly Lys Asn Leu Phe Ala Met Val Val Glu Gly
1235 1240 1245
Val Val Tyr Phe Leu Leu Thr Leu Leu Val Gln
1250 1255
<210> 24
<211> 1165
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成的多肽
<400> 24
Met Gly Phe Val Arg Gln Ile Gln Leu Leu Leu Trp Lys Asn Trp Thr
1 5 10 15
Leu Arg Lys Arg Gln Lys Ile Arg Phe Val Val Glu Leu Val Trp Pro
20 25 30
Leu Ser Leu Phe Leu Val Leu Ile Trp Leu Arg Asn Ala Asn Val Asp
35 40 45
Asp Ser Phe Met Ile Ile Leu Asn Arg Cys Phe Pro Ile Phe Met Val
50 55 60
Leu Ala Trp Ile Tyr Ser Val Ser Met Thr Val Lys Ser Ile Val Leu
65 70 75 80
Glu Lys Glu Leu Arg Leu Lys Glu Thr Leu Lys Asn Gln Gly Val Ser
85 90 95
Asn Ala Val Ile Trp Cys Thr Trp Phe Leu Asp Ser Phe Ser Ile Met
100 105 110
Ser Met Ser Ile Phe Leu Leu Thr Ile Phe Ile Met His Gly Arg Ile
115 120 125
Leu His Tyr Ser Asp Pro Phe Ile Leu Phe Leu Phe Leu Leu Ala Phe
130 135 140
Ser Thr Ala Thr Ile Met Leu Cys Phe Leu Leu Ser Thr Phe Phe Ser
145 150 155 160
Lys Ala Ser Leu Ala Ala Ala Cys Ser Gly Val Ile Tyr Phe Thr Leu
165 170 175
Tyr Leu Pro His Ile Leu Cys Phe Ala Trp Gln Asp Arg Met Thr Ala
180 185 190
Glu Leu Lys Lys Ala Val Ser Leu Leu Ser Pro Val Ala Phe Gly Phe
195 200 205
Gly Thr Glu Tyr Leu Val Arg Phe Glu Glu Gln Gly Leu Gly Leu Gln
210 215 220
Trp Ser Asn Ile Gly Asn Ser Pro Thr Glu Gly Asp Glu Phe Ser Phe
225 230 235 240
Leu Leu Ser Met Gln Met Met Leu Leu Asp Ala Ala Val Tyr Gly Leu
245 250 255
Leu Ala Trp Tyr Leu Asp Gln Val Phe Leu Ala Gln Ile Val Leu Pro
260 265 270
Ala Thr Phe Val Phe Leu Ala Leu Met Leu Ser Ile Val Ile Pro Pro
275 280 285
Phe Gly Glu Tyr Pro Ala Leu Thr Leu His Pro Trp Ile Tyr Gly Gln
290 295 300
Gln Tyr Thr Phe Phe Ser Met Asp Glu Pro Gly Ser Glu Gln Phe Thr
305 310 315 320
Val Leu Ala Asp Val Leu Leu Asn Lys Pro Gly Phe Gly Asn Arg Cys
325 330 335
Leu Lys Glu Gly Trp Leu Pro Glu Tyr Pro Cys Gly Asn Ser Thr Pro
340 345 350
Trp Lys Thr Pro Ser Val Ser Pro Asn Ile Thr Gln Leu Phe Gln Lys
355 360 365
Gln Lys Trp Thr Gln Val Asn Pro Ser Pro Ser Cys Arg Cys Ser Thr
370 375 380
Arg Glu Lys Leu Thr Met Leu Pro Glu Cys Pro Glu Gly Ala Gly Gly
385 390 395 400
Leu Pro Pro Pro Gln Arg Thr Gln Arg Ser Thr Glu Ile Leu Gln Asp
405 410 415
Leu Thr Asp Arg Asn Ile Ser Asp Phe Leu Val Lys Thr Tyr Pro Ala
420 425 430
Leu Ile Arg Ser Ser Leu Lys Ser Lys Phe Trp Val Asn Glu Gln Arg
435 440 445
Tyr Gly Gly Ile Ser Ile Gly Gly Lys Leu Pro Val Val Pro Ile Thr
450 455 460
Gly Glu Ala Leu Val Gly Phe Leu Ser Asp Leu Gly Arg Ile Met Asn
465 470 475 480
Val Ser Gly Gly Pro Ile Thr Arg Glu Ala Ser Lys Glu Ile Pro Asp
485 490 495
Phe Leu Lys His Leu Glu Thr Glu Asp Asn Ile Lys Val Trp Phe Asn
500 505 510
Asn Lys Gly Trp His Ala Leu Val Ser Phe Leu Asn Val Ala His Asn
515 520 525
Ala Ile Leu Arg Ala Ser Leu Pro Lys Asp Arg Ser Pro Glu Glu Tyr
530 535 540
Gly Ile Thr Val Ile Ser Gln Pro Leu Asn Leu Thr Lys Glu Gln Leu
545 550 555 560
Ser Glu Ile Thr Val Leu Thr Thr Ser Val Asp Ala Val Val Ala Ile
565 570 575
Cys Val Ile Phe Ser Met Ser Phe Val Pro Ala Ser Phe Val Leu Tyr
580 585 590
Leu Ile Gln Glu Arg Val Asn Lys Ser Lys His Leu Gln Phe Ile Ser
595 600 605
Gly Val Ser Pro Thr Thr Tyr Trp Val Thr Asn Phe Leu Trp Asp Ile
610 615 620
Met Asn Tyr Ser Val Ser Ala Gly Leu Val Val Gly Ile Phe Ile Gly
625 630 635 640
Phe Gln Lys Lys Ala Tyr Thr Ser Pro Glu Asn Leu Pro Ala Leu Val
645 650 655
Ala Leu Leu Leu Leu Tyr Gly Trp Ala Val Ile Pro Met Met Tyr Pro
660 665 670
Ala Ser Phe Leu Phe Asp Val Pro Ser Thr Ala Tyr Val Ala Leu Ser
675 680 685
Cys Ala Asn Leu Phe Ile Gly Ile Asn Ser Ser Ala Ile Thr Phe Ile
690 695 700
Leu Glu Leu Phe Glu Asn Asn Arg Thr Leu Leu Arg Phe Asn Ala Val
705 710 715 720
Leu Arg Lys Leu Leu Ile Val Phe Pro His Phe Cys Leu Gly Arg Gly
725 730 735
Leu Ile Asp Leu Ala Leu Ser Gln Ala Val Thr Asp Val Tyr Ala Arg
740 745 750
Phe Gly Glu Glu His Ser Ala Asn Pro Phe His Trp Asp Leu Ile Gly
755 760 765
Lys Asn Leu Phe Ala Met Val Val Glu Gly Val Val Tyr Phe Leu Leu
770 775 780
Thr Leu Leu Val Gln Arg His Phe Phe Leu Ser Gln Trp Ile Ala Glu
785 790 795 800
Pro Thr Lys Glu Pro Ile Val Asp Glu Asp Asp Asp Val Ala Glu Glu
805 810 815
Arg Gln Arg Ile Ile Thr Gly Gly Asn Lys Thr Asp Ile Leu Arg Leu
820 825 830
His Glu Leu Thr Lys Ile Tyr Pro Gly Thr Ser Ser Pro Ala Val Asp
835 840 845
Arg Leu Cys Val Gly Val Arg Pro Gly Glu Cys Phe Gly Leu Leu Gly
850 855 860
Val Asn Gly Ala Gly Lys Thr Thr Thr Phe Lys Met Leu Thr Gly Asp
865 870 875 880
Thr Thr Val Thr Ser Gly Asp Ala Thr Val Ala Gly Lys Ser Ile Leu
885 890 895
Thr Asn Ile Ser Glu Val His Gln Asn Met Gly Tyr Cys Pro Gln Phe
900 905 910
Asp Ala Ile Asp Glu Leu Leu Thr Gly Arg Glu His Leu Tyr Leu Tyr
915 920 925
Ala Arg Leu Arg Gly Val Pro Ala Glu Glu Ile Glu Lys Val Ala Asn
930 935 940
Trp Ser Ile Lys Ser Leu Gly Leu Thr Val Tyr Ala Asp Cys Leu Ala
945 950 955 960
Gly Thr Tyr Ser Gly Gly Asn Lys Arg Lys Leu Ser Thr Ala Ile Ala
965 970 975
Leu Ile Gly Cys Pro Pro Leu Val Leu Leu Asp Glu Pro Thr Thr Gly
980 985 990
Met Asp Pro Gln Ala Arg Arg Met Leu Trp Asn Val Ile Val Ser Ile
995 1000 1005
Ile Arg Glu Gly Arg Ala Val Val Leu Thr Ser His Ser Met Glu
1010 1015 1020
Glu Cys Glu Ala Leu Cys Thr Arg Leu Ala Ile Met Val Lys Gly
1025 1030 1035
Ala Phe Arg Cys Met Gly Thr Ile Gln His Leu Lys Ser Lys Phe
1040 1045 1050
Gly Asp Gly Tyr Ile Val Thr Met Lys Ile Lys Ser Pro Lys Asp
1055 1060 1065
Asp Leu Leu Pro Asp Leu Asn Pro Val Glu Gln Phe Phe Gln Gly
1070 1075 1080
Asn Phe Pro Gly Ser Val Gln Arg Glu Arg His Tyr Asn Met Leu
1085 1090 1095
Gln Phe Gln Val Ser Ser Ser Ser Leu Ala Arg Ile Phe Gln Leu
1100 1105 1110
Leu Leu Ser His Lys Asp Ser Leu Leu Ile Glu Glu Tyr Ser Val
1115 1120 1125
Thr Gln Thr Thr Leu Asp Gln Val Phe Val Asn Phe Ala Lys Gln
1130 1135 1140
Gln Thr Glu Ser His Asp Leu Pro Leu His Pro Arg Ala Ala Gly
1145 1150 1155
Ala Ser Arg Gln Ala Gln Asp
1160 1165

Claims (31)

1.一种分离的核酸,其包含编码具有SEQ ID NO:3-8和15-19任一所示序列的ABCA4小基因的转基因。
2.根据权利要求1所述的分离的核酸,其中所述转基因还包含与ABCA4小基因序列有效连接的启动子。
3.根据权利要求2所述的分离的核酸,其中所述启动子是组成型启动子、诱导型启动子或组织特异性启动子,任选地,其中所述组织特异性启动子是光感受器特异性启动子。
4.根据权利要求1至3任一项所述的分离的核酸,其中所述转基因的侧翼是腺相关病毒(AAV)反向末端重复序列(ITR)。
5.根据权利要求4所述的分离的核酸,其中至少一个ITR是AAV2ITR。
6.根据权利要求4或5所述的分离的核酸,其中至少一个ITR缺少末端解离位点,任选地,其中所述ITR是ΔITR。
7.一种分离的核酸,其包含具有编码ABCA4蛋白的核酸序列的转基因,其中所述ABCA4蛋白包含SEQ ID NO:9-14和20-24任一所示的氨基酸序列。
8.根据权利要求7所述的分离的核酸,其中所述转基因还包含与编码ABCA4蛋白的核酸序列有效连接的启动子。
9.根据权利要求8所述的分离的核酸,其中所述启动子是组成型启动子、诱导型启动子或组织特异性启动子,任选地,其中所述组织特异性启动子是光感受器特异性启动子。
10.根据权利要求7至9任一项所述的分离的核酸,其中所述转基因的侧翼是腺相关病毒(AAV)反向末端重复序列(ITR)。
11.根据权利要求10所述的分离的核酸,其中至少一个ITR是AAV2ITR。
12.根据权利要求10或11所述的分离的核酸,其中至少一个ITR缺少末端解离位点,任选地,其中所述ITR是ΔITR。
13.一种载体,其包含权利要求1至12任一项所述的分离的核酸。
14.根据权利要求13所述的载体,其中所述载体为质粒DNA、封闭端DNA、脂质/DNA纳米颗粒或病毒载体。
15.根据权利要求14所述的载体,其中所述病毒载体为腺相关病毒(AAV)载体、腺病毒(Ad)载体、慢病毒载体、逆转录病毒载体或杆状病毒载体。
16.一种宿主细胞,其包含权利要求1至12任一项所述的分离的核酸或权利要求13至15任一项所述的载体。
17.根据权利要求16所述的宿主细胞,其中所述细胞是哺乳动物(人)细胞、细菌细胞、酵母细胞或昆虫细胞。
18.一种重组腺相关病毒(rAAV),其包含:
(i)权利要求1至12任一项所述的分离的核酸;和
(ii)AAV衣壳蛋白。
19.根据权利要求18所述的rAAV,其中所述衣壳蛋白对眼细胞具有向性。
20.根据权利要求18或19所述的rAAV,其中所述衣壳蛋白是AAV8衣壳蛋白。
21.根据权利要求18至20任一项所述的rAAV,其中所述rAAV被配制用于递送至眼睛,任选地,其中所述rAAV被配制用于递送至感光细胞或视网膜色素上皮(RPE)。
22.一种组合物,其包含权利要求1至12任一项所述的分离的核酸或权利要求18至21任一项所述的rAAV,以及药学上可接受的赋形剂。
23.一种将转基因递送至细胞的方法,该方法包括向细胞施用权利要求1至12任一项所述的分离的核酸或权利要求18至21任一项所述的rAAV。
24.根据权利要求23所述的方法,其中所述细胞在受试者中,任选地,在哺乳动物(人)受试者中。
25.根据权利要求23或24所述的方法,其中所述细胞是眼细胞。
26.根据权利要求25所述的方法,其中所述眼细胞是感光细胞或视网膜色素上皮(RPE)。
27.一种治疗有需要的受试者的眼底黄色斑点症的方法,该方法包括向受试者施用权利要求1至12任一项所述的分离的核酸或权利要求18至21任一项所述的rAAV。
28.根据权利要求27所述的方法,其中所述受试者是哺乳动物,任选地,其中所述受试者是人。
29.根据权利要求27或28所述的方法,其中所述受试者的特征在于在ABCA4基因中具有一个或多个突变。
30.根据权利要求27至29任一项所述的方法,其中所述施用经由注射进行,任选地,经视网膜下注射或玻璃体内注射或脉络膜上注射。
31.根据权利要求27至29任一项所述的方法,其中所述施用是向受试者眼睛的局部施用。
CN202080044221.2A 2019-04-19 2020-04-16 眼底黄色斑点症(abca4)的基因疗法 Pending CN114126665A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962836493P 2019-04-19 2019-04-19
US62/836,493 2019-04-19
PCT/US2020/028504 WO2020214809A2 (en) 2019-04-19 2020-04-16 Gene therapies for stargardt disease (abca4)

Publications (1)

Publication Number Publication Date
CN114126665A true CN114126665A (zh) 2022-03-01

Family

ID=72838359

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080044221.2A Pending CN114126665A (zh) 2019-04-19 2020-04-16 眼底黄色斑点症(abca4)的基因疗法

Country Status (7)

Country Link
US (1) US20220177539A1 (zh)
EP (1) EP3955973A4 (zh)
JP (1) JP2022529782A (zh)
CN (1) CN114126665A (zh)
AU (1) AU2020257392A1 (zh)
CA (1) CA3137135A1 (zh)
WO (1) WO2020214809A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115074369A (zh) * 2022-06-24 2022-09-20 成都金唯科生物科技有限公司 表达全长abca4基因的腺相关病毒载体及应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202124722A (zh) 2019-09-18 2021-07-01 美商英特佳樂帝克醫療公司 合成dna載體及其使用方法
JP2023535632A (ja) 2020-07-27 2023-08-18 アンジャリウム バイオサイエンシズ エージー Dna分子の組成物、その作製方法、及びその使用方法
CA3205822A1 (en) * 2021-01-22 2022-07-28 Marcelo M. NOCIARI Compositions and methods for the identification of compounds that protect against lipofuscin cytotoxicity
CA3211687A1 (en) * 2021-03-19 2022-09-22 Ozan ALKAN Non-viral dna vectors and uses thereof for expressing pfic therapeutics
EP4330409A1 (en) * 2021-04-26 2024-03-06 University of Massachusetts Gene therapies for stargardt disease (abca4)
CA3218195A1 (en) * 2021-05-07 2022-11-10 Robin Ali Abca4 genome editing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070042462A1 (en) * 2005-08-21 2007-02-22 Markus Hildinger Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
US20150259395A1 (en) * 2014-03-17 2015-09-17 Avalanche Biotechnologies, Inc. Compositions and methods for enhanced gene expression in cone cells
WO2018109011A1 (en) * 2016-12-13 2018-06-21 Stichting Katholieke Universiteit Antisense oligonucleotides for the treatment of stargardt disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110172107A1 (en) * 2008-04-30 2011-07-14 Fox Chase Cancer Center Assay for identifying agents that modulate epigenetic silencing, and agents identified thereby

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070042462A1 (en) * 2005-08-21 2007-02-22 Markus Hildinger Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
US20150259395A1 (en) * 2014-03-17 2015-09-17 Avalanche Biotechnologies, Inc. Compositions and methods for enhanced gene expression in cone cells
CN106414474A (zh) * 2014-03-17 2017-02-15 阿德夫拉姆生物技术股份有限公司 用于视锥细胞中增强的基因表达的组合物和方法
WO2018109011A1 (en) * 2016-12-13 2018-06-21 Stichting Katholieke Universiteit Antisense oligonucleotides for the treatment of stargardt disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115074369A (zh) * 2022-06-24 2022-09-20 成都金唯科生物科技有限公司 表达全长abca4基因的腺相关病毒载体及应用
CN115074369B (zh) * 2022-06-24 2023-10-20 成都金唯科生物科技有限公司 表达全长abca4基因的腺相关病毒载体及应用

Also Published As

Publication number Publication date
EP3955973A2 (en) 2022-02-23
WO2020214809A2 (en) 2020-10-22
WO2020214809A3 (en) 2020-11-19
CA3137135A1 (en) 2020-10-22
US20220177539A1 (en) 2022-06-09
JP2022529782A (ja) 2022-06-24
AU2020257392A1 (en) 2021-11-18
EP3955973A4 (en) 2023-01-18

Similar Documents

Publication Publication Date Title
CN114126665A (zh) 眼底黄色斑点症(abca4)的基因疗法
JP6827320B2 (ja) LCA−8及び進行性RPを治療するための組換えAAV−Crumbsホモログ組成物及び方法
CN110709095B (zh) 小基因治疗
JP7303816B2 (ja) Aavベクター
CN114402075A (zh) 乌谢尔综合征(ush2a)的基因疗法
CN111936172A (zh) 用于治疗视网膜病症的组合物和方法
CN114206353A (zh) 小基因疗法
KR20210132109A (ko) Dna-결합 도메인 전사활성화제 및 이의 용도
WO2022066849A1 (en) Aav vectors encoding nf1 and uses thereof
WO2022056440A1 (en) Dual-aav vector delivery of pcdh15 and uses thereof
CN117916382A (zh) 眼底黄色斑点症(abca4)的基因疗法
JP2024515974A (ja) シュタルガルト病(abca4)の遺伝子治療
RU2793112C2 (ru) Векторы aav
TW202221119A (zh) Dna結合域轉活化子及其用途
KR20240005950A (ko) 벡터 시스템
JP2023513211A (ja) タンパク質合成を増強するためのCRISPR-Cas13による標的RNA翻訳
CN117836420A (zh) 重组tert编码病毒基因组和运载体

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination